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ABSTRACT 
The vaginal microbiome plays an important role in women’s reproductive health. 
Imbalances in this microbiota are associated with bacterial vaginosis, increased susceptibility to 
sexually transmitted infections, and negative reproductive outcomes. The causes of such 
variations, however, are poorly understood. A healthy vaginal microbiota is defined as 
Lactobacillus-dominated and an overgrowth of other species is often associated with unhealthy 
conditions. An appreciation of “atypical” microbiomes in healthy women, such as 
Bifidobacterium-dominated, has been gradually increasing. Although bifidobacteria play an 
important role in gut health, vaginal bifidobacteria have not yet been fully characterized.  
In this study, a baseline description of the “healthy” vaginal microbiome in pregnancy has 
been established based on cpn60 gene amplicon sequencing. The vaginal microbiota of pregnant 
women relative to non-pregnant women had lower richness and diversity, higher Lactobacillus 
abundance and lower Mollicutes/Ureaplasma prevalence. This gives a better understanding of the 
vaginal microbiome in healthy pregnancies and provides a control group for a subsequent 
comparison to women who experienced preterm birth. An association between Mollicutes and 
preterm was confirmed, and further suggested that a more rich and diverse microbiome is 
associated with prematurity. To better understand the relationship between reproductive outcomes 
and microbiota, an improved definition of the healthy microbiome is also needed, which should 
include evaluation of “atypical” microbiomes, such as Bifidobacterium-dominated. Phenotypic 
characterization of vaginal bifidobacteria indicated that they have health promoting characteristics 
similar to beneficial vaginal lactobacilli. Considering the importance of bifidobacteria as one of 
the primary colonizers of the neonatal gut, the genomes of vaginal and gut isolates of 
Bifidobacterium breve and Bifidobacterium longum were compared. Results indicated that vaginal 
and gut microbiomes are colonized by a shared community of Bifidobacterium, which may be 
transferred from mother to infant.  
Taken together, the results presented in this thesis provide a better understanding of the 
vaginal microbiome of pregnant women with low and high risk for preterm birth. It also improves 
the understanding of a healthy microbiome by phenotypically characterizing vaginal 
bifidobacteria, and contributes to elucidate aspects of bifidobacteria ecology by comparing the 
genomes of vaginal and gut bifidobacteria.  
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CHAPTER 1. Introduction and literature review 
 
1.1. Introduction 
The human body is estimated to contain as many bacterial cells as human cells, which 
represents a magnitude of 1013 bacteria (Sender et al., 2016). These bacteria live on external and 
internal surfaces including the gastrointestinal tract, vagina, breast, skin, and oral cavity. These 
microbial communities have the potential to impact human health by influencing processes related 
to development, nutrition, immunity, and resistance to pathogens (Bäckhed et al., 2004; Cho and 
Blaser, 2012; Maslowski and Mackay, 2011; Hooper and Gordon, 2001; Li et al., 2012). 
In the lower genital tract, the complex bacterial community that resides in the human vagina 
is referred to as the vaginal microbiome, which has a significant role in women’s reproductive 
health and neonatal health. Imbalances in this microbiota, also referred to as “dysbiosis”, may lead 
to several negative conditions like bacterial vaginosis (BV), increased susceptibility to pelvic 
inflammatory disease (Ness et al., 2004; Peipert et al., 1997), and increased transmission of 
sexually transmitted pathogens like Chlamydia trachomatis, Neisseria gonorrhoeae and HIV 
(Wiesenfeld et al., 2003; Borgdorff et al., 2014; Buvé et al., 2014). 
The current definition of a healthy vaginal microbiota in reproductive aged women is to be 
colonized by Lactobacillus spp.. Known mechanisms by which lactobacilli affect pathogen growth 
include adherence to mucus, developing a barrier that prevents pathogen colonization, and 
production of antimicrobial compounds such as lactic acid, hydrogen peroxide, bacteriocins, and 
biosurfactants (Boris and Barbés, 2000). Production of lactic acid is thought to be the hallmark 
characteristic of lactobacilli for maintaining vaginal microbiome homeostasis (O’Hanlon et al., 
2013; Conti et al., 2009; Juárez Tomás et al., 2003; Aldunate et al., 2013; Boskey et al., 1999, 
2001). 
Bacterial vaginosis is the most common gynaecological condition in reproductive aged 
women worldwide and is characterized by a shift from healthy lactobacilli to a polymicrobial, 
anaerobic overgrowth of several species including Gardnerella vaginalis, Bacteroides spp., and 
Mobiluncus spp., (Sobel, 2000; Oakley et al., 2008; Hillier, 1993). The current gold standard 
method for diagnosis of BV is the Nugent score (Nugent et al., 1991), which is based on a scoring 
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system that reflects the relative abundance of bacterial cell morphotypes in Gram-stained vaginal 
smears. Although quick and inexpensive, the Nugent score does not provide reliable identification 
and quantification of bacteria at the species level. 
In pregnancy, microbiome dysbiosis and BV have been associated with several negative 
reproductive outcomes of which preterm birth is the most common (Leitich et al., 2003; Meis et 
al., 1995). Nevertheless, no single bacterium or group of bacteria have yet been causally linked to 
prematurity, which emphasizes the complex multifactorial nature of this condition. In addition, 
understanding of the causes of microbiome imbalances in either pregnant or non-pregnant women 
is limited and the mechanisms underlying changes in the composition of the vaginal microbiota 
remain poorly characterized, which highlights the need for better methods to investigate the 
vaginal microbial community in health and “disease”. 
The development of culture-independent methods has facilitated comprehension of the 
composition of vaginal microbial communities. As a result of application of DNA sequence based 
methods, there is a growing appreciation of "atypical" (i.e. non-Lactobacillus dominated) 
microbiomes in healthy women, such as those dominated by Bifidobacterium spp. (Hyman et al., 
2005; Albert et al., 2015; Shipitsyna et al., 2013; Ravel et al., 2013). Based on the simplistic 
definition of healthy vaginal microbiome (Lactobacillus-dominated), those Bifidobacterium-
dominated microbiomes are often grouped with microbial profiles that are recognisably 
unhealthy/disturbed, which might misrepresent their importance in also promoting a healthy 
vaginal microbiome. 
Bifidobacteria have been extensively studied due to their health promoting characteristics 
in the gastro-intestinal tract, such as immune modulation (Fanning et al., 2012; Hart et al., 2004), 
production of bacteriocins (Martinez et al., 2013), improved gut metabolism (Sugahara et al., 
2015), and inhibition of pathogens (Bernet et al., 1993; Arboleya et al., 2011; Fukuda et al., 2011). 
In newborns, bifidobacteria play an important role as one of the primary colonizers of the 
gastrointestinal tract (Arrieta et al., 2014) and have critical implications for early healthy immune 
and metabolic maturation (Rautava et al., 2012). Although bifidobacteria play an important role in 
gut health, their contribution to promoting a healthy vaginal microbiome has not yet been 
investigated. It is also unclear if vaginal bifidobacteria are an adapted subpopulation or if they are 
ubiquitous bacteria that can colonize both the gut and the vagina.  
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Moreover, bifidobacteria are likely vertically transmitted from mother to infant as several 
studies have demonstrated the influence of maternal microbiotas (vagina, gut, and breast milk) on 
the neonatal gut microbiome (Matamoros et al., 2013; Bäckhed et al., 2015; Makino et al., 2013; 
Dominguez-Bello et al., 2010; Gabriel et al., 2017; Gomez-Gallego et al., 2016; Hunt et al., 2011; 
Milani et al., 2015; Duranti et al., 2017; Pannaraj et al., 2017). The overlapping occurrence of 
bifidobacteria species, among other microorganisms, in different body sites is one of the challenges 
in studying vertical transmission, and the specific contribution of each microbial community in 
mother-to-infant bifidobacteria transmission remains in discussion. Research investigations of 
vaginal and gut bifidobacteria using high-resolution methods (e.g. genome sequence comparison) 
might help to elucidate some aspects of bifidobacteria ecology and indirectly illuminate aspects of 
mother-infant bifidobacteria transmission, an important event for neonatal gut microbiota 
development.  
 
1.2. The vaginal microbiome 
The healthy microbiota 
The human vaginal microbiome is a complex bacterial community that has an important 
role in women’s reproductive health. Imbalances in this microbiota may lead to increased 
susceptibility to sexually transmitted diseases, bacterial vaginosis (BV), and negative reproductive 
outcomes. Currently, a healthy vaginal microbiota in reproductive age women is defined as being 
colonized by Lactobacillus spp., with the most commonly detected species being L. crispatus, L. 
gasseri, L. jensenii and L. iners (Ravel et al., 2011). Lactobacilli can inhibit pathogens and 
contribute to microbiome homeostasis by forming a barrier on the vaginal epithelium through self-
aggregation and adherence to mucus and epithelial cells. They can also compete with other bacteria 
for adherence and block their attachment to epithelial cells (Boris et al., 1998; Osset et al., 2001; 
Phukan et al., 2013; Atassi et al., 2006).  
Lactobacilli also produce several metabolites that interfere with pathogens, such as lactic 
acid, hydrogen peroxide, bacteriocins and biosurfactants. Lactic acid is present in high 
concentrations (~56-111 mM) in the healthy vagina and is considered a hallmark characteristic of 
the protective lactobacilli due its microbicidal and virucidal effects (O’Hanlon et al., 2013; Conti 
et al., 2009; Juárez Tomás et al., 2003; Aldunate et al., 2013). Lactic acid is mainly responsible for 
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lowering the vaginal pH to ~3.5-4.5 and this acidic condition has been shown to reduce viability 
of several urogenital pathogens (Boskey et al., 1999, 2001; O’Hanlon et al., 2013). Other 
microbicidal mechanisms of lactic acid include disruption of the outer membrane of Gram-
negative bacteria (Alakomi et al., 2000) and inhibition of viral replication and intracellular antigen 
synthesis (Conti et al., 2009).  
Bacteria, including lactobacilli, are the primary source of lactic acid in the vagina, with 
some species being able to produce both lactic acid enantiomers (D and L), as opposed to human 
cells that only make the L form (Boskey et al., 2001). Although both forms of lactic acid have been 
shown to be microbicidal at physiological concentrations, L-lactic acid has been reported as having 
greater microbicidal and virucidal activity than D-lactic acid, which suggests that the effect of 
lactic acid involves more than acidity alone (Fayol-Messaoudi et al., 2005; Aldunate et al., 2013; 
Leitch and Stewart, 2002). 
For decades hydrogen peroxide has been claimed to inhibit growth of opportunistic bacteria 
that do not have defensive mechanisms like production of catalase or peroxidases (Eschenbach et 
al., 1989; Strus et al., 2006; Klebanoff et al., 1991). Recent studies, however, have suggested that 
the level of hydrogen peroxide in vivo is much lower than the necessary concentration to be 
microbicidal (O’Hanlon et al., 2011). It has also been demonstrated that hydrogen peroxide at high 
concentrations is equally toxic to pathogens and lactobacilli, and that cervicovaginal fluid and 
semen inactivate the microbicidal activity of hydrogen peroxide produced by lactobacilli 
(O’Hanlon et al., 2010). Taken together, these recent findings challenge the claimed protective 
role of hydrogen peroxide and should be taken into account to better define the critical 
characteristics of health-promoting lactobacilli.  
Bacteriocins and bacteriocin-like substances are antimicrobial peptides produced by certain 
bacteria to inhibit the growth of other bacteria. Bacteriocins secreted by vaginal lactobacilli have 
been reported to be active against several genital pathogens (Sabia et al., 2014; Stoyancheva et al., 
2014; Ruíz et al., 2012). Lactobacilli also produce biosurfactants: substances composed of proteins 
and polysaccharides that reduce surface tension. In the vaginal environment, biosurfactants are 
thought to interfere with bacteria adhesion and subsequent biofilm formation (Satpute et al., 2016; 
Walencka et al., 2008). 
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Shifts in vaginal microbial composition occur naturally throughout a woman's life, mostly 
driven by hormonal changes. The sex steroid hormone estrogen stimulates the deposition of 
glycogen and the thickening of the vaginal epithelium, a stratified, squamous non-keratinized layer 
(Cruickshank and Sharman, 1934; BMJ, 1943). Glycogen is the main carbohydrate utilized by 
Lactobacillus for the production of lactic acid, which contributes to the protective effect of a low 
vaginal pH (Mirmonsef et al., 2014; Cruickshank, 1934; Boskey et al., 1999). At birth, newborn 
females have a stratified squamous vaginal epithelium resembling the adult epithelium due to 
maternal estrogen exposure. In childhood, the vaginal epithelium is thin and pH is near neutral due 
to the lack of glycogen. In this period, the vaginal microbiota is comprised of microorganisms 
similar to those found in the skin and gut microbiota like Staphylococcus and Enterococcus 
(Csángó, 1982; Gregoire et al., 1971; Cruickshank and Sharman, 1934). As estrogen levels rise 
during puberty, increasing amounts of glycogen are deposited in the vaginal epithelium. This 
acidic, glycogen rich, lactobacilli-dominated environment theoretically persists throughout a 
woman’s reproductive years. Since estrogen is directly related to glycogen levels in the vaginal 
epithelium, it has been hypothesized that the vaginal microbiota changes through a woman’s 
menstrual cycle in response to fluctuations in estrogen levels. Culture-based studies have led to 
variable conclusions, with some studies reporting no changes in the microbiota throughout the 
menstrual cycle (Wilks and Tabaqchali, 1987), and others describing a greater proportion of non-
Lactobacillus species during menses (Eschenbach et al., 2000). Recent culture-independent studies 
have demonstrated that although shifts in the vaginal microbiota are relatively common, those 
changes are unlikely to be associated with menstrual phases (Chaban et al., 2014; Hickey et al., 
2013). After menopause, the decrease in estrogen is accompanied by a decline in glycogen in the 
vaginal epithelium, which results in changes in the epithelial structure and a decline in lactobacilli 
(Cruickshank and Sharman, 1934). 
 
The vaginal microbiome in dysbiosis 
Shifts in the vaginal microbial composition are expected to occur due to aging, but changes 
in the vaginal microbiota during the reproductive years are also common. Understanding the 
causes of such variations, however, is limited and the mechanisms underlying changes in the 
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the vaginal microbiome, or dysbiosis, may lead to negative conditions including bacterial 
vaginosis (BV), which is the most common gynaecological condition in reproductive aged women 
worldwide (Sobel, 1997; Koumans et al., 2007; Kenyon et al., 2013). BV is currently characterized 
by a relatively low abundance of Lactobacillus spp. accompanied by polymicrobial anaerobic 
overgrowth, including species such as Gardnerella vaginalis, Prevotella spp., Bacteroides spp., 
Mobiluncus spp., and Mycoplasma hominis (Sobel, 2000; Oakley et al., 2008; Hillier, 1993). 
Typical signs of inflammation such as redness, swelling and pain are absent in BV, but a pro-
inflammatory response might occur as a result of BV-associated bacteria colonization (Mitchell 
and Marrazzo, 2014). 
Bacterial vaginosis has been historically reported as ‘nonspecific vaginitis’ to describe 
cases in which vaginitis-like symptoms were not attributable to the known etiologic agents 
Trichomonas vaginalis or Candida albicans (Hill, 1993). In 1955, Gardner and Dukes proposed 
that a new isolated rod named Haemophilus vaginalis (currently known as Gardnerella vaginalis) 
was the aetiologic agent of ‘nonspecific vaginitis’, which was then replaced by the term 
‘Haemophilus vaginalis vaginitis’ (Gardner and Dukes, 1955). Later, the idea that Gardnerella 
vaginalis was the sole agent of nonspecific vaginitis was criticized and the condition was 
recognized as multifactorial since other anaerobic bacteria are often associated with microbiome 
dysbiosis, and G. vaginalis is also detected in asymptomatic women with “healthy” microbiotas 
(Spiegel et al., 1980; Amsel et al., 1983). In the 1980’s, the term ‘bacterial vaginosis’ was gradually 
implemented to better reflect the bacterial diversity of the condition, and to avoid the misleading 
suggestion that BV causes inflammation (as opposed to vaginitis), which is absent during vaginal 
dysbiosis (Holmes et al., 1981; Easmon et al., 1992).  
Although BV does not have a specific etiologic agent, G. vaginalis is still considered a 
hallmark bacterium involved in this condition. G. vaginalis was first isolated by Leopold in 1953 
and described as a small, Gram-negative, non-motile, non-capsulated, pleomorphic rod-shaped 
bacterium. In 1955, Gardner & Dukes isolated the same organism from women with non-specific 
vaginitis (today known as BV) and named it ‘Haemophilus vaginalis’. Later, Zinnemann & Turner 
(1963) recommended the reclassification of H. vaginalis to the genus Corynebacterium based on 
morphological parameters, and they renamed the organism as Corynebacterium vaginale. In 1980, 
Greenwood & Pickett used DNA-DNA hybridization, biochemical and cell wall analysis and 
electron microscopy to show that H. vaginalis, or C. vaginale, did not belong to the genus 
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Haemophilus. They created the genus Gardnerella and renamed the organism after Hermann L. 
Gardner: Gardnerella vaginalis. In the same year, Piot and colleagues confirmed their study and 
supported the name G. vaginalis, which has been used since then (Piot et al., 1980). 
Phenotypic characteristics typically used for bacterial identification vary significantly 
among G. vaginalis strains; overall, they present beta-hemolysis on human blood agar, negative 
catalase reaction, positive hippurate hydrolysis and starch hydrolysis (Piot et al., 1982). G. 
vaginalis also have virulence factors that are thought to contribute to microbiome imbalances, 
including adherence to epithelial cells, biofilm production (Patterson et al., 2010), cytolysin 
activity (Cauci et al., 1993), and sialidase activity (Hardy et al., 2017). A genotyping method based 
on amplified ribosomal DNA restriction analysis (ARDRA) has been proposed to better identify 
biotypes of G. vaginalis that might share similar characteristics (Ingianni et al., 1997), but 
inconsistent reports failed to correlate biotype groups with specific phenotypes (Paramel 
Jayaprakash et al., 2012; Lopes dos Santos Santiago et al., 2011; Pleckaityte et al., 2012). More 
recently, four distinct subgroups of G. vaginalis (A, B, C and D) have been proposed based on 
their cpn60 sequences. These subgroups are supported by whole genome sequence data and have 
been shown to correlate with sialidase activity, which might have implications in their role in BV 
(Paramel Jayaprakash et al., 2012; Schellenberg et al., 2016). 
A mounting body of evidence has demonstrated that vaginal microbiome dysbiosis or BV 
is strongly associated with several negative conditions including increased susceptibility to pelvic 
inflammatory disease (Ness et al., 2004; Peipert et al., 1997), and increased transmission of several 
sexually transmitted pathogens including Chlamydia trachomatis, Neisseria gonorrhoeae, 
Trichomonas vaginalis, human immunodeficiency virus (HIV) and herpes simplex virus type 2 
(Allsworth and Peipert, 2011; Borgdorff et al., 2014; Brotman, 2011; Gallo et al., 2012; Martin et 
al., 1999; Taha et al., 1998; Wiesenfeld et al., 2003; Buvé et al., 2014; Bautista et al., 2016; Ziklo 
et al., 2016; Cherpes et al., 2003). 
The causes of BV/dysbiosis are not fully understood, but host and environmental factors 
are thought to play important roles in influencing the composition of microbial communities. 
Smoking (Ryckman et al., 2009; Brotman et al., 2014a), intercourse, douching, some sexual 
practices (Cherpes et al., 2008) and use of feminine hygiene products (Fashemi et al., 2013) are 
often associated with a decrease in vaginal lactobacilli and a shift toward an imbalanced 
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microbiome. Moreover, reports showing varying incidence of microbiome dysbiosis among 
women of different ethnicities suggest host factors also play a role in shaping the microbiota. 
Overall, there is lower incidence of vaginal communities dominated by Lactobacillus in black 
women than in Caucasian women (Zhou et al., 2007; Ravel et al., 2011). Hispanic and black 
women are also more likely to have higher vaginal pH compared to Asian and white women, which 
reflects the higher prevalence of communities not dominated by Lactobacillus spp. (Ravel et al., 
2011). These differences cannot be explained by external factors like personal hygiene and sexual 
behaviours alone (Goldenberg et al., 1996), which emphasizes the role of host factors in driving 
microbial community structure; differences in innate and adaptive immune systems, composition 
and quantity of vaginal secretions, and ligands on epithelial cell surfaces might be involved (Ravel 
et al., 2011).  
The gold standard method for diagnosis of BV is the microbiological criteria introduced by 
Nugent, Krohn, & Hillier (1991). The Nugent score is based on a numerical scoring system (0–
10), where a score of 0–3 is considered healthy, 4–6 as intermediate, and 7–10 as indicative of BV. 
The score reflects the relative abundances of three kinds of bacterial cell morphotypes in Gram-
stained vaginal smears: large Gram-positive rods (Lactobacillus), small Gram-negative and Gram-
variable rods (Gardnerella vaginalis/Bacteroides spp.), and curved Gram-negative rods 
(Mobiluncus) (Nugent et al., 1991). Bacterial vaginosis can also be diagnosed through the clinical 
criteria established by Amsel and colleagues in 1983, in which BV is characterized by the presence 
of at least three of the following four criteria: 1) thin, gray/white discharge; 2) malodorous “fishy” 
discharge upon adding 10% potassium hydroxide; 3) high vaginal pH (>4.5), and 4) identification 
of vaginal epithelial cells heavily coated with bacteria (i.e., “clue cells”) (Amsel et al., 1983).  
Current treatment strategies for BV include the administration of antibiotics either orally 
or topically. The Centers for Disease Control and Prevention (CDC) recommends treatment only 
for women with symptoms, which accounts for a low proportion of BV cases based on Nugent 
score (Koumans et al., 2007). Treatment regimens consist of metronidazole 500 mg orally twice a 
day for 7 days; or metronidazole gel 0.75%, one full applicator (5g) intravaginally, once a day for 
5 days; or clindamycin cream 2%, one full applicator (5g) intravaginally at bedtime for 7 days 
(CDC - Centers for Disease Control and Prevention, 2015b). Cure of BV is commonly defined as 
failure to meet Amsel’s criteria (≥3 symptoms present) after treatment (Verstraelen and Verhelst, 
2009). The main disadvantage of antimicrobial therapy is that it usually only provides a short term 
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relief from BV symptoms, typically assessed 7-14 days after starting treatment (Sobel, 2009). In 
the long term, BV cure rates vary widely, ranging from 60-90% after one month of treatment 
(Larsson and Forsum, 2005; Koumans et al., 2002) to 42% within a year after treatment (Bradshaw 
et al., 2006). Although BV recurrence is relatively common, most cases likely represent a relapse 
rather than a reinfection, especially if symptoms reappear shortly after treatment (Sobel, 2009).  
One of the main contributors to BV therapy failure is bacterial antibiotic resistance. Many 
non–spore-forming, Gram-positive anaerobic rods are resistant to metronidazole and clindamycin; 
this group of bacteria includes Propionibacterium and Actinomyces (Atopobium, Mobiluncus) 
(Hall and Copsey, 2015). Prevotella (Alauzet et al., 2010) and Gardnerella vaginalis have also 
been reported to be resistant to metronidazole (Aroutcheva et al., 2001; Kharsany et al., 1993). 
Vaginal biofilms also contribute to antibiotic treatment failure since they allow bacteria to reach 
much higher concentrations than in luminal fluids and prevent/delay antimicrobial agents to reach 
the bacteria (Swidsinski et al., 2008; Donlan and Costerton, 2002). Gardnerella vaginalis and 
Atopobium vaginae are often together in vaginal biofilms (Swidsinski et al., 2005) and it has been 
reported they are only temporarily suppressed by antibiotics and rapidly regain activity after 
antimicrobial treatment (Swidsinski et al., 2008). 
 
Pregnancy and the vaginal microbiome 
In past decades, several culture based and culture-independent studies have described the 
vaginal microbiome of healthy, reproductive aged, non-pregnant women, but studies of the 
microbiome in pregnancy are still scarce. Pregnancy is associated with a variety of physiological 
events that have the potential to influence the structure of the vaginal microbial community, 
including increased sex steroid hormone levels (Tulchinsky et al., 1972), host immune response 
modulation (Jamieson et al., 2006; Mor and Cardenas, 2010), altered immune-physicochemical 
properties of the cervical mucus (House et al., 2009; Luo et al., 2000; Lee et al., 2011a), as well 
as behavioural changes such as reduced drinking and smoking (Crozier et al., 2009). Nevertheless, 
the precise mechanisms by which these factors influence the vaginal microbiome are not fully 
understood.  
Considering the hormonal and physiological changes associated with pregnancy, a few 
culture-independent studies have compared the vaginal microbiome of healthy pregnant and non-
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pregnant women. The microbiomes of pregnant women are overall less diverse and less rich when 
compared to those of non-pregnant women; they also have higher abundance of Lactobacillus spp. 
and are more stable (Aagaard et al., 2012; Walther-António et al., 2014; Romero et al., 2014c; 
MacIntyre et al., 2015). After delivery, post-partum microbiomes become less Lactobacillus 
dominant and more rich and diverse (i.e. more similar to the microbiomes of non-pregnant 
women), which supports the idea that pregnancy has a transient effect on the vaginal microbial 
community (MacIntyre et al., 2015). These differences are likely driven by the increased levels of 
estrogen during pregnancy that lead to increased glycogen deposition when compared to non-
pregnant women (Cruickshank and Sharman, 1934; BMJ, 1943). As mentioned previously, 
glycogen is utilized by Lactobacillus to produce lactic acid and contributes to the protective role 
of low vaginal pH (Mirmonsef et al., 2014; O’Hanlon et al., 2013). 
Notably, most studies of the vaginal microbiome in pregnancy have only included study 
populations of American (United States) or European origin, and descriptions of the vaginal 
microbiome of pregnant women from other regions, including Canada, are lacking. Moreover, 
these studies are based on the sequencing of the 16S rRNA gene, a barcode that does not provide 
enough resolution to resolve closely related organisms, particularly some members of the 
Bifidobacteriaceae family like Bifidobacterium and Gardnerella (Paramel Jayaprakash et al., 
2012; Vermette et al., 2010; Verbeke et al., 2011; Lan et al., 2016; Hill et al., 2010). 
One of the main motivations for studying the vaginal microbiome in pregnancy relates to 
previous reports of an association between BV/dysbiosis and negative reproductive outcomes 
including increased risk of post-abortion infection (Larsson et al., 1992, 2000; Hamark and 
Forssman, 1991), early (Ralph et al., 2015; Donders et al., 2000) and late miscarriage (Llahi-Camp 
et al., 1996; Hay et al., 1994), chorioamnionitis (Gibbs, 1993; Hillier et al., 1988), postpartum 
endometritis (Watts et al., 1990; Jacobsson et al., 2002), preterm premature rupture of membranes 
(PPROM) (Parry and Strauss, 1998; Hillier et al., 1995) and preterm birth (Leitich et al., 2003; 
Meis et al., 1995). 
 
Approaches to studying the vaginal microbiome 
The structure of vaginal microbial communities has been investigated over past decades 
using a wide range of culture-dependent and -independent techniques. Culture based studies rely 
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on the ability of microorganisms to grow in laboratory culture media, and therefore, they are likely 
to underestimate the diversity of the vaginal microbiota since many fastidious bacteria will not 
grow in the culture media. Culture-based studies, however, were essential in the early days when 
vaginal dysbiosis was a completely uncharacterized condition. By using culture methods, Gardner 
and Dukes were able to isolate a bacterium from women with ‘nonspecific vaginitis’ which led to 
the proposition that G. vaginalis was the etiologic agent of BV (Gardner and Dukes, 1955). It is 
known today that other anaerobic bacteria also play a role in BV, but those initial reports were an 
important step towards a better understanding of the vaginal microbiota. Subsequent culture-based 
studies not only contributed to a better understanding of microbiota diversity, but also improved 
knowledge regarding the role of pH, lactic acid, hydrogen peroxide and lactobacilli in the 
microbiome (Wilks and Tabaqchali, 1987; Spiegel et al., 1980; Eschenbach et al., 1989; Csángó, 
1982; Goldenberg et al., 1996; Onderdonk et al., 1986). Culturing microorganisms also provides 
the opportunity for establishing a culture collection that can be used to investigate virulence factors 
or health promoting effects through in vitro assays or whole genome sequencing.  
In 1983, Amsel and colleagues proposed the clinical criteria (vaginal pH>4.5; vaginal 
discharge; amine odour upon KOH addition; clue cells in Gram stain) as the first attempt to 
formally diagnose BV. BV symptoms might be subtle and subjective to interpret; also, G. vaginalis 
and other anaerobic bacteria are often isolated from the vaginal microbiota of asymptomatic 
women. Thus, in 1991, Nugent, Krohn & Hillier proposed microbiological criteria (Nugent score) 
to diagnose BV based on Gram-stained vaginal smears. The Nugent score became the gold 
standard method and it has been used since then in studies investigating the vaginal microbiota. 
The Nugent score is inexpensive, quick and widely available in many research and clinic facilities, 
but it does not provide reliable quantification and identification of bacteria at the species level. 
The development of culture-independent methods has greatly facilitated the investigation 
of the vaginal microbiota, and improved the resolution of vaginal microbiome characterization in 
a variety of cohorts. Some of the fingerprint techniques that have been used to analyse the 
composition of the vaginal microbiota include PCR-denaturing gradient gel electrophoresis 
(DGGE) (Ling et al., 2010; Gao et al., 2013; Burton et al., 2003a) and terminal restriction fragment 
length polymorphism (tRFLP) (Verstraelen et al., 2009; Thies et al., 2007; Zhou et al., 2007). 
These approaches are relatively inexpensive and give an overview of the species present in a 
sample, but do not provide a high resolution analysis (Walker, 2016). Other molecular techniques 
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like end-point PCR (DiGiulio et al., 2010; Fredricks et al., 2007) and quantitative PCR (Menard 
et al., 2010; Fredricks et al., 2009; Jespers et al., 2012) are also widely used due to their specificity 
to detect organisms at the genus or species level, but they do not give information about new 
species since only known targets can be detected. 
Advances in DNA sequence-based methods have revolutionized the study of the human 
microbiome. One common methodology is to carry out surveys of universal marker genes, such 
as 16S rRNA or cpn60, which provide a broad representation of the bacterial species present in a 
sample. The universal target genes are PCR-amplified generating a mixed pool of PCR amplicons 
that can be used to construct clone libraries for subsequent sequencing, or alternatively, be directly 
sequenced en masse (Walker, 2016). Clone libraries containing 16S rRNA amplicons (Oakley et 
al., 2008; Hyman et al., 2005) or cpn60 amplicons have both been used as an approach to study 
the vaginal microbiota (Hill et al., 2005b; Schellenberg et al., 2011). 
Direct amplicon sequencing is currently the most common approach to study the 
composition of the vaginal microbiota, either based on the PCR amplification of 16S rRNA gene 
(Hummelen et al., 2010; Ravel et al., 2013; MacIntyre et al., 2015; Hickey et al., 2013; Aagaard 
et al., 2012; Shipitsyna et al., 2013; Huang et al., 2015; Gajer et al., 2012; Ravel et al., 2011) or 
the cpn60 gene (Schellenberg et al., 2011, 2009; Chaban et al., 2014; Albert et al., 2015). As a 
result of application of DNA sequence based methods to characterize the composition of the 
vaginal microbiome, there is a growing appreciation of "atypical" (i.e. non-Lactobacillus 
dominated) microbiomes in healthy women, such as those dominated by Bifidobacterium spp. that 
have been identified in several cohorts of healthy women (Hyman et al., 2005; Albert et al., 2015; 
Shipitsyna et al., 2013; Ravel et al., 2013). Atypical healthy microbiomes are often grouped with 
microbial profiles that are recognisably unhealthy/disturbed, and they are also often overlooked 
and generally not further investigated in vaginal microbiome studies. 
Recently developed “–omics” approaches have great potential to provide in-depth analysis 
of any microbial community, and several studies have used metagenomics/whole-genome shotgun 
sequencing (Prince et al., 2016; Zevin et al., 2016), transcriptomics (Macklaim et al., 2013), 
proteomics (Borgdorff et al., 2015; Klatt et al., 2017; Zevin et al., 2016), and metabolomics 
(McMillan et al., 2015; Srinivasan et al., 2015) to investigate the vaginal microbiome. Although 
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promising, sequencing costs and scarce bioinformatics tools for “big data” analysis are still 
limiting factors for the –omics approaches (Martin and Marrazzo, 2016). 
 
1.3. Preterm birth 
Definition 
Preterm birth (PTB) is defined by WHO as delivery before 37 weeks of gestational age 
(WHO et al., 2012). PTB can be further sub-categorized into extremely preterm (≤27+6 weeks+days), 
very preterm (28 to 31+6), and late preterm (32 to 36+6) (Quinn et al., 2016). Eleven percent of all 
live births worldwide are preterm, which is estimated to be the cause of 35% of the world’s 
neonatal deaths and represents 3.1 million deaths per year (Blencowe et al., 2012). In Canada, the 
average preterm birth rate among live births was 7.8% in 2013, with Nunavut (12.6%) and Prince 
Edward Island (7.1%) having the highest and lowest preterm rates, respectively (Statistics Canada, 
2016). Preterm birth complications are responsible for an increased risk of cardiovascular 
disorders, respiratory distress syndrome, neurodevelopmental disabilities and learning difficulties 
in children who are born prematurely in comparison with children born at term (Behrman and 
Butler, 2007). 
 
Hypothesis of mechanisms 
Pathogenesis of preterm labour is not yet fully understood, but current hypotheses involve 
early idiopathic activation of the normal labour process or pathological insults (Goldenberg et al., 
2008). Both term and preterm labour involve similar events as part of the “common pathway” of 
labour, which includes increased uterine contractility, cervical dilatation, rupture of the 
chorioamniotic membranes, and changes in the concentrations of hormones corticotrophin-
releasing factor and cortisol (Romero et al., 2006). Two pathways are thought to regulate the timing 
of parturition: an endocrine cascade comprising the fetal hypothalamic–pituitary–adrenal–
placental axis, and a mechanical pathway in which fetal growth enhances uterine wall tension, 
inducing biochemical and molecular changes in the myometrium (Shynlova et al., 2013). These 
changes in the myometrium are thought to shift the signalling from anti-inflammatory to pro-
inflammatory pathways, which involves several events like progesterone withdrawal (Renthal et 
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al., 2013), cervical ripening, and decidual activation (Romero et al., 2014a) that in turn lead to the 
‘common pathway’ of labour. Thus, a coordinated inflammatory response, including infiltration 
of neutrophils and macrophages in the myometrium (Thomson et al., 1999), has been implicated 
to have a central role in term labour (Bollopragada et al., 2009; Dudley et al., 1996). 
Known pathological mechanisms implicated in preterm labour include: 1) Failure of 
physiologic transformation (disappearance of the normal muscular and elastic structures of the 
arteries and their replacement by fibrinoid material) that can cause maternal lesions and 
uteroplacental ischaemia predisposing to preeclampsia (Kim et al., 2003); 2) Uterine 
overdistension (as a result of multiple gestations), polyhydramnios (an excessive amount of 
amniotic fluid) or macrosomia (large fetal weight) that might induce expression of gap junction 
proteins, IL-8 and collagenase production facilitating cervical ripening and myometrium activation 
(Behrman and Butler, 2007); 3) Cervical insufficiency, a syndrome that leads to cervical ripening 
and is caused by congenital disorders (i.e. hypoplastic cervix), surgical trauma (i.e. conization 
resulting in substantial loss of connective tissue), or traumatic damage to the structural integrity of 
the cervix (i.e. repeated cervical dilatation associated with termination of pregnancy) (Romero et 
al., 2006); 4) Progesterone withdrawal mediated by local changes in metabolism or alterations in 
progesterone receptors isoforms/coactivators (Romero et al., 2014a); 5) Disruption of maternal-
fetal tolerance caused by abnormalities in the recognition and adaptation to fetal antigens (Lee et 
al., 2011b). 
Preterm birth is considered a complex multi-factorial condition and several risk factors 
have been associated with early parturition. Such factors include history of prematurity (Mercer et 
al., 1999), black ethnicity (Kistka et al., 2007), close temporal proximity to a previous delivery 
(Conde-Agudelo et al., 2006), multiple gestations (Kurdi et al., 2004; Stock and Norman, 2010), 
short cervix (Iams et al., 1996), low and high maternal ages (Fraser et al., 1995; Jacobsson et al., 
2004; Schempf et al., 2007), low maternal BMI (Han et al., 2011), tobacco use, heavy alcohol 
intake, illicit drug use (Behrman and Butler, 2007), and maternal medical disorders (e.g. thyroid 
disease, asthma, diabetes, hypertension) (Behrman and Butler, 2007). Maternal periodontal disease 
has also been implicated in prematurity, though the exact mechanism has not been elucidated. It is 
thought that periodontal infections can stimulate a local and systemic host response that activates 
the pro-inflammatory cascade involved in preterm birth (Bobetsis et al., 2006; Xiong et al., 2006). 
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Although studied extensively, some preterm cases remain unexplained for women with no 
pathological conditions or known risk factors. 
An intrauterine ascending infection hypothesis has been proposed as an important 
contributor for preterm birth, and is supported by the fact that many organisms isolated from the 
amniotic fluid/membranes of women who had preterm delivery are also found in the lower genital 
tract of pregnant women (Gardella et al., 2004; Krohn et al., 1995; Hillier et al., 1988; Romero et 
al., 1989). By ascending from the vagina, bacteria can reach the uterus and decidua and stimulate 
a local inflammatory reaction through the production of proinflammatory cytokines and 
inflammatory mediators. They can also cross the chorioamnion into the amniotic cavity and 
stimulate the production of inflammatory mediators by local macrophages and other host cells. 
Eventually, the organisms might gain access to the fetus and initiate a systemic inflammatory 
response (Romero et al., 2006). 
A large number of studies support the ascending infection hypothesis based on the strong 
association between intra-amniotic bacterial infection and preterm birth (Gardella et al., 2004; 
Hillier et al., 1988; Romero et al., 1989; Watts et al., 1992; Yoon et al., 2001; DiGiulio et al., 2008; 
Hillier et al., 1993; Jacobsson et al., 2005). Most intra-amniotic infections, however, are 
considered subclinical (Romero et al., 1989) since they do not meet criteria for clinical 
chorioamnionitis (fever, uterine fundal tenderness, maternal tachycardia >100/min, fetal 
tachycardia >160/min, and purulent or foul amniotic fluid) (Tita and Andrews, 2010), which might 
lead to an underestimation of the importance of infection as a contributor for preterm birth. 
Preterm labour caused by an ascending infection is mediated by an inflammatory process. 
Microorganisms are recognized by toll-like receptors (TLRs) and other pattern recognition 
receptors that initiate a proinflammatory cascade mostly mediated by the transcription factor NF-
kB (Lee et al., 2003). This cascade stimulates the production of cytokines (IL-1β, IL-6 and TNF-
α), chemokines (IL-8) (Romero et al., 2006), prostaglandins (Mitchell et al., 1991, 1993), and 
proteases (Phillippe et al., 2001) that lead to the activation of the ‘common pathway’ of parturition 
(Romero et al., 2006; Agrawal and Hirsch, 2012). However, the precise timing between infection 
and initiation of labour might be difficult to estimate as the inflammatory cascade might be 
activated long before the signs of labour are apparent (Agrawal and Hirsch, 2012). 
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The presence of bacteria alone may not be sufficient to cause preterm labour as reports 
have shown that bacteria may be present in fetal membranes without necessarily causing an 
inflammatory response (Steel et al., 2005). This also indicates that not all dysbiotic microbiomes 
(simplistically defined as lack of lactobacilli) are involved in preterm birth since different bacteria 
have different virulence factors and might stimulate distinct inflammatory responses. Studies 
based on culture-dependent techniques have failed to provide in-depth understanding of the 
microbial community that is associated with preterm birth, and studies using high throughput 
sequencing technologies to address this question are still scarce. 
 
Microorganisms and preterm birth 
Gardnerella vaginalis 
Several pathogens and BV-associated bacteria have been previously associated with early 
onset of labour. G. vaginalis, a hallmark bacteria in BV, is often detected in women who 
experienced preterm birth (Bretelle et al., 2015). G. vaginalis is often described as Gram-variable 
due to a very thin cell wall, but ultrastructural characteristics and chemical composition indicate 
they are in fact Gram-positive (Sadhu et al., 1989). G. vaginalis produce enzymes including 
sialidases that can degrade cervicovaginal mucus (Lewis et al., 2013) and therefore facilitate 
bacteria ascension to the uterus. Elevated sialidase levels have been strongly associated with early 
spontaneous preterm birth (Cauci and Culhane, 2011). Sialidases (neuraminidases) cleave the 
terminal sialic acid residues linked to oligosaccharide chains (Lewis and Lewis, 2012); by breaking 
down the sialic acid-containing mucus components in the vagina, G. vaginalis contributes to the 
depletion of protective host mucus barriers (Lewis et al., 2013). Other immune molecules present 
in the vaginal mucosal surface, including immunoglobulins (IgA, IgG), lysozyme, cytokines and 
cell surface receptors that are important to the ability of the reproductive mucosa to neutralize and 
eliminate pathogens, are also metabolized by sialidases (Lewis et al., 2012; Lewis and Lewis, 
2012). 
BV-associated bacteria 
Several BV-associated bacteria have been associated with preterm birth. The most 
commonly detected bacteria associated with BV are Megasphaera, Prevotella, 
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Leptotrichia/Sneathia, Atopobium vaginae, Eggerthella-like bacterium, and bacteria in the order 
Clostridiales (BVAB1, BVAB2, BVAB3) (Fredricks et al., 2007). High levels of Atopobium 
vaginae have been associated with preterm delivery (Menard et al., 2010). A. vaginae is a 
fastidious, Gram-positive, anaerobic, cocci-shaped bacterium that often occurs together with G. 
vaginalis (Trama et al., 2008). Both bacteria trigger similar inflammation and vaginal epithelial 
innate immune responses mediated by activation of the proinflammatory transcription factor NF-
kB in vaginal epithelial cells (Libby et al., 2008).  
Prevotella are anaerobic, Gram-negative, pleomorphic, non-motile rods previously 
classified as Bacteroides that have also been associated with preterm birth (Holst et al., 1994; 
Callahan et al., 2017). Prevotella are often detected with G. vaginalis and a synergistic relationship 
between them has been described; ammonia produced by Prevotella enhances G. vaginalis growth, 
which in turn produces amino acids that are utilized by Prevotella (Pybus and Onderdonk, 1998). 
Similarly to G. vaginalis, P. bivia and P. disiens also exhibit sialidase activity (Briselden et al., 
1992), and P. bivia is thought to trigger proinflammatory responses in the vaginal mucosa by 
stimulating the production of IL-8 and NF-kB activation (Fichorova et al., 2011), which might be 
involved in the role of Prevotella in prematurity. Some recent studies, however, have reported no 
association between specific taxa of BV-associated bacteria and preterm birth (Romero et al., 
2014b; Stout et al., 2017). Interestingly, several BV-associated bacteria (Gardnerella, Prevotella, 
Atopobium, Mobiluncus) were associated with preterm birth in a low risk cohort that mostly 
included Caucasian and Asian participants; while only Prevotella was associated with prematurity 
in a high risk for preterm cohort mainly composed of African American women with history of 
preterm birth, which suggest that preterm–microbiota associations are population-dependent 
(Callahan et al., 2017). 
Mollicutes 
Mollicutes (from the Latin ‘soft skin’) is a class of organisms that includes the genera 
Mycoplasma and Ureaplasma. They are typically very small bacteria and have a trilayered external 
membrane, rather than a rigid cell wall, rendering them resistant to b-lactam antibiotics (Taylor-
Robinson, 2007). The most common species detected in the human genital tract are Mycoplasma 
hominis, Mycoplasma genitalium, Ureaplasma urealyticum and Ureaplasma parvum, and they are 
often referred as ‘genital mycoplasmas’ (Taylor-Robinson and Lamont, 2011). Mollicutes have 
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been associated with preterm birth likely mediated by an increased proinflammatory response, but 
inconsistent findings from different studies still make it unclear if they are involved with early 
parturition. An association between preterm birth and the following species have been reported: 
M. hominis (Lamont et al., 1987; Donders et al., 2000; Kwak et al., 2014), M. genitalium (Hitti et 
al., 2010; Lis et al., 2015; Edwards et al., 2006), U. urealyticum (Gerber et al., 2003; Yoon et al., 
1998) and U. parvum (Kataoka et al., 2006). Other studies, however, have suggested that preterm 
birth occurs independently of mycoplasma colonization (Lu et al., 2001; Oakeshott et al., 2004; 
Carey et al., 1992).  
Some genital mycoplasmas might be considered part of the “normal” microbiota of some 
women. M. hominis is detected in the cervix or vagina of 20–50% of sexually mature, 
asymptomatic woman, ureaplasmas in 40–80% and M. genitalium in 0–5% (Taylor-Robinson and 
Jensen, 2010). While some of these organisms are often found in the lower genital tract of women, 
they are less prevalent (<5%) in the upper genital tract and chorioamnion of pregnant women in 
the absence of labour or membrane rupture (Tita and Andrews, 2010). Moreover, an association 
between BV and Mollicutes has been reported (Taylor-Robinson, 2017), which indicates that the 
role of Mollicutes in preterm birth might involve the presence of other bacteria or conditions 
(Capoccia et al., 2013; Cox et al., 2016). Clearly, further studies investigating the vaginal microbial 
community in pregnancy are needed to clarify the role of Mollicutes in preterm birth. 
Chlamydia trachomatis 
Chlamydia trachomatis is an obligate intracellular pathogen that causes ocular and genital 
infections (Brunham and Rey-Ladino, 2005). Chlamydial infections are the most common sexually 
transmitted infections, are often asymptomatic, and if untreated, can cause pelvic inflammatory 
disease and infertility in women, and urethritis in men (PHAC - Public Health Agency of Canada, 
2014). Women with chlamydial infections are also more likely to experience preterm birth 
(Andrews et al., 2000; Claman et al., 1995; Liu et al., 2013; Mann et al., 2010; Schoeman et al., 
2011) probably mediated by an inflammatory response (Rours et al., 2011), although some studies 
have found no association between chlamydia and preterm birth (Andrews et al., 2006b; Hitti et 
al., 2010; Edwards et al., 2006). These inconsistent reports indicate that infection by chlamydia 
might be influenced by other factors such as the vaginal microbiota, that would affect the ability 
of chlamydia to cause, or not, preterm birth.  
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During chlamydia infection, the host immune response stimulates the production of the 
cytokine INF-γ. One of the roles of INF-γ is to upregulate the host enzyme IDO (indoleamine 2,3-
dioxygenase), which converts tryptophan to kynurenine. Tryptophan is an essential amino acid for 
C. trachomatis and under this stressful condition of tryptophan depletion, the Chlamydia 
developmental cycle is disrupted driving the bacteria into its noninfectious form, known as 
reticulate bodies (RB) (AbdelRahman and Belland, 2005; Ziklo et al., 2016). To overcome the 
tryptophan depletion, it has been hypothesized that C. trachomatis can use its trpBA genes to 
rescue tryptophan from indole, which, in turn, is a product of anaerobic members of the vaginal 
microbiota, but not produced by lactobacilli (Ziklo et al., 2016). In vivo examination of women 
infected with C. trachomatis and BV revealed high levels of indole in their vaginal secretions 
(Lewis et al., 2014). This demonstrates how a disturbed microbiome can increase susceptibility to 
chlamydial infections, which in turn might influence whether chlamydia might cause preterm birth 
or not. 
Neisseria gonorrhoeae  
Neisseria gonorrhoeae is the second most commonly reported sexually transmitted 
pathogen in Canada (PHAC - Public Health Agency of Canada, 2014). It causes cervicitis, pelvic 
inflammatory diseases and infertility in women, and urethritis and infertility in men (CDC - 
Centers for Disease Control and Prevention, 2015a). Gonorrhea is currently treated with 
antimicrobial therapy, however there is a growing concern worldwide about widespread 
antimicrobial resistance (Wi et al., 2017). Gonorrhea has also been associated with preterm birth, 
but like mycoplasmas and chlamydia, the role of N. gonorrhoeae in preterm birth is still unclear 
based on inconsistent reports (Johnson et al., 2011; Liu et al., 2013; Mann et al., 2010; Heumann 
et al., 2017; Edwards et al., 2006; Hitti et al., 2010). It is known that lactic acid acidification or 
adherence inhibition mediated by lactobacilli strongly inhibits N. gonorrhoeae, which indicates 
that BV or lack of lactic acid–producing bacteria in the vaginal microbiota increases susceptibility 
to gonorrhea infection (Graver and Wade, 2011; Breshears et al., 2015; Spurbeck and Arvidson, 
2008). Like chlamydia, it is possible that gonorrhea infection is influenced by the presence of 
specific organisms from a disturbed microbiota, which would affect N. gonorrhoeae ability to 
cause infection and preterm birth.  
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1.4. The genus Bifidobacterium 
History 
Bifidobacteria were first described by Henry Tissier (1889, 1900), who isolated a bacterium 
from breast-fed infant feces and named it Bacillus bifidus communis, or simply, B. bifidus. They 
were described as rods with ends split to give the characteristic Y- shape, which led to the 
designation of "bifid". Bifidobacterium have a complex taxonomic history; B. bifidus was initially 
assigned to the genus Bacillus (and later to the genus Lactobacillus) due morphological and 
biochemical similarities to Bacillus acidophilus (Poupard et al., 1973). In 1924, Orla-Jensen 
proposed the genus Bifidobacterium as a separate taxon for these organisms (Orla-Jensen, 1924). 
This designation was not generally accepted though, and the term Bacillus/Lactobacillus continued 
to be used to describe species that today are known to belong to Bifidobacterium. Numerous other 
names and re-classifications were also proposed in the following years. All the organisms’ names 
proposed for B. bifidum are listed here in chronological order: Bacillus bifidus communis, Bacillus 
bifidus, Bacteroides bifidus, Lactobacillus bifidus, Bifidobacterium bifidum, Bacterium bifidum, 
Tissieria bifida, Actinomyces befidus, Actinobacterium bifidum, Corynebacterium bifidum, and 
Cohnistreptothrix bifidus (Poupard et al., 1973). 
In 1957, Dehnart realized the existence of multiple biotypes of Bifidobacterium that could 
be differentiated based on their carbohydrate fermentation patterns. This drove the “discovery” of 
several Bifidobacterium species in the following years. In 1971, Reuter designated seven type 
strain species of Bifidobacterium, in addition to the known B. bifidum: B. adolescentis, B. breve, 
B. infantis, B. lactentis, B. liberorum, B. longum, and B. parvulorum. In 1974, Scardovi and 
Crociani proposed three type strains: B. catenulatum, B. dentium, and B. angulatum. And in 1979, 
Scardovi and colleagues proposed another four type strains: B. cuniculi, B. choerinum, B. boum, 
and B. pseudocatenulatum. 
The genus Bifidobacterium was recognized as an independent genus only in the eighth 
edition of Bergey's Manual of Determinative Bacteriology, included in the family of 
Actinomycetaceae of the order Actinomycetales (Rogosa, 1974). Using 16S rRNA analysis, 
Stackebrandt and colleagues (1997) proposed a novel hierarchical structure in which the genera 
Bifidobacterium and Gardnerella were combined into the single family of Bifidobacteriaceae in 
the order of Bifidobacteriales, class Actinobacteria, phylum Firmicutes of the domain Bacteria. 
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The characteristic metabolic pathway of hexose fermentation in the Bifidobacterium genus was 
elucidated by Scardovi and Trovatelli (1965) and De Vries and colleagues (1967). Glucose is 
degraded exclusively by the fructose 6-phosphate shunt in which fructose-6-phosphoketolase 
cleaves fructose 6-phosphate into acetylphosphate and erythrose 4-phosphate. This fructose-6-
phosphate phosphoketolase is a key enzyme of glycolytic fermentation in Bifidobacterium and 
serves as an identifying characteristic for the genus.  
Currently, bifidobacteria are considered Gram-positive, anaerobic, non-motile, non-spore 
forming rod-shaped bacteria, with varied branching. They belong to the Bifidobacteriaceae family 
and have high genomic G+C content (55-67 mol%) (Biavati and Mattarelli, 2012). Bifidobacteria 
are known to colonize the human vagina, oral cavity, breast milk, and, more abundantly, the 
gastrointestinal tract (GIT) (Gomez-Gallego et al., 2016; Biavati and Mattarelli, 2006). Beyond 
the human microbiome, they can be found in sewage, fermented milk products, and the 
gastrointestinal tracts of several animals including cattle/calf, chicken, lamb, rabbit, piglet, rat, and 
honeybees (Biavati and Mattarelli, 2006). Although members of the genus inhabit a wide range of 
habitats, most Bifidobacterium spp. are host-specific (Biavati and Mattarelli, 2006).  
 
Significance of lactic acid bacteria 
Lactic acid bacteria (LAB) are defined as a group of Gram-positive, catalase-negative, 
acid-tolerant, bacterial species that produce lactic acid as the main end-product of fermentation. 
The most common LAB are the rod-shaped bifidobacteria and lactobacilli, but LAB also comprises 
cocci like Streptococcus, Pediococcus, and Leuconostoc (Kandler, 1983). The first indication that 
high numbers of bifidobacteria and other lactic acid bacteria in the adult large intestine provides 
good health was proposed by Metchnikoff in 1908. He observed that aging adults had lower 
bifidobacteria counts than younger adults and that extended longevity of the Balkan people could 
be attributable to their habit of consuming fermented milk products like yoghurt (O’Sullivan and 
Kullen, 1998). Several other studies followed Metchnikoff’s theory to investigate the potential of 
lactic acid bacteria consumption to improve human and animal health. This concept is now referred 
as ‘probiotics’ and is defined as ‘live microorganisms which when administered in adequate 
amounts confer a health benefit on the host’ (FAO and WHO, 2002). Probiotics are often 
incorporated in yogurt and fermented milk, but other dairy products like buttermilk, sour cream, 
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powdered milk, and frozen desserts, are also utilized for formulations. Production and 
consumption of fermented foods dates back many thousands of years, in which food is modified 
by the action of microorganisms or their products to achieve a desired change in the food (Naidu 
et al., 1999). 
Since Tissier, bifidobacteria have been the subject of numerous studies due to their 
probiotic potential and health promoting characteristics, such as immune modulation (Fanning et 
al., 2012; Hart et al., 2004), production of bacteriocins (Martinez et al., 2013), improved gut 
metabolism (Sugahara et al., 2015) and inhibition of pathogens (Bernet et al., 1993; Arboleya et 
al., 2011; Fukuda et al., 2011). Several mechanisms of action of probiotics on intestinal epithelial 
cells have been proposed, including blocking pathogen entry into the epithelial cell by providing 
a physical barrier (colonization resistance); creating a mucus barrier by causing the release of 
mucus from goblet cells; maintaining intestinal permeability by increasing the intercellular 
integrity of apical tight junctions; producing antimicrobial factors; stimulating the innate immune 
system by signalling dendritic cells, which then travel to mesenteric lymph nodes and lead to the 
induction of regulatory T cells, and the production of anti-inflammatory cytokines, including IL-10 
and TGF-β; preventing or triggering an innate immune response by initiating TNF production by 
epithelial cells and inhibiting (or activating) NFκB in macrophages and dampening (or priming) 
the host immune response by influencing the production of IL-8 and subsequent recruitment of 
neutrophils to sites of intestinal injury (Gareau et al., 2010). 
Beyond the gastro-intestinal tract, lactic acid bacteria, such as Lactobacillus spp., are well-
recognized organisms that promote good health in the female genital tract. Lactobacilli compete 
with urogenital pathogens (Boris et al., 1998; Osset et al., 2001; Phukan et al., 2013; Atassi et al., 
2006) and produce bacteriocins, biosurfactants and hydrogen peroxide, that have all been shown 
to be microbicidal against several genital pathogens (Sabia et al., 2014; Stoyancheva et al., 2014; 
Ruíz et al., 2012; Satpute et al., 2016; Walencka et al., 2008). Nevertheless, production of lactic 
acid seems to be the main health-promoting feature of lactobacilli (O’Hanlon et al., 2013; Conti et 
al., 2009; Juárez Tomás et al., 2003; Aldunate et al., 2013; Boskey et al., 1999, 2001). The health-
promoting features of other LAB like bifidobacteria in the vaginal microbiome have not yet been 
adequately investigated. 
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Mother to infant bifidobacteria transmission 
While it is well known there is a microbial community residing in the human vagina, the 
upper genital tract, including uterus and fallopian tubes, is generally thought to be sterile. This 
would require the cervix to be a perfect barrier, but changes in the cervical mucus due to certain 
conditions may in theory allow bacteria to ascend to the uterus (Chen et al., 2017). A recent study 
demonstrated the existence of distinct bacterial communities throughout the female genital tract 
forming a continuum of microbial communities from the vagina to the ovaries (Chen et al., 2017). 
The placenta has also been reported to harbour its own microbiota (Aagaard et al., 2014). Although 
the potential of contamination during sample collection has raised some concerns regarding the 
conclusions from these studies (Lauder et al., 2016), their proposition that the upper genital tract, 
including the placenta, is not sterile challenges the traditional view of human fetal development as 
a sterile event. Nevertheless, in absence of infection, it is still generally accepted that the fetus is 
maintained in a sterile state, referred as the ‘sterile womb paradigm’, in which microbes are 
acquired both vertically (from the mother) and horizontally (from other humans or the 
environment) only during and after birth (Perez-Muñoz et al., 2017).  
Hence, human microbial colonization likely begins at birth and continues to develop and 
change in composition for about 3 years, until the microbiota becomes adult-like (Arrieta et al., 
2014). Early microbial colonization is an essential process for a healthy immune and metabolic 
maturation (Rautava et al., 2012). This initial colonization may be affected by many factors, such 
as the mode of delivery (vaginal or caesarean section), feeding type (breast-fed or formula-fed), 
exposure to antibiotics and hygiene (Fanaro et al., 2003; Mueller et al., 2015).  
The newborn gut microbiota is generally initially colonized by enterobacteria that provide 
the conditions for anaerobe colonization (Arrieta et al., 2014). Around the first month of life, 
human milk oligosaccharides (HMOs) present in the maternal breast milk modulate neonatal gut 
microbial composition by promoting the growth of bifidobacteria (Mueller et al., 2015), which 
have also been shown to prevent gut infection (Fukuda et al., 2011; Penders et al., 2006). In this 
period, bifidobacteria may represent 60 to 91% of fecal bacteria in breast-fed infants (Harmsen et 
al., 2000; Turroni et al., 2012). This proportion decreases with age to less than 10% of the adult 
fecal microbiota (Yatsunenko et al., 2012; Turroni et al., 2008). The introduction of solid foods at 
around 4–6 months is accompanied by an increase of clostridial species; members of the 
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Ruminococcaceae family increase in abundance in the following months, and by 2–3 years of age, 
the microbiota composition consists of mainly Bacteroidaceae, Lachnospiraceae, and 
Ruminococcaceae, which then remains stable into adulthood (Arrieta et al., 2014).  
Regardless of whether there is a microbial community residing in the upper genital tract, 
the contribution of maternal gut, vaginal and breast milk microbiota, specifically bifidobacteria, to 
infant microbiota is undeniable. Although the mere presence of common bacterial species does not 
necessarily indicate vertical transmission, numerous studies have been conducted to investigate 
and demonstrate the influence of maternal microbiotas on the neonatal gut microbiome 
(Matamoros et al., 2013; Bäckhed et al., 2015; Makino et al., 2013; Dominguez-Bello et al., 2010; 
Gabriel et al., 2017; Gomez-Gallego et al., 2016; Hunt et al., 2011; Milani et al., 2015; Duranti et 
al., 2017; Pannaraj et al., 2017; Asnicar et al., 2017; Takahashi et al., 2010; Sakwinska et al., 
2017). 
Asnicar and colleagues (2017) demonstrated vertical transmission of B. bifidum by 
applying shotgun metagenomic sequencing for strain-level profiling of fecal and breast milk 
samples from mother-infant pairs. Duranti and colleagues (2017) also demonstrated vertical 
transmission of bifidobacteria species and bifido(pro)phages from breast milk based on the internal 
transcribed spacer (ITS). In a study comparing mode of delivery, Bäckhed and colleagues (2015) 
observed that ~70% of the bacteria taxa present in the gut of vaginally delivered infants were also 
present in their mothers’ gut microbiome; while in C-section infants vertical mother-infant 
transmission was less frequent for organisms like Bifidobacterium. Similarly, Domiguez-Bello and 
colleagues (2010) reported that a mother’s vaginal bacterial community is significantly more 
similar to her own baby’s microbiota than to the microbiota of other vaginally delivered babies, 
suggesting that the vaginal bacterial community is unique to each mother and is vertically 
transmitted to her baby. Millani and colleagues (2015) also reported vertical transmission of a B. 
breve and a B. longum subsp. longum strains from mother to infant by comparing mother’s fecal 
and milk samples with the corresponding infant’s fecal sample. 
All these studies demonstrate and emphasize the importance of maternal microbiota 
collectively as a source of bacteria for the neonatal gut, especially bifidobacteria, which have 
several health-promoting characteristics in neonatal development. Nevertheless, the specific 
contribution of each bacterial community (gut, vaginal and milk) in the mother-to-infant 
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bifidobacteria transmission remains in discussion and more studies using high-resolution methods 
for comparison of strains are needed. 
 
Genetic diversity of bifidobacteria 
Considering the health-promoting characteristics of bifidobacteria in the gut, and 
consequently, their probiotic potential (Lee and O’Sullivan, 2010), there is a collective effort to 
increase the number of bifidobacteria genome sequences available. Genome sequence analysis 
provides new insights about bacterial evolution and helps to reveal the genetic attributes of 
bifidobacteria that contribute to their role in promoting gut health (O’Callaghan and van Sinderen, 
2016). As a consequence of the emerging number of studies investigating the genomes of gut 
commensals, a new research theme has been proposed: the probiogenomics (Ventura et al., 2009a). 
The National Center for Biotechnology Information data base currently holds 424 publicly 
available bifidobacteria genome sequences, complete or draft, among which B. longum, B. 
animalis, B. breve, B. bifidum, and B. adolescentis are the species with the highest number of 
genome sequences available (https://www.ncbi.nlm.nih.gov/genome/?term=Bifidobacterium, 
November 2017). 
The genus Bifidobacterium currently comprises ~50 species and according to taxonomic 
classification based on comparative analyses of 16S rRNA gene sequences and multilocus 
sequence typing based on several concatenated house-keeping genes (clpC, dnaJ, xfp, dnaB, rpoC 
and purF), bifidobacteria can be clustered into six phylogenetic groups: B. boum, B. asteroides, B. 
adolescentis, B. pullorum, B. longum, and B. pseudolongum. B. asteroides, isolated from the insect 
gut, appears to be the closest relative of the ancient progenitor of the genus Bifidobacterium 
(Bottacini et al., 2014; Ventura et al., 2006).  
The average size of a Bifidobacterium genome is 2.2 Mb, with significant variation within 
the genus ranging from 1.7 (B. indicum and B. coryneforme) to ~3.3 Mb (B. scardovi and B. 
biavati). Such size differences suggest that bifidobacteria genomes have evolved as a result of 
many gene loss and/or acquisition events (Milani et al., 2014; Koskiniemi et al., 2012). 
Bifidobacterium is known to have high G+C content (mol%), with species B. tsurumiense (52.8%), 
B. kashiwanohense (56%), B. saguini (56.3%), B. catenulatum (56.4%) and B. pseudocatenulatum 
(56.4%) having the lowest G+C content, and species B. gallinarum (64.2%), B. pullorum (64.3%), 
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B. scardovi (64.6%), B. cuniculi (64.8%) and B. choerinum (65.7%) having the highest G+C 
content (Sun et al., 2015; Milani et al., 2014). Bifidobacteria typically encode 52–58 tRNA genes 
per genome, with the exception of B. longum subsp. infantis ATCC 15697 that has 79 tRNA-
encoding genes (O’Callaghan and van Sinderen, 2016). 
Comparison of Bifidobacterium spp. genome sequences has revealed a high degree of 
conservation and synteny across their genomes (Ventura et al., 2007). Nevertheless, phenotypic 
differences have been described among bifidobacteria, suggesting that niche adaptation has led to 
some degree of specialization (Ventura et al., 2009a). The human genome encodes 97 glycoside 
hydrolases, but just eight of those enzymes are directly linked to carbohydrate digestion, indicating 
that many complex dietary carbohydrates reach the colon undigested and therefore can be 
metabolized by (bifido)bacteria (Kaoutari et al., 2013). The types of carbohydrates in the diet have 
a significant impact on the metabolism of different groups of bacteria. While some members of 
the gut microbiota can use different substrates, from diet or host origin for example, others are 
more specialized. Bifidobacteria are presumably able to metabolize complex sugars derived from 
the diet as well as from the host, which gives them an ecological advantage among other members 
of the gut microbiota (Ventura et al., 2009a). 
Analysis of bifidobacteria genomes reveals that more than 12% of the annotated open 
reading frames within their genome sequences are attributed to carbohydrate metabolism (Milani 
et al., 2014) and nearly 10% of the gene content in B. longum is dedicated to sugar internalization, 
via ABC transporters (Schell et al., 2002). Other members of the gut microbiota, such as 
Escherichia coli or Enterococcus faecium, and non-gut resident bacteria, such as Lactococcus 
lactis, have a substantially lower percentage of genes related to carbohydrate metabolism in 
comparison with bifidobacteria (Ventura et al., 2009a).  
Genome analysis of B. bifidum and B. longum subsp. infantis revealed adaptations for the 
metabolism of human milk oligosaccharides (HMO) (Sela et al., 2008; Duranti et al., 2015). While 
B. breve and B. longum subsp. longum do not have the same efficient genetic repertoire for HMO 
degradation, they can utilize some HMOs and use carbohydrates that are broken down by other 
bifido(bacteria) via cross-feeding (Egan et al., 2014; Chaplin et al., 2015). In addition, B. 
adolescentis and B. longum subsp. longum can utilize plant-derived sugars, which are likely to be 
more abundant as diet changes after weaning. B. bifidum might also shift its HMO-metabolic 
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abilities towards mucin degradation when infants start weaning (Schell et al., 2002; Turroni et al., 
2010; Sela et al., 2008; Duranti et al., 2014). Notably, genome analysis of B. dentium indicated 
adaptations towards the human oral cavity that include specialized nutrient acquisition and 
defences against antimicrobials (Ventura et al., 2009b). 
Although the number of bifidobacteria genome sequences has been increasing over the 
years, most sequences available are from the species that commonly reside in the human gut, likely 
due their potential probiotic properties. Based on genomic studies of bifidobacteria, which often 
focus on carbohydrate metabolism, the genetic diversity within the Bifidobacterium genus is 
mostly related to the ability to metabolize different types of carbohydrates. Overall, the greater 
number of genes related to carbohydrate metabolism in bifidobacteria is an ecological advantage 
for this group in the gut microbiota and might indicate niche specialization for some bifidobacteria 
species. Lastly, genomic information is still very limited for other bifidobacteria species that are 
less common in the gut, and further studies are needed to better understand the genetic diversity 
of the whole Bifidobacterium genus. 
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OBJECTIVES 
1. Describe the vaginal microbiome of pregnant women at low risk for preterm birth by comparing 
their microbial profiles to those of healthy non-pregnant women. 
2. Assess whether there are differences in the vaginal microbiota composition early in gestation of 
women who had spontaneous preterm birth (sPTB) or term delivery that could be further 
investigated as diagnostic indicators of preterm birth risk. 
3. Apply species-specific quantitative PCR to confirm the relative abundance of Bifidobacterium 
in the vaginal microbiomes of reproductive aged women previously determined based on high-
throughput DNA sequencing methods, and characterize vaginal Bifidobacterium isolates based on 
carbohydrate fermentation patterns, hydrogen peroxide production, lactic acid production, 
resistance to low pH and lactic acid, and susceptibility to antibiotics. 
4. Compare the genomes of gut and vaginal isolates of B. breve and B. longum to identify evidence 
of specialization that could indicate if vaginal and gut strains represent two distinct, niche-adapted 
subpopulations. 
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CHAPTER 2. The vaginal microbiome of pregnant women is less rich and 
diverse, with lower prevalence of Mollicutes, compared to non-pregnant women 
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Chapter transition 
The vaginal microbiome has a profound impact in both women’s and neonatal health, and 
although the knowledge in the field has advanced in the past decades, still little is known about the 
effect of pregnancy on the vaginal microbiota. In this study chapter I focused on establishing a 
baseline description of the vaginal microbiome of healthy pregnant women. My objective was to 
characterize the vaginal microbiome of healthy pregnant women and compare them to those of 
healthy non-pregnant women. The results showed that overall microbiome cannot predict 
pregnancy status, although pregnancy affects the microbiome by mainly increasing lactobacilli 
abundance and decreasing Mollicutes prevalence. The ultimate goal of this study chapter was to 
establish a suitable description of the microbiome of healthy pregnant women that could be used 
as the “control group” for forthcoming studies focusing on specific cohorts, such as women who 
experienced preterm birth.  
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2.1. Abstract 
The vaginal microbiome plays an important role in maternal and neonatal health. 
Imbalances in this microbiota (dysbiosis) during pregnancy are associated with negative 
reproductive outcomes, such as pregnancy loss and preterm birth, but the underlying mechanisms 
remain poorly understood. Consequently, a comprehensive understanding of the baseline 
microbiome in healthy pregnancy is needed. We characterized the vaginal microbiomes of healthy 
pregnant women at 11-16 weeks of gestational age (n=182) and compared them to those of non-
pregnant women (n=310). Profiles were created by pyrosequencing of the cpn60 universal target 
region. Microbiome profiles of pregnant women clustered into six Community State Types (CST): 
I, II, III, IVC, IVD and V. Overall microbiome profiles could not be distinguished based on 
pregnancy status. However, the vaginal microbiomes of women with healthy ongoing pregnancies 
had lower richness and diversity, lower prevalence of Mycoplasma and Ureaplasma and higher 
bacterial load when compared to non-pregnant women. Lactobacillus abundance was also greater 
in the microbiomes of pregnant women with Lactobacillus-dominated CSTs in comparison with 
non-pregnant women. This study provides further information regarding characteristics of the 
vaginal microbiome of low-risk pregnant women, providing a baseline for forthcoming studies 
investigating the diagnostic potential of the microbiome for prediction of adverse pregnancy 
outcomes. 
Keywords: vaginal microbiome, cpn60, pregnancy, Lactobacillus, Mycoplasma, Ureaplasma, 
community state type. 
 
2.2. Introduction 
The complex microbial community present in the female lower genital tract is an important 
factor in a woman’s reproductive health. Imbalances in this microbiota can lead to bacterial 
vaginosis (BV), one of the most common gynaecologic conditions in women of reproductive age 
throughout the world (Ryckman et al., 2009; Sobel, 2000; Brotman, 2011). At present, it is 
understood that the healthy vaginal microbiome is dominated by Lactobacillus species, while BV 
is characterized by a relatively low abundance of Lactobacillus spp. accompanied by 
polymicrobial anaerobic overgrowth, including species such as Gardnerella vaginalis, Prevotella 
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spp., Bacteroides spp., Mobiluncus spp., and Mycoplasma hominis (Oakley et al., 2008; Zhou et 
al., 2010). 
In pregnancy, such imbalances in the vaginal microbiome are associated with an increased 
risk of post-abortal infection (Larsson et al., 1992, 2000), early (Donders et al., 2000; Ralph et al., 
2015) and late miscarriage (Llahi-Camp et al., 1996; Hay et al., 1994), histological 
chorioamnionitis (Gibbs, 1993; Hillier et al., 1988), postpartum endometritis (Watts et al., 1990; 
Jacobsson et al., 2002), preterm premature rupture of membranes (PPROM) (Parry and Strauss, 
1998; Hillier et al., 1995) and preterm birth (Leitich et al., 2003). The relationship between BV 
and preterm birth in particular has profound implications since children who are born prematurely 
have higher rates of cardiovascular disorders, respiratory distress syndrome, neurodevelopmental 
disabilities and learning difficulties compared with children born at term (Behrman and Butler, 
2007), along with increased risk of chronic disease in adulthood (Mwaniki et al., 2012). Also, 
preterm birth complications are estimated to be responsible for 35% of the world’s annual neonatal 
deaths (Liu et al., 2012). 
The development of culture-independent techniques, such as high throughput DNA 
sequencing, has greatly facilitated the comprehension of the composition and role of the vaginal 
microbial community. These tools can be used to exploit the potential of the microbiome to 
diagnose BV-associated conditions. However, while most studies have focused on the vaginal 
microbiome of healthy, non-pregnant, reproductive aged women, relatively little is known about 
this microbiome in pregnancy. Pregnancy is associated with a variety of physiological events 
including increased sex steroid hormone levels (Tulchinsky et al., 1972), host immune response 
modulation (Jamieson et al., 2006; Mor and Cardenas, 2010), altered immune-physicochemical 
properties of the cervical mucus (House et al., 2009; Luo et al., 2000; Lee et al., 2011a), as well 
as behavioural changes such as reduced drinking and smoking (Crozier et al., 2009). These factors 
may drive changes in the structure and/or composition of the microbial community resulting in a 
microbiome that is different from that of non-pregnant women. Thus, the current definition of a 
healthy microbiome, which has been based on findings in non-pregnant women, cannot necessarily 
be extrapolated to the microbiome in pregnancy. Establishing baseline data for the vaginal 
microbiome during pregnancy is a crucial step in the process of developing tools to predict and 
prevent pregnancy complications such as preterm birth, which is in turn associated with infection 
and/or inflammation as well as significant infant mortality and morbidity. 
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A few recent studies have used an amplicon sequencing approach to analyze the vaginal 
microbiome in pregnancy, all of which have been based on amplification and sequencing of 
variable regions of the 16S rRNA gene. The results of these studies suggest that pregnancy has a 
marked effect on the vaginal microbiome, leading to greater stability, increased Lactobacillus 
proportional abundance and reduced richness and diversity relative to the vaginal microbiomes of 
non-pregnant women (Aagaard et al., 2012; Romero et al., 2014c; Walther-António et al., 2014; 
MacIntyre et al., 2015; DiGiulio et al., 2015). 
The objectives of this study were to describe the vaginal microbiome of pregnant women 
at low risk for preterm birth and to compare their microbial profiles to those of healthy non-
pregnant women (Albert et al., 2015). This approach enabled direct comparisons between the two 
cohorts in which the main difference was their pregnancy status. Microbiome profiling was based 
on sequencing of the cpn60 universal target, which provides higher resolution than 16S rRNA 
variable regions (Links et al., 2012) and has allowed us to resolve previously undescribed vaginal 
microbiome community state types (Albert et al., 2015).  
 
2.3. Methods 
Study population and sampling 
This study received ethical approval from the Mount Sinai Hospital Research Ethics Board 
(Approval Number 08-0005-A). All participants provided written informed consent and all 
methods were performed in accordance with the relevant guidelines and regulations. Women 
attending antenatal clinics at Mount Sinai Hospital (Toronto, ON, Canada) between May 2012 and 
October 2013 were invited to be part of a clinical trial to determine the effect of oral probiotic 
lactobacilli in altering the vaginal microbiome in asymptomatic pregnant women with an abnormal 
Nugent score (Nugent et al., 1991; Yang et al., 2015). Nugent score was determined on Gram-
stained swabs taken at the same time as the swab for microbial analysis. Women with normal 
Nugent scores were excluded from the probiotic trial and are included in this analysis. Samples 
from women with an abnormal Nugent score who were subsequently randomized and included in 
the analysis for this study were taken prior to any intervention in these women and there was no 
difference in the pregnancy outcomes between the lactobacilli and placebo groups (Yang et al., 
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2015). A preliminary report on the results of that probiotic trial have been presented previously 
(Yang et al., 2015).  
Women were eligible to participate if the following inclusion criteria were met: currently 
pregnant, adequate comprehension of English language to sign written informed consent, age ≥18 
years old, no evidence of fetal complications such as intrauterine growth restriction, and no 
evidence of medical complications of pregnancy. Exclusion criteria included inability to provide 
informed written consent, multi-fetal pregnancies, currently taking antibiotics or other 
antimicrobial therapy for BV treatment. Study data were collected and managed using REDCap 
electronic data capture tools (Harris et al., 2009). 
Vaginal swabs were collected under direct visualization using a speculum by either a 
physician or a nurse and placed in dry tubes prior to being placed in -80˚C. A total of 182 pregnant 
women at 11-16 weeks gestation were enrolled in the vaginal microbiome study, including 111 
women with normal Nugent scores (inconsistent with BV), 61 women with Nugent scores that 
were intermediate or consistent with BV, and 10 women with indeterminate Nugent scores due to 
poor quality smears. Total nucleic acid was extracted from swabs using the MagMAX™ Total 
Nucleic Acid Isolation Kit (Life Technologies, Burlington, ON, Canada) as per manufacturer’s 
instructions. Kit reagents are aliquoted to eliminate repeated accessing of open reagents, and 
samples are processed in small batches using filter-tips to prevent cross-contamination. Pipettes 
and other lab surfaces are regularly treated with DNA surface decontaminant (DNA Away, 
ThermoFisher Scientific, Waltham, MA). Regular monitoring of reagent only DNA extraction 
controls in our lab by universal PCR confirms that these procedures are sufficient to eliminate 
detectable template contamination of study samples. 
The microbial profiles of low-risk pregnant women were compared to profiles previously 
generated from healthy, reproductive aged, non-pregnant Canadian women from the greater 
Vancouver area, British Columbia, Canada (n=310) (Albert et al., 2015). Samples were collected 
as being non-menstrual but were not sampled at any specific non-menstrual cycle time as other 
studies have demonstrated there is little variation in microbiome profiles through the cycle 
(Chaban et al., 2014). Samples from this previous study were processed in the same way as in the 
current work in terms of swab type, storage temperature, DNA extraction, library preparation and 
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sequencing. Although the year of sampling was different between the two cohorts, there was no 
difference in time from sample collection to sequencing between the two groups. 
 
Total Bacterial DNA (qPCR) and Detection of Mollicutes (PCR) 
Quantitative PCR (qPCR): Total bacterial DNA quantity in each sample was estimated 
using a SYBR Green assay based on amplification of the V3 region of the 16S rRNA gene. Primer 
sequences were as follows: SRV3-1 (5’-CGGYCCAGACTCCTAC-3’), SRV3-2 (5’-
TTACCGCGGCTGCTGGCAC-3’) (Lee et al., 1996). Reactions run on a MyiQ thermocycler 
using the following cycling parameters: 95°C for 3 min, followed by 30 cycles of 95°C for 15 sec., 
62°C for 15 sec., 72°C for 15 sec., with a final extension at 72°C for 5 minutes (Chaban et al., 
2013). 
Conventional PCR: Some Mollicutes (Mycoplasma and Ureaplasma) species lack a cpn60 
gene (Hill et al., 2004). Thus, we performed a family-specific semi-nested PCR targeting the 16S 
rRNA gene to detect Mollicutes (van Kuppeveld et al., 1992), and a PCR targeting the multiple 
banded antigen gene to detect Ureaplasma spp.. In this assay, PCR products from Ureaplasma 
parvum and U. urealyticum can be differentiated by size (Watson et al., 1990).  
 
cpn60 Universal Target (UT) PCR and Pyrosequencing 
Universal primer PCR targeting the 552-558 bp cpn60 UT region was performed using a 
mixture of cpn60 primers consisting of a 1:3 molar ratio of primers H279/H280:H1612/H1613, as 
described previously (Chaban et al., 2014; Hill et al., 2006b; Schellenberg et al., 2011). To avoid 
cross-contamination, samples were handled in small batches, and a no template control was 
included with each set of PCR reactions. To allow multiplexing of samples in a single sequencing 
run, primers were modified at the 5' end with one of 24 unique decamer multiplexing identification 
(MID) sequences, as per the manufacturer’s recommendations (Roche, Brandford, CT, USA). 
Amplicons were pooled in equimolar amounts for sequencing on the Roche GS Junior sequencing 
platform. The sequencing libraries were prepared using the GS DNA library preparation kit and 
emulsion PCR (emPCR) was performed with a GS emPCR kit (Roche Diagnostics, Laval, 
Canada). 
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Analysis of Operational Taxonomic Units (OTU) 
Raw sequence data was processed by using the default on-rig procedures from 454/Roche. 
Filter-passing reads were used in the subsequent analyses for each of the pyrosequencing libraries. 
MID-partitioned sequences were mapped using Bowtie 2 (http://bowtie-
bio.sourceforge.net/bowtie2/) on to a manually curated reference set of 1,561 OTU sequences 
representing human vaginal microbiota. Bowtie 2 was run using the default end-to-end alignment 
mode, in which the minimum “cutoff” for any individual read to be validly aligned to a reference 
sequence is an alignment score of -0.6 + -0.6 * L, where L is the length of the read. The best valid 
alignment for each read is reported. Mapping quality was also evaluated by MAPQ value, which 
is based on the probability that alignment does not correspond to the read’s true point of origin. 
The OTU reference set was generated originally by de novo assembly of cpn60 sequence 
reads from each of 546 vaginal microbiomes, which included 182 samples from pregnant women 
(this study) and 364 samples from non-pregnant women from previous studies by our research 
group. The reference assembly was created by the microbial Profiling Using Metagenomic 
Assembly pipeline (mPUMA, http://mpuma.sourceforge.net) (Links et al., 2013) with Trinity as 
the assembly tool (Grabherr et al., 2011). Assembled OTU were labeled according to their nearest 
reference sequence determined by watered-Blast comparison (Schellenberg et al., 2009) to the 
cpn60 reference database, cpnDB_nr (downloaded from http://www.cpndb.ca (Hill et al., 2004)). 
cpnDB_nr is a subset of the cpnDB database that includes a non-redundant collection of sequences 
representing all species in cpnDB, with a preference for inclusion of the type strain for each species 
when available. This reference assembly approach allows us to compare the microbial profiles 
from various cohorts under investigation, including the 182 pregnant women described in this 
study. To improve comprehension of some figures, we have pooled reads from OTU into “nearest 
neighbour species” based on their taxonomic label. Thus, the term “species” refers to OTUs that 
have the same nearest neighbour match in cpnDB.  
 
Statistical Analysis  
Comparisons across pregnancy status cohorts were based on analysis of variance 
(ANOVA), t-test and Chi-square, performed in IBM SPSS (Statistical Package for the Social 
Sciences, version 21) at 5% level of significance. For analysis of associations between 
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microbiological-socio-demographic characteristics and microbiome profiles, a false discovery rate 
(FDR) correction for multiple comparisons was applied (Benjamini and Hochberg, 1995). 
Alpha (Shannon diversity and Chao1 estimated species richness) and beta diversity 
(jackknifed Bray-Curtis dissimilarity matrices) were calculated as the mean of 100 subsamplings 
of 1000 reads (or all reads available when less than 1000) in QIIME (Quantitative Insights Into 
Microbial Ecology) (Caporaso et al., 2010). Plots of alpha diversity measures against bootstrap 
sample number were generated in R and visually inspected to ensure that an adequate sampling 
depth for each sample was achieved. Microbiome profiles were also compared based on Bray-
Curtis dissimilarity matrices using Principal coordinates analysis (PCoA) in QIIME. 
For community state type analysis, a Jensen-Shannon distance matrix was calculated in R 
with a custom distance function that calculates the square root of the Jensen-Shannon divergence 
(Endres and Schindelin, 2003). This distance matrix was used for hierarchical clustering using the 
‘hclust’ function in R, with Ward linkage.  
 
Data availability 
Raw sequence data files for the 182 samples described in this study were deposited to the 
NCBI Sequence Read Archive (Accession SRP073152, BioProject PRJNA317763). Due to ethical 
and legal restrictions related to protecting participant privacy imposed by the Mt. Sinai Hospital 
Research Ethics Board, all other relevant data are available upon request pending ethical approval. 
Please submit all requests to initiate the data access process to the corresponding author. 
 
Comparison between microbiological and demographic characteristics of the pregnant 
cohort.  
Microbiological and demographic characteristics were compared to CST (I, II, III, IVC, 
IVD, V), presence of Mollicutes (yes/no) and Ureaplasma (yes/no), microbiome richness 
(continuous variable) and diversity (continuous variable). Each of these five observations were 
compared to the following metadata: Nugent score category (BV-, intermediate BV, BV+), 16S 
RNA gene copy number (<104, 105-106, 107-108, >109), maternal age (18-25, 26-35, 36-45), 
maternal age (18-35, 35-45), BMI category (underweight, normal, overweight, obese), BMI (<25, 
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³25), pre-existing conditions (yes/no), surgeries in the past 10 years (yes/no), smoking (yes/no), 
drinking alcohol (yes/no), antibiotics at enrolment (yes/no), gestational age at delivery (<37, ³37), 
mode of delivery (vaginal, C-section), mode of delivery (vaginal, C-section, C-section-elective), 
fetal sex (male, female), neonate in level 2 care nursery (yes/no), birth weight (continuous variable) 
and Apgar score at 5 minutes (0-9).  
 
2.4. Results 
Cohort description 
Socio-demographic characteristics were comparable between pregnant and non-pregnant 
participants in terms of age, BMI, ethnicity and smoking status (Table 2.1). There was no 
significant difference in BMI (t-test, p=0.211) or ethnicity (Chi-square, p=0.372). However, 
pregnant women (age 33 ± 4) were on average older than non-pregnant women (age 31 ± 7) (t-
test, p<0.0001). The number of current smokers also differed between pregnant (2%) and non-
pregnant women (12%) (t-test, p<0.0001). 
Sixty-four percent of women described themselves as of Caucasian (white) background in 
the pregnant cohort, which was not different from the non-pregnant cohort. This was followed by 
East Asian (14%) and South Asian (7%). Ten percent of participants had other or mixed ethnicity. 
Pregnancy outcome data was not available for five women (5/182) since they delivered in different 
hospitals. Sixty women (33%) were nulliparous and the average gestational ages at enrolment and 
at delivery were 13+2 and 39+2 weeks, respectively (Table 2.2). Seventeen women (9.3%) had 
assisted conception and the majority of women had a vaginal delivery (74%) as opposed to C-
section (26%). All infants were liveborn and seven were delivered prior to 37 weeks gestation. 
Average birth weight was 3376 g and only three newborns weighed less than 2500 g at birth, with 
one of these being preterm (<37 weeks gestation). Vaginal microbiomes from the women who 
delivered infants less than 2500 g were determined to belong to CST II (L. gasseri dominated) 
(1/3) and III (L. iners dominated) (2/3). Five infants were admitted to a level 3 intensive-care 
unit (NICU), four of which were preterm. None of these five infants had low birth weight. Vaginal 
microbiomes of the mothers of the five infants were determined to belong to CST III (L. iners 
dominated) (1/5), V (L. jensenii dominated) (2/5), IVC (G. vaginalis subgroup A dominated) (1/5) 
and IVD (mixed microbiome) (1/5).  
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Table 2.1. Sociodemographic, clinical and microbiological characteristics across pregnant 
and non-pregnant cohort. 
1t-test; 2Chi-square. *Characteristic with significant differences (at 5% level) between pregnant 
and non-pregnant cohorts. + [(total copies of 16S rRNA gene) / swab] 
Characteristics Pregnant  Non-pregnant 
Age 1 * (n=182) (n=310) 
(Mean ± SD, Range)  33.6 ± 4.3 (21 - 45) 30.1 ± 7.6 (18.6 - 49.2) 
18-25 5 (2.7%) 111 (36%) 
26-35 122 (67%) 131 (42%) 
36-49 55 (30.2%) 68 (22%) 
Body mass index 1 (n=182) (n=307) 
(Mean ± SD, Range) 23.1 ± 4.21 (17 - 43) 23.9 ± 5.2 (15 - 50) 
Underweight (<18.50) 7 (3.8%) 18 (5.8%) 
Normal weight (18.51-24.9) 140 (76.9%) 194 (62.6%) 
Overweight (25.0-29.9) 26 (14.3%) 55 (17.7%) 
Obese (>30) 9 (4.9%) 40 (12.9%) 
Ethnicity 2 (n=182) (n=306) 
White 117 (64.3%) 200 (64.5%) 
East Asian 26 (14.3%) 60 (19.4%) 
South Asian 13 (7.1%) 12 (3.9%) 
Black 4 (2.2%) 9 (2.9%) 
Other/Mixed ethnicity 22 (12%) 25 (8%) 
Status (n=182) (n=310) 
Smoking 2 * 4 (2.2%) 39 (12.6%) 
Alcohol 2 11 (6%) no data 
Unprotected sex 2 * (in the past 4 days) (in the past 2 days) 
Yes  47 (25.8%) 45 (14.5%) 
Nugent category 2 * (n=172) (n=307) 
Not consistent with BV 111 (61%) 250 (80.6%) 
Intermediate BV 36 (20%) 25 (8%) 
Consistent with BV 25 (14%) 32 (10.3%) 
CST 2 * (n=182) (n=310) 
I 56 (30.7%) 156 (50.3%) 
II 12 (6.6%) 0 (0%) 
III 30 (16.5%) 50 (16.1%) 
IVA  0 (0%) 36 (11.6%) 
IVC 26 (14.3%) 22 (7.1%) 
IVD 42 (23.0%) 24 (7.7%) 
V 16 (8.8%) 22 (7.1%) 
+Estimated bacterial load 1 * (n=181) (n=309) 
(Mean ± SD, Range)  7.77 ± 0.93 (4.89 - 10.67) 6.83 ± 1.55 (3.50 - 10.31) 
104 or less 1 (0.5%) 47 (15.2%) 
105-106 27 (15%) 97 (31.4%) 
107-108 133 (73.5%) 146 (47.2%) 
109 or more 20 (11%) 19 (6.1%) 
Presence of Mollicutes 2 * 74 (40%) 217 (70%) 
Presence of Ureaplasma 2 * 42 (23%) 149 (48%) 
U. parvum 39 (21.4%) 127 (41%) 
U. urealyticum 3 (1.6%) 5 (1.6%) 
Both 0 (0%) 1 (0.3%) 
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Table 2.2. Pregnant cohort description and pregnancy outcomes. 
Characteristics Descriptive 
Folic acid (n=182) 
Before conception 49 (26.9%) 
During pregnancy 50 (27.5%) 
Vitamins  (n=182) 
Before conception 100 (54.9%) 
During pregnancy 174 (95.6%) 
Natural conception  (n=182) 
No 18 (9.9%) 
Parity (n=182) 
0 60 (33%) 
1 98 (53.8%) 
2-4 24 (13.2%) 
Pre existing medical condition (n=182) 
Hypo/Hyperthyroidism 16 (8.8%) 
Depression 9 (4.9%) 
Asthma 6 (3.3%) 
Anemia 5 (2.7%) 
Other condition 41 (22.5%) 
No 105 (57.7%) 
Surgeries in the past 10 years (n=182) 
Yes 83 (45.6%) 
Antibiotics at enrolment (for other infections 
excluding vaginitis/BV)  (n=182) 
Amoxicillin/Penicillin 8 (4.4%) 
Nitrofurantoin 3 (1.6%) 
Other 3 (1.6%) 
Unknown/Unsure 6 (3.3%) 
No 162 (89%) 
Gestational age at enrollment (n=182) 
(Mean ± SD, Range)  13+2 ± 1+1 (11+1 - 16+6) 
Gestational age at delivery (n=177) 
(Mean ± SD, Range)  39+2 ± 1+2 (32+1 -  41+2) 
Preterm birth (< 37 weeks) 7 (4%) 
Mode of delivery (n=177) 
Vaginal delivery 131 (74.0%) 
C-section  46 (26%) 
Fetal sex (n=177) 
Female (%) / Male (%) 91 (51%) / 86 (49%) 
Birth weight (g)  (n=177) 
(Mean ± SD, Range) 3376 ± 474 (1876 - 5200) 
Low (< 2500 g) 3 (1.7%) 
Normal (2500 - 4200 g) 166 (93.8%) 
Large (> 4200 g) 8 (4.5%) 
Apgar score at 5 min (n=177) 
(Mean ± SD, Range)  8.97 ± 0.17 (8 - 9) 
Neonate in level 3 care nursery after birth (n=176) 
 5 (2.8%) 
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Sequencing results and OTU analysis 
We characterized the vaginal microbiomes of pregnant women at low risk of preterm birth 
using pyrosequencing of the universal target region of the cpn60 gene. Sequence reads from the 
vaginal microbiomes of pregnant women were mapped on to a manually curated reference set of 
1,561 OTU sequences as described in the methods. Raw sequence data files for the 182 samples 
described in this study were deposited to the NCBI Sequence Read Archive (BioProject 
PRJNA317763). A total of 1,415,117 cpn60 reads was generated. Median and average read count 
per sample was 5,024 and 7,775 (range 494 – 43,245), respectively. Average read length was 448 
bp. The average MAPQ value was 21.1.  
Results of Bowtie2 mapping showed that these reads corresponded to 645 OTUs from the 
reference assembly (Supplementary Table 2.4S). A total of 82 OTUs (corresponding to 53 nearest 
neighbour “species”) were at least 1% abundant in at least one sample. And only 22 “species” were 
detected in at least 50% of samples (Table 2.3). Although the ranges of percent identity to reference 
sequences are large in some cases, reflecting the diversity in the community, the most abundant 
OTU were at the high end of the range. In fact, of the 25 most abundant OTU in the study 
(accounting for 95% of the sequence reads generated), 22/25 were >95% identical to their nearest 
neighbour (Supplementary Table 2.4S). 
Most reads (68.8%) were identified as Lactobacillus spp. And only three OTUs, all of 
which matched to Lactobacillus spp., accounted for 55.7% of all reads generated: OTU 1403: L. 
crispatus (30.6%), OTU 1174: L. iners (15.4%) and OTU 1479: L. jensenii (9.7%). Species with 
the highest sample prevalence were L. jensenii (181/182), Streptococcus devriesei (180/182), L. 
crispatus (178/182), L. acidophilus (178/182), followed by Atopobium vaginae (176/182) and 
Weissella viridescens (173/182). Even though OTUs with similarity to Streptococcus devriesei 
and Weissella viridescens were detected in most samples, they had very low abundance, 
representing only 0.33% and 0.22% of all reads, respectively (Supplementary Table 2.4S).  
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Table 2.3. Prevalence and proportion of total reads for “species” detected in at least 50% of 
samples. 
Nearest neighboura 
% OTU identity 
range 
Prevalence /182 
(%) 
% total 
reads  
 Lactobacillus jensenii 81.6 - 100 181 (99.4) 10.66 
 Streptococcus devriesei 83 180 (98.9) 0.34 
 Lactobacillus crispatus 78.8 - 99.8 178 (97.8) 31.93 
 Lactobacillus acidophilus 91.8 - 100 178 (97.8) 1.22 
 Atopobium vaginae 82.5 - 96.9 176 (96.7) 1.62 
 Weissella viridescens 58.8 - 99.5 173 (95.0) 0.22 
 Desulfotalea psychrophila 76.1 167 (91.7) 0.12 
 Lactobacillus iners 86.8 - 100 165 (90.6) 15.85 
 Lactobacillus gasseri 65.4 - 100 164 (90.1) 5.69 
 Streptococcus parasanguinis 94.9 – 97.0 162 (89.0) 0.08 
 Prevotella tannerae 77.5 - 98.7 162 (89.0) 0.07 
 Faecalibacterium cf. prausnitzii 77.5 - 79.6 159 (87.3) 0.16 
 Gardnerella vaginalis subgroup C 78.5 - 99.3 156 (85.7) 4.45 
 Peptoniphilus harei 89.9 - 98.5 156 (85.7) 0.07 
 Clostridium innocuum 75.4 148 (81.3) 0.06 
 Sphingobium yanoikuyae 99.3 - 99.4 145 (79.6) 0.08 
 Eubacterium siraeum 84.4 144 (79.1) 0.05 
 Gardnerella vaginalis subgroup B 93.2 - 99.6  133 (73.0) 0.54 
 Massilia timonae 82 126 (69.2) 0.03 
 Gardnerella vaginalis subgroup A 86.7 - 99.6 123 (67.5) 7.64 
 Bifidobacterium breve 89.6 - 99.5 119 (65.3) 2.12 
 Megasphaera sp. genomsp. type 1 58.1 - 86.7 112 (61.5) 3.09 
aClosest match in the cpnDB reference database based on sequence identity. 
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Community state type analysis 
Hierarchical clustering of vaginal microbiome profiles from pregnant women resulted in 
the resolution of six Community State Types (CST) (Figure 2.1). All Lactobacillus-dominated 
CST, previously described by Ravel and Gajer (Ravel et al., 2011) based on pyrosequencing of the 
16S rRNA gene, were detected. Most profiles (114/182) were dominated by one of four 
Lactobacillus species that define four different CST: CST I (L. crispatus, n=56), CST II (L. 
gasseri, n=12), CST III (L. iners, n=30), and CST V (L. jensenii, n=16). All non-Lactobacillus-
dominated samples were assigned to CST IVC or CST IVD, as previously described by Albert et 
al. (Albert et al., 2015). CST IVC (n=26) is dominated by Gardnerella vaginalis subgroup A, 
Megasphaera sp. genomosp type 1, and G. vaginalis subgroup C. CST IVD (n=42) was the most 
heterogeneous group, including a mixture of Bifidobacterium dentium, B. infantis, B. breve, L. 
delbrueckii, Alloscardovia omnicolens, G. vaginalis subgroup C, and Atopobium vaginae.  
CST distribution of the pregnant participants was compared to the previously described 
non-pregnant cohort. Twelve pregnant women had microbiome profiles identified as the L. 
gasseri-dominated CST II, which was not observed among the profiles of non-pregnant women 
(Albert et al., 2015). Additionally, CST IVA was not detected among pregnant women, including 
61 with intermediate or high Nugent scores. In the non-pregnant group, 14/57 (24.6%) of women 
with intermediate or high Nugent scores were assigned to CST IVA, with the remainder in CST 
IVC (15/57, 26.3%), CST IVD (20/57, 35.1%) or one of the Lactobacillus dominated CST (8/57, 
14.0%). CST IVA was defined by Albert et al. (Albert et al., 2015) as a very heterogeneous group, 
dominated by G. vaginalis subgroup B or Atopobium vaginae, or combinations of Stapylococcus, 
Streptococcus, Prevotella, Alloscardovia, Gardnerella, Bifidobacterium and Lactobacillus. As 
expected, Lactobacillus-dominated CST, i.e. CST I, CST II, CST III and CST V, were associated 
with low Nugent score samples (BV negative), while CST IVC and CST IVD were associated with 
intermediate and high Nugent scores (BV positive) (Figure 2.1). Although there were differences 
regarding presence/absence of specific CST in the pregnant and non-pregnant cohorts, overall 
microbial profiles could not be distinguished based on pregnancy status alone (Figure 2.2 A-B). 
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Figure 2.1. Vaginal microbial profiles of pregnant women at low risk of preterm birth. 
Heatmap of hierarchical clustering of Jensen-Shannon distance matrices with Ward linkage on the 
relative proportions of reads for each OTU within individual vaginal samples (n=182). Each 
column represents a woman’s vaginal microbiome profile, and each row represents an OTU. Only 
OTUs that are at least 1% abundant in at least one sample are shown. The proportion of the total 
microbiome comprised is indicated by white to red colour according to the legend. The coloured 
bars above the heatmap show the community state type (CST) and the Nugent score category 
(Nugent) for each woman. Legend: white = missing data. 
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Figure 2.2. CST and pregnancy status of participants. 
Jackknifed principal coordinates analysis (PCoA) of Bray-Curtis distance matrices of microbial 
profiles from all participants in the study, with individuals coloured by CST (A) or pregnancy 
status (B). Samples with fewer than 1000 sequence reads (16/492) were not plotted. 
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Abundance of Lactobacillus spp.  
The proportion of Lactobacillus spp. in vaginal samples followed a bimodal distribution 
(Figure 2.3). Microbiomes of most pregnant women had either low (0-20%, n=46/182) or high 
(80-100%, n=113/182) Lactobacillus spp. abundance, whereas only 23/182 (12.6%) of samples 
had intermediate levels (20-80%) of Lactobacillus spp. Also, pregnant women in Lactobacillus-
dominated CST had greater proportions of lactobacilli (95.7% ± 6.2) (i.e. were more Lactobacillus 
dominated) than non-pregnant women (89.9% ± 14.8) (t-test, p<0.0001) (Figure 2.4A). 
 
Ecological analysis  
Assessment of alpha diversity revealed that microbiomes of pregnant women were less 
diverse (Shannon diversity index, 1.3 ± 0.9) and less rich (Chao1, 38.9 ± 15.3) when compared to 
those of non-pregnant women (1.6 ± 1.1; 47.6 ± 26) (t-test, p<0.001) (Figure 2.4B-C). When 
comparisons were conducted within CST, profiles of pregnant women in CST I, III and V were 
less diverse and less rich than profiles of non-pregnant women in the same category (t-test, p<0.05) 
but no statistically significant differences were observed in CST IVC and IVD. 
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Figure 2.3. Lactobacillus spp. abundance. 
Bimodal distribution of vaginal microbiome profiles of non-pregnant (upper panel) and pregnant 
(lower panel) women based on Lactobacillus spp. abundance (%). 
 
 
 
 
 
 
 
0 20 40 60 80 100
Lactobacillus abundance (%)
N
um
be
r o
f w
om
en
150
125
100
75
50
25
0
150
125
100
75
50
25
0
Pregnant
N
on-pregnant
Pregnancy status
 49 
 
 
 50 
Figure 2.4. Comparison of the microbial community features between pregnant and non-
pregnant participants within each CST. 
Lactobacillus spp. abundance (A), Shannon diversity (B), Chao1 richness (C), Mollicutes 
prevalence (D), Ureaplasma prevalence (E) and bacterial load (F) were compared between 
pregnant and non-pregnant women in each CST. For continuous variables (A, B, C, F), the mean 
value is plotted with error bars indicating standard deviation. Significant differences (p<0.05) 
between pregnant and non-pregnant women within each CST are indicated by an asterisk. p-values 
in the main panels refer to the comparison between pregnant and non-pregnant women in 
Lactobacillus-dominated CST (yellow panel) and non-Lactobacillus-dominated CST (blue panel). 
A comparison of pooled data from all CST is shown in the right-most panel. Statistical tests used 
are indicated on the right side of the graph. 
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Prevalence of Mollicutes and Ureaplasma (PCR) 
Mollicutes (Mycoplasma and/or Ureaplasma) were detected by family-specific 
conventional PCR in 74/182 (40%) of pregnant women, but prevalence varied between CST: 43%, 
25%, 43%, 18%, 50% and 43% in CST I, II, III, V, IVC and IVD, respectively (Figure 2.4D). 
Ureaplasma species were detected by genus-specific PCR in samples of 42/182 (23%) pregnant 
women, with 39 testing positive for U. parvum and 3 for U. urealyticum (Figure 2.4E). All 
pregnant women PCR positive for U. urealyticum (3/3) were in CST III. Pregnant women were 
less likely to be positive for Mollicutes detection by PCR when compared to non-pregnant women, 
regardless of CST (Chi-square, p<0.0001, Mollicutes positive: 217/310 non-pregnant women and 
74/182 pregnant women) (Figure 2.4D). Additionally, pregnant women in both Lactobacillus- and 
non-Lactobacillus-dominated CST had lower prevalence of Ureaplasma species than non-
pregnant women (Chi-square, p<0.0001, Ureaplasma positive: 149/310 non-pregnant women and 
42/182 pregnant women) (Figure 2.4E).  
 
Total bacterial load (qPCR)  
Total bacterial load was assessed based on qPCR targeting the 16S rRNA gene, and 
expressed as log copy number per swab (Figure 2.4F). Average bacterial load was log 7.77 ± 0.93 
16S rRNA gene copies per swab (range log 4.89 – 10.67). Bacterial load within each CST for the 
pregnant women’s samples were: CST I (log 7.6 ± 0.7), CST II (log 7.3 ± 0.8), CST III (log 8.0 ± 
0.7), CST V (log 7.0 ± 0.7), CST IVC (log 8.8 ± 1) and CST IVD (log 7.4 ± 0.7).  
Higher bacterial loads were detected in samples from pregnant women (log 7.7 ± 0.9) when 
compared to non-pregnant women (log 6.8 ± 1.5) (t-test, p<0.0001) (Figure 2.4F). Comparisons 
within CST confirmed that samples from pregnant women in CST I (log 7.6 ± 0.7), CST III (log 
8.0 ± 0.7) and CST IVC (log 8.8 ± 1) had higher bacterial load than non-pregnant women in the 
same categories (CST I = log 6.7 ± 1.4, CST III = log 6.7 ± 1.4. CST IVC = log 7.3 ± 1.5) (t-test, 
p<0.0001). In a second analysis, samples were pooled into two groups: Lactobacillus- (I, II, III, 
V) and non-Lactobacillus dominated (IVA, IVC, IVD) CST. Bacterial load values were 
statistically different (t-test, p<0.0001) between pregnant and non-pregnant women in both groups, 
with pregnant women having greater bacterial load (Lactobacillus-dominated CST: log 7.6 ± 0.8, 
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non-Lactobacillus dominated CST: log 8 ± 1) than non-pregnant women (Lactobacillus-dominated 
CST: log 6.7 ± 1.4, non-Lactobacillus dominated CST: log 7.0 ± 1.8). 
 
Relationships between microbiological and socio-demographic characteristics across the 
pregnant cohort 
The characteristics of the microbial community of pregnant women were analyzed in terms 
of their relationship with the socio-demographic and clinical data. First, we determined whether 
there was any relationship between the CST (I, II, III, IVC, IVD, V) and demographic 
characteristics such as BMI, ethnicity, unprotected sex, folic acid intake, vitamins, natural 
conception, antibiotic use, gestational age at delivery, mode of delivery, neonatal in high level care 
nursery, parity, pre-existing conditions, surgeries (past 10 years), smoking and alcohol drinking 
status as well as Nugent score (Figure 2.5). Besides Nugent score, the only significant interaction 
was between CST and parity (0 or ≥1) (Chi-square, p=0.033), with 45% of women at parity 0 in 
CST I (27/60) and 23% of women at parity ≥ 1 in CST I (29/122). Microbiological and 
demographic characteristics were also compared to presence of Mollicutes (yes/no) and 
Ureaplasma (yes/no), microbiome richness (continuous variable) and diversity (continuous 
variable). These four observations were compared to 29 other variables. PCR detection of 
Mollicutes (p=0.017) and Ureaplasma (p=0.017) was significantly associated with bacterial load 
(Chi-square).  
Although smoking has been previously shown to have a possible effect on the vaginal 
microbiota (Brotman et al., 2014a), there was no significant association between CST and smoking 
status in this study (Chi-square, p>0.05). Also, microbiome analysis was redone excluding samples 
from participants who are smokers (results not shown). The results led to the same conclusions 
regarding the overall microbiome (PCoA), Lactobacillus abundance, Shannon diversity, Chao1 
richness, bacterial load and Mollicutes/Ureaplasma prevalence. 
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Figure 2.5. Socio-demographic characteristics of pregnant participants in relation to CST. 
Hierarchical clustering of microbiome profiles based on Jensen-Shannon distance matrices with 
Ward linkage of the relative proportions each OTU within individual vaginal samples (n=182). 
Demographic characteristics are indicated on the left side, and categories indicated on the right 
side of each row. Numbers on the right side indicate adjusted p-values of Chi-square test after false 
discovery rate correction. Fisher’s Exact test was conducted for variables where at least one 
category had an expected frequency of less than 5. Legend: white = missing data. 
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2.5. Discussion  
In this study we characterized the vaginal microbiome of pregnant women with healthy 
ongoing pregnancies, at low risk of experiencing pregnancy complications such as preterm birth, 
and compared these results to our previously characterized cohort of non-pregnant women of 
similar ethnicity. We focused our studies on the vaginal microbiome at 11-16 weeks. Pregnancy 
pathologies such as spontaneous preterm birth and early onset pre-eclampsia have their origins in 
the first or early second trimester and therapeutic interventions at this stage have been shown to 
be efficacious (Roberge et al., 2012). This is also the gestational age at which pregnant women in 
Canada often have their first prenatal visit with a health care provider and a vaginal swab is taken 
to assess the presence or absence of vaginal/cervical infections.  
We used the cpn60 universal target region in our study due to its superior resolution of 
bacterial taxa relative to 16S rRNA sequences (Paramel Jayaprakash et al., 2012; Vermette et al., 
2010; Verbeke et al., 2011; Hill et al., 2006a; Lan et al., 2016; Masson et al., 2006; Brousseau et 
al., 2001), its establishment as a preferred barcode for bacteria (Links et al., 2012), and the 
availability of a reference database of vaginal bacterial cpn60 sequences from previous studies 
(Hill et al., 2005b; Schellenberg et al., 2011; Chaban et al., 2014; Albert et al., 2015; Schellenberg 
et al., 2012). This approach has been applied to numerous animal (Mckenney et al., 2014; Costa 
et al., 2014; Desai et al., 2012), human (Peterson et al., 2016) and environmental microbial 
populations (Bondici et al., 2013; Dumonceaux et al., 2006; Links et al., 2014; Oliver et al., 2008) 
and has previously resulted in discovery of novel community state types based on the resolution 
of distinct subgroups of Gardnerella vaginalis (Albert et al., 2015). 
In order to make valid comparisons between pregnant and non-pregnant women 
microbiomes, we analyzed the results from both cohorts based on socio-demographic 
characteristics (Table 2.1). The two cohorts were comparable, with no significant differences 
detected in any category except for maternal age and smoking. Differences regarding smoking 
status were not surprising since behavioural changes such as reduced drinking and smoking have 
been documented in pregnancy (Crozier et al., 2009). Although statistically significant, the 
identified difference in maternal age (pregnant: 33 ± 4 and non-pregnant: 30 ± 7) was not 
considered biologically relevant since the difference of the mean values was only 3 years.  
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Overall microbial profiles could not be distinguished from each other based on pregnancy 
status alone. However, a more detailed analysis revealed several differences between the 
microbiomes of healthy pregnant women and those of healthy non-pregnant women. The BV-
associated CST IVA (dominated by G. vaginalis subgroup B and Atopobium) was not detected in 
the pregnant cohort, whereas L. gasseri dominated CST II, which was not detected among the 310 
non-pregnant women in our previous study (Albert et al., 2015), was detected in 12 women in the 
pregnant cohort. Pregnant women in Lactobacillus-dominated CST had higher relative abundance 
of Lactobacillus spp. when compared to non-pregnant women. Vaginal microbiomes of pregnant 
women had lower richness and diversity and a correspondingly lower prevalence of Mollicutes 
and Ureaplasma when compared to non-pregnant women. 
Microbial profiles from the pregnant women clustered in six different groups, mostly 
Lactobacillus-dominated CST (CST I, CST II, CST III and CST V), originally defined by Ravel 
& Gajer (Brotman et al., 2014b). Non-Lactobacillus-dominated (CST IV) profiles are described in 
the literature as either very heterogeneous or dominated with BV-associated bacteria (Romero et 
al., 2014b; Albert et al., 2015). None of the pregnant women, including 61 with intermediate or 
high Nugent scores, were identified as belonging to CST IVA, which is characterized by 
dominance of G. vaginalis subgroup B and Atopobium (Albert et al., 2015). This distribution is 
notably different from the non-pregnant cohort, where 24.6% of women with intermediate or high 
Nugent scores were assigned to CST IVA (Albert et al., 2015). Results of other studies have 
suggested that CST dominated by BV-associated microorganisms are less frequently detected in 
pregnancy (Romero et al., 2014c; MacIntyre et al., 2015). While our study design does not allow 
us to address the issue of overall prevalence of BV-associated CST in pregnancy, our results 
suggest that the distribution of these CST among pregnant women may be different than in non-
pregnant women. This suggests a role CST IVA could be playing in early pregnancy loss.  
OTUs that were weakly similar to Streptococcus and Weissella species were detected in 
most samples, but they represented only 0.33% and 0.22% of all reads, respectively. These OTUs 
were previously described as highly prevalent in the vaginal microbiome of healthy non-pregnant 
women (Albert et al., 2015). They have low sequence identity to any reference sequences in the 
cpnDB_nr database (OTU 0026: S. devriesei 83% and OTU 0021: W. viridescens 58.8%). 
However, this subset of the cpnDB database contains only selected representative sequences of 
named species. A broader search shows that these OTU are more similar to metagenomic 
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sequences derived from the fecal microbiome (OTU 0021 is 97% identical to Genbank accession 
GQ178631) or oral microbiome (OTU 0026 is 85% identical to KJ406686) that represent 
uncharacterized Firmicutes; reminders of the common but still uncharacterized constituents of the 
human microbiome.  
Our findings of greater Lactobacillus abundance and lower richness and diversity in the 
vaginal microbiomes of pregnant women relative to non-pregnant women are consistent with 
previous studies in the literature. Aagaard et al. (Aagaard et al., 2012) analyzed the microbiomes 
of 24 healthy, pregnant American women sampled at three different locations within the vagina. 
Vaginal site did not drive the structure of the microbial community, but the authors found that 
overall microbiomes of pregnant women were less diverse and less rich when compared to non-
pregnant women. Similarly, Walther-António et al. (Walther-António et al., 2014) described the 
microbiomes of 12 White pregnant American women based on longitudinal sampling and observed 
reduced microbiome diversity and higher Lactobacillus spp. relative abundance during pregnancy. 
Romero et al. (Romero et al., 2014c) also reported that Lactobacillus spp. abundance was 
significantly higher in pregnant women in comparison to non-pregnant and increased as a function 
of gestational age. They also described higher stability of the microbiome during pregnancy when 
compared to reproductive age non-pregnant women. In another longitudinal study, MacIntyre et 
al. (MacIntyre et al., 2015) analyzed the microbiomes of 42 British women during pregnancy and 
the post-partum period. L. jensenii-dominated profiles were more common among these women 
than Northern American women. The authors also observed that post-partum microbiomes become 
less Lactobacillus spp. dominant and more rich and diverse (i.e. more similar to the microbiomes 
of non-pregnant women) regardless of ethnicity, providing strong support for the idea that 
pregnancy has a transient effect on the vaginal microbial community. Importantly, the conclusions 
of these studies and our current study are consistent despite differences in the cohort studied 
(Canadian, American or European cohorts of varying mixtures of ethnicity), universal target 
amplified (cpn60 universal target or 16S rRNA gene) or sequencing platforms used (454/Roche 
pyrosequencing or Illumina MiSeq). 
The explanations for these pregnancy-associated changes are not well established, but a 
relationship between sex steroid hormone levels and the composition of the vaginal microbiome 
has been previously reported (Brotman et al., 2014b; Devillard et al., 2004; Farage et al., 2010). 
Increased levels of estrogen during pregnancy lead to increased thickness of the vaginal mucosa 
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and increased deposition of glycogen (BMJ, 1943; Cruickshank and Sharman, 1934). Glycogen is 
the main carbohydrate utilized by Lactobacillus spp. for the production of lactic acid, which 
contributes to the protective effect of a low vaginal pH (Mirmonsef et al., 2014; Prince et al., 2014; 
O’Hanlon et al., 2013; Cruickshank, 1934). This may contribute to the greater dominance of 
Lactobacillus in pregnancy and, consequently, the lower richness and diversity in this cohort. 
A novel finding in our study was the lower prevalence of Mollicutes and Ureaplasma in 
pregnancy detected by family and genus-specific PCR. Mollicutes have been associated with 
preterm birth, preterm premature rupture of membranes and low birth weight (Perni et al., 2004; 
Foxman et al., 2014; Kwak et al., 2014). The lower prevalence of Mollicutes and Ureaplasma is 
consistent with the overall lower species richness and diversity in the vaginal microbiomes of 
pregnant relative to non-pregnant women. We also found that pregnant women had higher bacterial 
load than non-pregnant women as estimated by quantitative PCR targeting the 16S rRNA gene. 
Hormone induced production of glycogen may offer a nutritionally richer environment for 
bacterial growth in the vagina during pregnancy. Additionally, it is known that pregnancy alters 
the amount and consistency of the mucus, which becomes more abundant and thicker (Chrétien, 
1978). Thus, it is possible that swabs sampled from the pregnant women carried more material 
when compared to non-pregnant women. We are unable to resolve this question since the swabs 
were not weighed before DNA extraction steps. In addition to pregnancy associated physiological 
differences and mucus consistency, other technical factors such as storage conditions or inherent 
differences in the study populations cannot be ruled out. 
One limitation of this study was the assessment of pregnancy outcomes and microbial 
profiles since there were very few poor outcomes in this cohort, as it would be expected for a low 
risk group. This study, however, does provide crucial baseline information for future studies in 
pregnant women. In addition, we detected significant interaction between parity and CST. 
Considering the large number of variables in the metadata, analysis of these associations should 
be interpreted with caution. We can speculate that the prevalence of the L. crispatus-dominated 
CST I among nulliparous women might be associated with more cautious or health conscious 
behaviour among women in their first gestation. Pregnancy-induced physiologic alterations that 
can persist after delivery have been previously reported (Clifton et al., 2012). In addition to 
physiologic changes, a disturbed vaginal microbiome that persisted for up to a year post-partum 
has also recently been described (DiGiulio et al., 2015). Those persistent changes might explain 
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the association between CST and parity we observed, with post-partum microbiome changes 
affecting the current status of primiparous and multiparous women. Further studies are needed to 
investigate these relationships in more detail. 
In conclusion, we have identified several differences in the composition of the vaginal 
microbial communities of pregnant women living in Canada relative to non-pregnant women: 
larger total bacterial community, lower richness and diversity, higher Lactobacillus abundance and 
lower Mollicutes/Ureaplasma prevalence. These findings give us a better understanding of the 
vaginal microbiome in pregnancy, which is a critical step toward being able to exploit the 
diagnostic potential of the microbiome for the prediction of adverse pregnancy outcomes as well 
as to explore alternative therapeutic procedures through microbiological intervention. Establishing 
an understanding of the normal microbiome in low risk pregnant women is a vital baseline for 
comparison to the microbiome of women who have adverse perinatal outcomes such as preterm 
birth. 
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Chapter transition 
Preterm birth affects millions of babies every year and preterm birth complications are the 
leading cause of neonatal mortality. Preterm birth is a multifactorial condition and an intra-uterine 
infection ascending from the vagina is thought to be one of the potential contributors to preterm 
birth. In the previous chapter, I established a baseline description of the vaginal microbiome in 
healthy pregnancies. Having the information of how the microbiome in a “healthy state” in 
pregnancy looks like provided me the opportunity to investigate the effect of the microbiota in 
preventing or leading to preterm birth. The goal was to identify traits in the microbiome of women 
who had spontaneous preterm birth that could be potentially used as diagnostic targets. The results 
of this study showed that the microbiomes of women who experienced preterm birth have higher 
richness and diversity, and Mollicutes prevalence than the microbiomes of women with term 
deliveries. At the overall level, I did not identify a core microbiome or specific traits that could 
predict outcome, i.e., preterm birth. The differences in the microbial profiles of women with term 
and preterm deliveries, however, suggest that the microbiome indeed is somehow associated with 
reproductive outcomes. 
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3.1. Abstract 
The bacterial community present in the female lower genital tract plays an important role 
in maternal and neonatal health. Imbalances in this microbiota have been associated with negative 
reproductive outcomes, such as spontaneous preterm birth (sPTB), but the mechanisms underlying 
the association between a disturbed microbiota and sPTB remain poorly understood. An 
intrauterine infection ascending from the vagina is thought to be an important contributor to the 
onset of preterm labour. Our objective was to characterize the vaginal microbiota of pregnant 
women who had sPTB (n=46) and compare to those of pregnant women who delivered at term 
(n=170). Vaginal swabs were collected from women at 11-16 weeks of gestational age. Microbiota 
profiles were created by PCR amplification and pyrosequencing of the cpn60 universal target 
region. Profiles clustered into seven Community State Types: I (Lactobacillus crispatus 
dominated), II (Lactobacillus gasseri dominated), III (Lactobacillus iners dominated), IVA 
(Gardnerella vaginalis subgroup B or mix of species), IVC (G. vaginalis subgroup A dominated), 
IVD (G. vaginalis subgroup C dominated) and V (Lactobacillus jensenii dominated). The 
microbiota of women who experienced preterm birth (<37 weeks gestation) had higher richness 
and diversity, and higher Mollicutes prevalence when compared to those of women who delivered 
at term. The two groups did not cluster according to CST, likely because CST assignment is driven 
in most cases by the dominance of one particular species, overwhelming the contributions of more 
rare taxa. In conclusion, we did not identify a specific microbial community structure that predicts 
sPTB, but differences in microbiota richness, diversity and Mollicutes prevalence were observed 
between groups. Although a causal relationship remains to be determined, our results confirm 
previous reports of an association between Mollicutes and sPTB, and further suggest that a more 
diverse microbiome may be important in the pathogenesis of some cases.  
Keywords: microbiome, vagina, Lactobacillus, CST, diversity, richness, Mollicutes, preterm 
birth, pregnancy, infection. 
 
3.2. Introduction 
Preterm birth is defined as delivery before 37 completed weeks of gestational age (WHO 
et al., 2012) and can be further sub-categorized in: extremely preterm (≤27+6 weeks+days), very 
preterm (28 to 31+6), and late preterm (32 to 36+6) (Quinn et al., 2016). Preterm birth comprises 
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11% of all livebirths worldwide and its complications are estimated to cause 35% of world’s 
neonatal deaths, which represents 3.1 million deaths annually (Blencowe et al., 2012). Children 
who are born prematurely also have higher rates of cardiovascular disorders, respiratory distress 
syndrome, neurodevelopmental disabilities and learning difficulties compared with children born 
at term (Behrman and Butler, 2007). 
Preterm birth is a complex multi-factorial condition with several known risk factors, such 
as low and high maternal ages (Fraser et al., 1995; Jacobsson et al., 2004; Schempf et al., 2007), 
low BMI (Han et al., 2011), black ethnicity (Kistka et al., 2007), tobacco use, heavy alcohol intake, 
illicit drug use (Behrman and Butler, 2007), close temporal proximity to a previous delivery 
(Conde-Agudelo et al., 2006), and multiple gestation (Stock and Norman, 2010). Although studied 
extensively, some preterm cases remain unexplained for women with no known risk factors. 
Intrauterine infection with organisms ascending from the vagina has been hypothesized as an 
important contributor to preterm birth since many organisms isolated from the amniotic 
fluid/membranes of women who experienced preterm are also found in the lower genital tract of 
pregnant women (Gardella et al., 2004; Krohn et al., 1995; Hillier et al., 1988; Romero et al., 
1989). A large number of studies support this hypothesis based on the strong association between 
intra-amniotic bacterial infection and preterm birth (Gardella et al., 2004; Hillier et al., 1988; 
Romero et al., 1989; Watts et al., 1992; Yoon et al., 2001; DiGiulio et al., 2008; Hillier et al., 1993; 
Jacobsson et al., 2005).  
The microbiological diagnosis of a “normal” or disturbed vaginal microbiota has 
historically been based on the Nugent score, the current gold standard diagnostic method that relies 
on Gram stain of vaginal smears (Nugent et al., 1991). The “normal” vaginal microbiota in non-
pregnant reproductive aged women is understood to be dominated by Lactobacillus species, while 
an abnormal microbiota (defined as Bacterial vaginosis) is characterized by low abundance of 
lactobacilli and an overgrowth of anaerobic bacteria, such as Gardnerella vaginalis, Prevotella 
spp., Bacteroides spp., Mobiluncus spp., and Mycoplasma hominis (Hill, 1993). In low risk 
pregnant women, it has been shown that the vaginal microbiota has reduced richness and diversity, 
and increased abundance of lactobacilli compared to those of non-pregnant women (Romero et al., 
2014c; Freitas et al., 2017; Aagaard et al., 2012; Walther-António et al., 2014; MacIntyre et al., 
2015). An abnormal microbiota has been previously associated with preterm birth (Leitich et al., 
2003), but only a few in depth culture independent studies of the vaginal microbiota of women 
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who had preterm birth have been published, with inconsistent conclusions (Romero et al., 2014b; 
Hyman et al., 2014; DiGiulio et al., 2015).  
The objective of this study was to assess whether there are differences in the vaginal 
microbiota composition of women who had spontaneous preterm birth (sPTB) and term delivery 
early in gestation that could be further investigated as diagnostic indicators of preterm birth risk. 
Microbiome profiling was based on sequencing of the cpn60 universal target, which provides 
higher resolution than 16S rRNA variable regions (Links et al., 2012) and allows the resolution of 
Gardnerella vaginalis subgroups, a hallmark bacterium in the disturbed microbiota (Paramel 
Jayaprakash et al., 2012). 
 
3.3. Methods 
Study population and sampling 
This study received ethical approval from the University of British Columbia Children’s 
and Women’s Research Ethics Board (Approval Number H14-01954), and Mount Sinai Hospital 
Research Ethics Board (Approval Number 15-0184-E). All participants provided written consent 
at enrolment. 
This retrospective cohort study analyzed the vaginal microbiota of women who 
experienced spontaneous preterm birth (sPTB) and compared the resulting microbial profiles to 
those of pregnant women who delivered at term. The bacterial profiles of pregnant Canadian 
women at low-risk of sPTB who had term deliveries (n=170) were previously generated by our 
research group (Freitas et al., 2017). The vaginal microbial profiles of Canadian women who had 
preterm birth originated from samples of this previous study (n=7) (Freitas et al., 2017), and from 
the Ontario Birth Study (n=39), resulting in 46 samples. The Ontario Birth Study is an open 
longitudinal pregnancy cohort at Mount Sinai Hospital, Toronto, Canada. It is a platform for 
studies of both pregnancy complications as well as Developmental Origins of Health and Disease 
related research. All biospecimens, including maternal vaginal swabs and maternal and infant 
blood, are collected concurrently with routine clinical specimens to reduce the burden on study 
participants. Detailed demographic and lifestyle characteristics are obtained from women during 
pregnancy and postpartum and clinical information is extracted from the health records. For the 
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purposes of this report, self-administered vaginal swabs were taken at 16 weeks gestation and 
placed in dry tubes prior to being placed in -80˚C for storage in the Lunenfeld Tanenbaum 
Research Institute Biospecimen Storage and processing Laboratory. Specimens from all cohorts 
were processed similarly in terms of sample collection, storage, DNA extraction, library 
preparation and sequencing. 
Clinical and behavioural questionnaire data (pregnancy history, family and personal 
medical history, psychosocial health, demographic factors and other lifestyle and environmental 
exposures) were transferred to the Research Electronic Data Capture (REDCap) database protected 
by a secure server (Harris et al., 2009). For the PTB group, eligible participants for this study were 
women who had undergone preterm delivery at greater than 20 weeks but less than 37 weeks 
gestational age, where onset of labour occurred spontaneously or in association with cervical 
incompetence or preterm premature rupture of membranes (PPROM). Vaginal swabs collected 
from pregnant women (both PTB and term groups) at 11-16 weeks of gestational age were used 
for bacterial genomic analysis 
Total nucleic acid was extracted from swabs using the MagMAX™ Total Nucleic Acid 
Isolation Kit (Life Technologies, Burlington, ON, Canada) as per manufacturer’s instructions. Kit 
reagents are aliquoted to eliminate repeated accessing of open reagents, and samples are processed 
in small batches using filter-tips to prevent cross-contamination. Pipettes and other lab surfaces 
are regularly treated with DNA surface decontaminant (DNA Away, Thermo Fisher Scientific, 
Waltham, MA).  
 
Total Bacterial DNA (qPCR) and Detection of Mollicutes (PCR) 
Quantitative PCR (qPCR): Total bacterial DNA quantity in each sample was estimated 
using a SYBR Green assay based on amplification of the V3 region of the 16S rRNA gene. Primer 
sequences were as follows: SRV3-1 (5’-CGGYCCAGACTCCTAC-3’), SRV3-2 (5’-
TTACCGCGGCTGCTGGCAC-3’) (Lee et al., 1996). Reactions run on a MyiQ thermocycler 
using the following cycling parameters: 95°C for 3 min, followed by 30 cycles of 95°C for 15 sec., 
62°C for 15 sec., 72°C for 15 sec., with a final extension at 72°C for 5 minutes (Chaban et al., 
2013). 
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Conventional PCR: Some Mollicutes (Mycoplasma and Ureaplasma) species lack a cpn60 
gene (Hill et al., 2004). Thus, we performed a family-specific semi-nested PCR targeting the 16S 
rRNA gene to detect Mollicutes (van Kuppeveld et al., 1992), and a PCR targeting the multiple 
banded antigen gene to detect Ureaplasma spp.. PCR products from U. parvum and U. urealyticum 
can be differentiated by size (Watson et al., 1990).  
 
cpn60 Universal Target (UT) PCR and Pyrosequencing 
Universal primer PCR targeting the 549-567 bp cpn60 UT region was performed using a 
mixture of cpn60 primers consisting of a 1:3 molar ratio of primers H279/H280:H1612/H1613, as 
described previously (Chaban et al., 2014; Hill et al., 2006b; Schellenberg et al., 2011). To allow 
multiplexing of samples in a single sequencing run, primers were modified at the 5' end with one 
of 24 unique decamer multiplexing identification (MID) sequences, as per the manufacturer’s 
recommendations (Roche, Brandford, CT, USA). Amplicons were pooled in equimolar amounts 
for sequencing on the Roche GS Junior sequencing platform. The sequencing libraries were 
prepared using the GS DNA library preparation kit and emulsion PCR (emPCR) was performed 
with a GS emPCR kit (Roche Diagnostics, Laval, Canada).  
Samples were handled in small batches to avoid cross-contamination and experimental 
controls were included at several steps in the study. Regular monitoring DNA extraction controls 
in our lab by universal PCR confirms that these procedures are sufficient to eliminate detectable 
template contamination of study samples. A no template control was also included in each set of 
PCR reaction as negative controls. Experimental controls were not sequenced as they did not yield 
any amplification.  
 
Analysis of Operational Taxonomic Units (OTU) 
Raw sequence data was processed by using the default on-rig procedures from 454/Roche. 
Filter-passing reads were used in the subsequent analyses for each of the pyrosequencing libraries. 
MID-partitioned sequences were mapped using Bowtie 2 (http://bowtie-
bio.sourceforge.net/bowtie2/) on to a manually curated reference set of 1,561 OTU sequences 
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representing the human vaginal microbiota. Bowtie 2 was run using the default end-to-end 
alignment mode.  
The OTU reference set was generated originally by de novo assembly of cpn60 sequence 
reads from 546 vaginal microbiomes using the microbial Profiling Using Metagenomic Assembly 
pipeline (mPUMA, http://mpuma.sourceforge.net) (Links et al., 2013) with Trinity as the assembly 
tool (Grabherr et al., 2011). OTU were labeled according to their nearest reference sequence 
determined by watered-Blast comparison (Schellenberg et al., 2009) to the cpn60 reference 
database, cpnDB_nr (downloaded from http://www.cpndb.ca (Hill et al., 2004)). This reference 
assembly approach allows us to compare the microbial profiles from various cohorts under 
investigation, including the 46 pregnant women who had sPTB described in this study.  
The result of mapping is an OTU frequency table (Supplementary Table 3.4S) that was 
used for microbiome data analysis. Some analyses were also performed at species level, i.e., 
combined OTU that have the same nearest neighbour. 
 
Statistical Analysis  
Comparisons of socio-demographic characteristics of cohorts and participants were based 
on analysis of variance (ANOVA), t-test and Chi-square, performed in IBM SPSS (Statistical 
Package for the Social Sciences, version 21) at 5% level of significance. For analysis of 
associations between socio-demographic characteristics and microbiota profiles (CST), a false 
discovery rate (FDR) correction for multiple comparisons was applied (Benjamini and Hochberg, 
1995).  
Alpha (Shannon diversity and Chao1 estimated species richness) and beta diversity 
(jackknifed Bray-Curtis dissimilarity matrices) were calculated as the mean of 100 subsamplings 
of 1000 reads (or all reads available when less than 1000) in QIIME (Quantitative Insights Into 
Microbial Ecology) (Caporaso et al., 2010). Plots of alpha diversity measures against bootstrap 
sample number were generated in R and visually inspected to ensure that an adequate sampling 
depth for each sample was achieved.  
For community state type (CST) analysis, a Jensen-Shannon distance matrix was calculated 
in R with a custom distance function that calculates the square root of the Jensen-Shannon 
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divergence (Endres and Schindelin, 2003). This distance matrix was used for hierarchical 
clustering using the ‘hclust’ function in R, with Ward linkage.  
The function aldex.clr from the ALDEx2 package in R was used to compare the differential 
relative abundance of individual taxa in term and preterm groups (Fernandes et al., 2013). 
Significant differences were determined based on the false discovery rate (FDR), which is the 
result of a Benjamini-Hochberg corrected p-value from a Welch’s t-test calculated within 
ALDEx2. 
 
3.4. Results 
Description of the study population and pregnancy outcomes 
Socio-demographic characteristics of women who had spontaneous preterm birth (n=46) 
and women who had term deliveries (n=170) are summarized in Table 3.1. There were no 
significant differences in maternal age, BMI, ethnicity, smoking status, consumption of alcohol or 
use of probiotics between term and preterm groups (all p>0.05). Average maternal age was 33 for 
participants in both cohorts. Average body mass index (BMI) was 22.9 and 24.2 for women in the 
term and preterm groups, respectively. Most women in both cohorts identified themselves as white 
ethnicity, followed by East Asian and South/Southeast Asian (Table 3.1). Consumption of tobacco 
(term 2.3%; preterm 0%), alcohol (term 5.9%; preterm 4.3%) or probiotic supplements (term 4.1%; 
preterm 6.5%) was low among women in both groups (chi-square, all p>0.05). 
Most women in the preterm group had a Bachelor/graduate degree (29/46) and an average 
house income higher than CAD 100000 per year (25/46). A minority of women who had preterm 
birth (5/46) reported consumption of substances without prescription prior pregnancy, of which 
3/46 women consumed marijuana/hashish, 1/46 woman consumed tranquilizers/nerve pills and 
1/46 woman consumed cocaine/crack. Approximately 74% of the participants in the preterm group 
reported a pre-existing condition. A total of 12/46 women had some condition related to mental 
health, such depression or anxiety. Twenty four percent of women (11/46) had a genitourinary 
condition and 17% (8/46) had neurological condition, such as migraines. 
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Table 3.1. Socio-demographic and microbiological characteristics of subjects. 
Characteristics Term pregnancies (n=170) 
Preterm pregnancies 
(n=46) p-value 
Age [Mean ± SD (Range)] 1* 33.6 ± 4.2 (21 - 45) 33.65 ± 4.1 (25 - 45) 0.948 
21-25 5 (2.9%) 1 (2.1%)  
26-35 114 (67.1%) 32 (69.5%)  
36-45 51 (30.0%) 13 (28.2%)  
BMI [Mean ± SD (Range)] 1 22.9 ± 3.8 (17 - 40) 24.2 ± 5.6 (19 - 43) 0.125 
Underweight (<18.50) 7 (4.1%) 0 (0%)  
Normal weight (18.51-24.9) 131 (77.0%) 33 (73.3%)  
Overweight (25.0-29.9) 25 (14.7%) 8 (17.7%)  
Obese (>30) 7 (4.1%) 4 (9.0%)  
MD 0 (0%) 1 (2.2%)  
Ethnicity 2   0.261 
White 108 (63.5%) 22 (47.8%)  
East Asian 26 (15.3%) 6 (13.0%)  
South / Southeast Asian 15 (8.8%) 4 (8.7%)  
Latin America / Hispanic 8 (4.7%) 3 (6.5%)  
Black 3 (1.8%) 2 (4.4%)  
Other/Mixed ethnicity 10 (5.9%) 6 (13.0%)  
MD 0 (0%) 3 (6.5%)  
Community state type (CST) 2   0.361 
I 56 (32.9%) 17 (37%)  
II 9 (5.3%) 5 (10.9%)  
III 28 (16.5%) 8 (17.4%)  
IVA 31 (18.2%) 6 (13%)  
IVC 19 (11.2%) 2 (4.3%)  
IVD 11 (6.5%) 1 (2.2%)  
V 16 (9.4%) 7 (15.2%)  
Estimated bacterial load (log copies of 16S 
rRNA gene) / swab [Mean ± SD (Range)]1 
7.78 ± 0.93  
(4.89 - 10.67) 
8.07 ± 0.71  
(6.32 - 10.33) 0.049 
Presence of Mollicutes 2 68 (40%) 28 (60.8%) 0.012 
Presence of Ureaplasma 2 40 (23.4%) 14 (30.4%) 0.337 
U. parvum 37 (21.7%) 14 (30.4%)  
U. urealyticum 3 (1.7%) 0 (0%)  
Shannon diversity [Mean ± SD (Range)] 1 1.28 ± 0.86  (0.13 - 4.52) 
1.81 ± 1.13  
(0.34 - 5.16) 0.004 
Chao1 richness [Mean ± SD (Range)] 1 36.22 ± 14.80  (14.39 - 115.74) 
46.38 ± 24.19  
(20.20 - 126.01) 0.009 
*1t-test; 2Chi-square. MD = missing data.   
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Characteristics regarding pregnancy and neonatal outcomes are described in Table 3.2. 
Pregnancy outcome information was not available for one woman in the preterm group as she was 
lost to follow-up. There were no significant differences in gestational age at enrolment, mode of 
conception or fetal sex between groups (all p>0.05). Average gestational age at delivery was 39+3 
weeks for the women who delivered at term and 34+2 weeks for women who had preterm birth, 
most of which were considered late preterm, i.e., delivery between 32 to 36+6 weeks of gestational 
age. Women in the preterm group were more likely to have experienced preterm birth or 
miscarriage in their previous pregnancy (Chi-square, p<0.001). They also had higher percentage 
of caesarean sections than women who delivered at term. Parity also differed between groups; 
women who had preterm birth were more likely to be nulliparous. There was a significant 
difference between term and preterm groups regarding birth weight and number of infants admitted 
to level 3 neonatal intensive care unit (NICU) (Table 3.2). Apgar score at 1 (term 8.75 ± 0.6; 
preterm 8.38 ± 1.1) and 5 minutes (term 8.97 ± 0.17; preterm 8.76 ± 0.7) between groups also 
differed (t-test, all p<0.001). One preterm infant (1/46) died shortly after birth (20 weeks of 
gestational age).  
Among women who delivered preterm, 56% (26/46) had premature rupture of membranes 
(PPROM), 10.8% (5/46) had gestational diabetes and 4.3% (2/46) had anemia unresponsive to 
therapy. Twenty-four percent of women (11/46) presented one of the following conditions: 
maternal elevated liver enzymes, short cervix and incompetent cervix; fetal ascites, fetal distress, 
large fetus for gestational age; placental findings of marginal cord insertion, two vessel umbilical 
cord, placenta previa, low lying placenta. 
 
Sequencing results and OTU analysis 
Raw sequence data files for the samples described in this study were deposited to the NCBI 
Sequence Read Archive (Accession SRP073152, BioProject PRJNA317763; BioProject 
PRJNA403856). Total dataset contained 1,635,072 cpn60 reads; median and average read count 
per sample were 4936 and 7569 (range 402 – 37378), respectively. Average read length was 424 
bp. Results of Bowtie2 mapping showed that these reads corresponded to 728 OTUs from the 
reference assembly (Supplementary Table 3.4S).  
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Table 3.2. Gestation characteristics, pregnancy and neonatal outcomes. 
Characteristics Term pregnancies (n=170) 
Preterm pregnancies 
(n=46) p-value 
Gestational age in weeks+day     
At enrolment [Mean ± SD (Range)] 1 13+2 ± 1+1 (11+1 - 16+6) 13+3 ± 1+0 (11+6 - 16+0) 0.641 
At delivery [Mean ± SD (Range)] 1 39+3 ± 0+6 (39+3 -  41+2) 34+2 ± 2+6 (20+0 -  36+6) <0.0001 
Late preterm (32 to 36+6) NA 39 (84.8%)  
Very preterm (28 to 31+6) NA 5 (10.8%)  
Extremely early (≤27+6) NA 1 (2.1%)  
Previous pregnancy history (excludes 
women in first pregnancy) 2 (n=125) (n=24) <0.0001 
Livebirth, term 89 (71.2%) 9 (37.5%)  
Livebirth, preterm 0 (0%) 3 (12.5%) <0.0001 
Spontaneous abortion 20 (16%) 8 (33.3%) 0.046 
Pregnancy termination 16 (12.8%) 3 (12.5%) 0.968 
Ectopic pregnancy 0 (0%) 1 (4.1%)  
Mode of delivery 2   0.042 
Vaginal delivery 128 (75.3%) 27 (58.7%)  
C-section 42 (24.7%) 18 (39.1%)  
Parity 2   0.005 
0 55 (32.3%) 28 (60.8%)  
1 94 (55.3%) 12 (26%)  
2-4 21 (12.3%) 6 (13%)  
Assisted conception 2 17 (10%) 6 (13%) 0.591 
Fetal sex (% male / % female) 2 (48.8%) / (51.1%) (41.3%) / (56.5%) 0.430 
Birth weight (g) [Mean ± SD (Range)] 1 3398 ± 459 (1970 - 5200) 
2550 ± 559 (1300 - 
3595) <0.0001 
Infant in NICU (n, %) 2 1 (0.6%) 24 (52.2%) <0.0001 
*1t-test; 2Chi-square.   
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Microbiota profiles 
Microbiota profiles were created by PCR amplification and pyrosequencing of the cpn60 
universal target region. Hierarchical clustering of vaginal microbiota profiles resulted in seven 
Community State Types (CST): I (Lactobacillus crispatus dominated), II (Lactobacillus gasseri 
dominated), III (Lactobacillus iners dominated), IVA (Gardnerella vaginalis subgroup B or mix 
of different species), IVC (G. vaginalis subgroup A dominated), IVD (G. vaginalis subgroup C 
dominated) and V (Lactobacillus jensenii dominated) (Figure 3.1). Each CST is defined by the 
dominance of one species of Lactobacillus (I, II, III, IV), Gardnerella vaginalis (IVC, IVD) or a 
mixture of bacteria species (IVA), as previously described (Ravel et al., 2011; Albert et al., 2015).  
Overall microbiota profiles did not cluster together based on gestational age at delivery 
(Figure 3.1 and 3.2). Most microbial profiles from the preterm group (80.5%) were assigned to 
Latobacillus-dominated CST: CST I (37% of profiles), CST III (17.4%), CST V (15.2%), and CST 
II (10.9%). The remaining profiles (19.5%) were assigned to CST IVA, IVC or IVD (Table 3.1). 
The CST IVA was the most heterogeneous group, represented by the dominance of Lactobacillus 
delbrueckii, Bifidobacterium dentium, Bifidobacterium infantis, Atopobium vaginae, 
Bifidobacterium breve or a mixture of different bacteria species. The CST IVC was dominated by 
G. vaginalis subgroup A and Megasphaera spp., and CST IVD was dominated by G. vaginalis 
subgroup C (Figure 3.1). 
 
Ecological analysis and total bacterial load 
Assessment of alpha diversity revealed that microbiomes of women who delivered preterm 
were richer (Chao1 richness 46.3 ± 24.1) and more diverse (Shannon diversity index 1.8 ± 1.1) 
when compared to those of women in the term group (36.2 ± 14.8; 1.2 ± 0.8) (t-test, p<0.01) (Table 
3.1). Total bacterial load was estimated based on qPCR targeting the 16S rRNA gene and it was 
expressed as log 16S rRNA gene copy number per swab. Higher bacterial loads were detected in 
samples from the preterm group (7.7 ± 0.9) compared to term group (8.0 ± 0.7) (t-test, p=0.049) 
(Table 3.1). 
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Figure 3.1. Vaginal microbiota profiles of women who had sPTB and term deliveries. 
(A) Hierarchical clustering of Jensen-Shannon distance matrices with Ward linkage on the relative 
proportions of reads for each OTU within individual vaginal samples. (B) Community state type 
(CST). (C) Gestational age at delivery. (D) Heatmap of relative abundances of bacterial species 
within each vaginal microbiota. Each column represents a woman’s vaginal microbiota profile, 
and each row represents a bacteria species. Only species that are at least 1% abundant in at least 
one sample are shown. (E) Shannon diversity indices calculated for each sample. 
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Figure 3.2. Vaginal microbiota profiles coloured by gestational age at delivery or CST. 
Jackknifed principal coordinates analysis (PCoA) of Bray-Curtis distance matrices of microbial 
profiles from all participants in the study. 
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Bacterial species relative abundance and prevalence  
To investigate whether there was an association between individual taxa and sPTB, the 
abundance and prevalence of each species was evaluated. The ALDEx2 analysis assessed the 
relative abundance of each taxa (at the OTU and species level) in term and preterm groups. Eight 
OTU/species were more abundant in the term group in comparison with preterm, all of which were 
considered rare members of the bacterial community (Figure 3.3). L. acidophilus represented 1% 
of the total reads in the dataset and had a low relative abundance average of 1.98% (range 0-69%) 
and 0.18% (range 0-0.87%) in samples from term and preterm groups respectively. All the other 
seven bacteria together represented only 0.4% of the total reads in the dataset. 
Bacteria prevalence (presence/absence) was also assessed (only species with at least 10 
total reads were included). A total of 60 taxa had significant differences in prevalence between 
term and preterm groups; 11 species had greater prevalence in the term cohort and 49 species were 
more prevalent in the preterm cohort (Table 3.3). Bifidobacterium infantis, for example, was two 
times more prevalent in the term group in comparison with preterm, and Prevotella timonensis was 
1.58 times more prevalent in the preterm group (Table 3.3). Several Prevotella spp. were 
associated with both term and preterm. Prevotella amnii and P. tannerae had greater prevalence 
in the term cohort, whereas P. timonensis, P. bivia, P. corporis and P. bucalis were more prevalent 
in the preterm group (Table 3.3). 
Mollicutes (Mycoplasma and/or Ureaplasma) were detected by family-specific 
conventional PCR in 28/46 (60%) of pregnant women who delivered preterm (Table 3.1). 
Ureaplasma species were detected by genus-specific PCR in samples of 14/46 (30%) women who 
had PTB, with all women testing positive for U. parvum and none for U. urealyticum. Women 
who delivered at term were less likely to be PCR positive for Mollicutes compared to women who 
had PTB (Table 3.1). No significant differences were observed in Ureaplasma prevalence between 
the two groups (Table 3.1). 
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Figure 3.3. Bacteria relative abundance differences between term and preterm groups 
represented by ALDEx2. 
(A) ALDEx2 between- and within-difference values for individual organisms across gestational 
age category. Organisms (at OTU and nearest neighbour species level) with significant p-values 
are shown as pink circles (Welch's t statistical test). (B) Violin plots showing the bacteria relative 
abundance (centre log transformed, CLR) in term and preterm groups. Only the eight bacteria with 
significant relative abundance differences between term and preterm groups are shown. In the 
violin plots, the white dot represents the median value, the black bar is the interquartile range, and 
the vertical width of the plot shows the density of the data along the X-axis 
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Table 3.3. Bacteria prevalence in the vaginal microbiomes of women who delivered preterm 
and at term. 
Panel A: species with greater prevalence in the term group (ratio term/preterm). Panel B: species 
with greater prevalence in the preterm group (ratio preterm/term). 
 Total Preterm (n=46) Term (n=170) Prevalence  
Species reads Reads Prevalence (%) Reads 
Prevalence 
(%) 
ratio FDR 
* 
A      term/preterm  
Bifidobacterium infantis 56246 409 19.57 55837 40.00 2.04 0.033 
Lactobacillus delbrueckii subsp. 
lactis 48063 9 4.35 48054 28.82 6.63 0.005 
Lactobacillus acidophilus 17440 569 89.13 16871 97.65 1.10 0.033 
Prevotella amnii 13339 68 4.35 13271 21.76 5.01 0.023 
Pseudovibrio sp. 1634 52 15.22 1582 91.76 6.03 0.000 
Streptococcus parasanguinis 1199 63 19.57 1136 88.82 4.54 0.000 
Sphingobium yanoikuyae 1174 16 13.04 1158 80.00 6.13 0.000 
Prevotella tannerae 930 58 15.22 872 88.24 5.80 0.000 
Clostridium innocuum 814 42 13.04 772 81.18 6.22 0.000 
Eubacterium siraeum 641 43 17.39 598 78.24 4.50 0.000 
Massilia timonae 426 6 8.70 420 70.00 8.05 0.000 
B      preterm/term  
Prevotella timonensis 11450 4211 71.74 7239 45.29 1.58 0.005 
Dialister micraerophilus 7381 2850 67.39 4531 44.12 1.53 0.021 
Prevotella sp. 2216 626 47.83 1590 14.71 3.25 0.000 
Bacteroides coagulans 1283 1212 41.30 71 7.06 5.85 0.000 
Corynebacterium accolens 1083 999 52.17 84 13.53 3.86 0.000 
Porphyromonas uenonis 1040 795 28.26 245 12.94 2.18 0.038 
Actinomyces neuii subsp. 
anitratus 877 738 43.48 139 10.00 4.35 0.000 
Peptoniphilus harei 875 811 45.65 64 7.65 5.97 0.000 
Lactobacillus fermentum 729 664 17.39 65 5.29 3.29 0.026 
Facklamia hominis 711 709 15.22 2 1.18 12.93 0.000 
Prevotella bivia 638 228 26.09 410 8.24 3.17 0.005 
Prevotella corporis 535 463 23.91 72 5.88 4.07 0.000 
Corynebacterium timonense 503 355 34.78 148 10.00 3.48 0.000 
Corynebacterium genitalium 372 323 34.78 49 7.06 4.93 0.000 
Tepidanaerobacter sp. 329 303 23.91 26 4.12 5.81 0.000 
Corynebacterium amycolatum 264 228 32.61 36 4.71 6.93 0.000 
Parvimonas micra 193 183 10.87 10 1.18 9.24 0.005 
Mobiluncus curtsii subsp. curtsii 183 171 21.74 12 2.35 9.24 0.000 
Finegoldia magna 155 149 13.04 6 3.53 3.70 0.038 
Coprococcus eutactus 154 68 47.83 86 27.06 1.77 0.026 
Brevibacterium linens 147 142 10.87 5 0.59 18.48 0.000 
Rothia dentocariosa 144 120 30.43 24 5.29 5.75 0.000 
Streptococcus thermophilus 132 126 19.57 6 2.35 8.32 0.000 
Magnetospirillum 
magnetotacticum 116 40 43.48 76 24.12 1.80 0.033 
Dethiobacter alkaliphilus 101 97 10.87 4 1.76 6.16 0.017 
Brevibacterium massiliense 99 86 15.22 13 1.18 12.93 0.000 
Eremococcus coleocola 90 82 10.87 8 1.76 6.16 0.017 
Anaeromusa acidaminophila 86 85 15.22 1 0.59 25.87 0.000 
Arthrobacter globiformis 66 48 10.87 18 1.76 6.16 0.017 
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Staphylococcus epidermidis 54 47 13.04 7 2.35 5.54 0.009 
Corynebacterium simulans 52 41 26.09 11 1.76 14.78 0.000 
Anaeroglobus geminatus 52 49 15.22 3 1.18 12.93 0.000 
Cellvibrio gilvus 42 26 15.22 16 1.76 8.62 0.000 
Prosthecochloris vibrioformis 41 40 6.52 1 0.59 11.09 0.028 
Prevotella buccalis 33 33 15.22 0 0.00 - 0.000 
Acidaminococcus fermentans 31 29 13.04 2 1.18 11.09 0.000 
Brevibacterium casei 25 24 8.70 1 0.59 14.78 0.005 
Streptococcus sanguinis 23 18 13.04 5 2.35 5.54 0.009 
Atopobium parvulum 23 20 8.70 3 1.18 7.39 0.023 
Peptoniphilus duerdenii 22 20 10.87 2 0.59 18.48 0.000 
Pelobacter propionicus 21 18 6.52 3 0.59 11.09 0.028 
Staphylococcus hominis 21 17 15.22 4 1.76 8.62 0.000 
Atopostipes suicloacalis 18 8 10.87 10 1.18 9.24 0.005 
Corynebacterium 
pyruviciproducens 18 13 13.04 5 1.76 7.39 0.005 
Corynebacterium jeikeium 14 11 13.04 3 0.59 22.17 0.000 
Sporichthya polymorpha 13 11 8.70 2 1.18 7.39 0.023 
Rhodococcus jostii 13 7 8.70 6 1.18 7.39 0.023 
Nitrospina gracilis 10 5 8.70 5 0.59 14.78 0.005 
Megasphaera sp. BV3C16-1 10 9 6.52 1 0.59 11.09 0.028 
*FDR (false discovery rate) represents the corrected p-value for multiple comparisons. 
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Relationships between microbiological and socio-demographic characteristics within the 
preterm group 
The association between CST (I, II, III, IVC, IVD, V) from profiles of women who 
delivered preterm and several microbiologic-socio-demographic characteristics was investigated. 
Only two associations were significant: CST and microbiota richness, and CST and microbiota 
diversity (ANOVA, p<0.001). There was no significant association between CST and the 
remaining following metadata: microbiota richness and diversity (continuous variable), presence 
of Mollicutes and Ureaplasma (yes/no), log 16S rRNA gene copies (continuous variable), 
maternal age (continuous variable; 18-25, 26-35, 36-45), BMI category (underweight, normal, 
overweight, obese; <25, ≥25), ethnicity (White, East Asian, South Asian, Black, Hispanic, Other), 
natural conception (yes/no), parity (0, >1), gestational age (continuous variable), mode of delivery 
(vaginal, C-section), pre-existing condition (yes/no), folic acid intake before or during pregnancy 
(yes/no), drinking alcohol (yes/no), neonate in high level care (yes/no),  birth weight (continuous 
variable), and Apgar score at 1 and 5 minutes (1-9).   
 
3.5. Discussion 
In this study we determined the composition of the vaginal microbiota of women who had 
spontaneous preterm birth and compared these profiles to those of women who delivered at term, 
previously reported by our research group (Freitas et al., 2017). The cohorts were comparable in 
terms of maternal age, BMI, ethnicity, consumption of tobacco, alcohol and probiotics, which is 
of interest given that several of these characteristics have been previously associated with preterm 
delivery. In particular, previously described factors included: low and high maternal ages (Fraser 
et al., 1995; Jacobsson et al., 2004; Schempf et al., 2007), low BMI (Han et al., 2011), black 
ethnicity (Kistka et al., 2007), high levels of tobacco, alcohol and illicit drugs consumption 
(Behrman and Butler, 2007), close temporal proximity to a previous delivery (Conde-Agudelo et 
al., 2006), and multiple gestation (Stock and Norman, 2010). This cohort is unique in that it did 
offer the opportunity to have gestational age at delivery as the main characteristic distinguishing 
these two groups recognizing that the majority of preterm births occurred beyond 32 weeks 
gestation. 
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Other known risk factors for sPTB includes maternal medical disorders like hypertension, 
asthma, diabetes, and thyroid disease (Behrman and Butler, 2007). Although some women in both 
cohorts reported these conditions, there were not enough participants to stratify the data based on 
the individual disorder and therefore was not possible to investigate the interaction between those 
medical conditions and gestation outcome. We were, however, able to confirm previous reports of 
history of prematurity as a risk factor for preterm birth (Mercer et al., 1999). 
Since many organisms isolated from the amniotic cavity of women who experienced 
preterm birth are also found in the genital tract (Gardella et al., 2004; Krohn et al., 1995; Hillier et 
al., 1988; Romero et al., 1989), an intrauterine infection ascending from the vagina is one of the 
currently hypothesized triggers of PTB (Goldenberg et al., 2000). In this study, however, we did 
not identify a signature microbiota composition (CST) associated with preterm birth. This 
observation is consistent with the results presented by others (Hyman et al., 2014; Romero et al., 
2014b). CST assignments are largely driven by the dominance of a single species, which may mask 
differences in rare taxa that would differentiate term and preterm groups, and indeed, further 
analysis revealed that the vaginal microbiota of women who experienced preterm birth was richer 
and more diverse than those of women who delivered at term. Also, most women in our study were 
considered late preterm and although we cannot address this question, it is possible that sPTB 
driven by an ascending infection would be more evident in a high-risk cohort or extreme preterm 
cases. A recent study of a high-risk pregnant cohort has reported that L. iners was strongly 
associated with short cervix and preterm birth, as L. crispatus was associated with term deliveries 
(Kindinger et al., 2017). Those differences in study outcomes indicate that the pathogenesis of 
sPTB in low- and high-risk groups might be different. 
One controversy that challenges the current hypothesis of preterm caused by an ascending 
infection is that antibiotic administration to pregnant women with a disturbed vaginal microbiota 
does not improve outcome in most cases, as demonstrated by study trials (Kekki et al., 2001; 
Andrews et al., 2006a) and systematic reviews (Morency and Bujold, 2007; Okun et al., 2005; 
Thinkhamrop et al., 2015). One explanation for the inefficacy of antibiotic treatment in the 
prevention of preterm birth relies is the high rates of antibiotic resistance among bacterial-
vaginosis associated bacteria (Beigi et al., 2004; Budd et al., 2016). In this case, antibiotics not 
only do not kill the targeted bacteria, but might also reduce the vaginal lactobacilli population 
leading to an even more disturbed microbiota. 
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In addition to differences in richness and diversity, differences in the microbiota between 
the two cohorts regarding bacteria abundance and prevalence were also identified. The ALDEx2 
analysis indicated that eight rare taxa were more abundant in the term group, which does not 
necessarily mean they are associated with a “healthier” state or implicated in preventing sPTB. 
Since these bacteria are detected at very low abundance within the microbiota profiles, their 
biological significance in the vaginal microbiome is questionable. Differences in the prevalence 
of several other taxa between groups were also observed. For example, more women in the term 
group had Prevotella amnii and P. tannerae detected in their vaginal samples, whereas P. 
timonensis, P. bivia, P. corporis and P. buccalis were more frequently detected in samples from 
women in the preterm group (Table 3.3). Prevotella spp. have been previously associated with 
bacterial vaginosis and preterm labour (Hill, 1993; Paramel Jayaprakash et al., 2016; Ling et al., 
2010), and our results indicate that different Prevotella species might have different roles in sPTB. 
Several of the taxa that were significantly different in their prevalence among women in the two 
groups also had low sequence read counts (Table 3.3). Further investigation would be required to 
determine if these rare members of the microbial community play a yet unknown role in sPTB. 
It is also important to note that the number of bacterial species with greater prevalence in 
the preterm (49/60) was higher than in the term (11/60) cohort (Table 3.3), which is consistent 
with our results of increased microbial richness and diversity in the samples from women who 
experienced preterm birth. This might indicate that increased richness, rather than the presence of 
specific taxa, might be associated with sPTB. Those differences might also be an indicator of 
physiological/biochemical dissimilarities in the vaginal microbiomes of women who deliver at 
term or preterm. In other words, the physiological state that leads to sPTB might also create an 
environment that supports a richer/more diverse microbiota. 
Our results also confirmed previous reports of an association between Mycoplasma and 
preterm birth (Foxman et al., 2014). Mollicutes were detected significantly more often in women 
in the preterm group compared to women in the term group, but no differences were observed in 
Ureaplasma prevalence between groups indicating that the difference in Mollicutes prevalence is 
primarily driven by the presence of Mycoplasma spp. Although individual Mycoplasma species 
could not be discerned based on assays used in our study, both Mycoplasma genitalium (Hitti et 
al., 2010; Edwards et al., 2006; Lis et al., 2015) and Mycoplasma hominis (Donders et al., 2009; 
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Kwak et al., 2014; Hillier et al., 1995; Lamont et al., 1987) have been previously associated with 
negative reproductive outcomes including PTB. 
Collectively, our overall findings were similar to other two studies, which provided us the 
opportunity to compare different study designs that addressed the same research question. Hyman 
and colleagues (Hyman et al., 2014) described the vaginal microbiota of 83 pregnant women (term 
n=66, preterm n=17) based on Sanger sequencing of cloned 16S rRNA. Samples were collected at 
each trimester and preterm was defined as delivery before 37 weeks of gestation. There was no 
correlation between preterm and absence/low abundance of Lactobacillus in the microbiota; in 
other words, preterm outcome could not be predicted based on CST. Similar to our results, they 
found an association between increased microbiota diversity and preterm delivery among women 
of white ethnicity (n=40) (data from women of other ethnicities was not included in the analysis 
because of small sample sizes).  
Romero and colleagues (Romero et al., 2014b) also investigated the vaginal microbiota of 
pregnant women who experienced preterm delivery, defined as delivery before 34 weeks of 
gestation (term n=72, preterm n=18). The profiles were created by 16S rRNA amplicon 
sequencing, and samples were collected every 4 weeks until 24 weeks of gestation and then every 
2 weeks. They found no differences in the frequency of different CST between women who had 
term and preterm deliveries. Likewise, no differences in bacterial relative abundance were 
observed between the two cohorts, although only bacteria that were present in at least 25% of 
samples were included in the analysis. These results are consistent with our findings of bacterial 
abundance based on the ALDEx analysis since we only found significant differences in relative 
abundance for eight rare bacteria. Unlike Hyman et al. (Hyman et al., 2014) and our results, 
Romero et al. (Romero et al., 2014b) did not find differences in microbiota diversity between 
women who delivered preterm and at term. One possible explanation for this contradictory result 
might be related to differences in participant ethnicity among these studies. While most women in 
our study and the Hyman et al. study described themselves as white, the majority of participants 
in the Romero et al. study described themselves as African American. It has been reported that the 
composition of the vaginal microbiota is strongly associated with a woman’s ethnicity (Ravel et 
al., 2011; Zhou et al., 2007). Other studies have also demonstrated that black ethnicity is associated 
with an increased microbiota diversity in comparison with white ethnicity (Fettweis et al., 2014), 
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which could have masked differences in bacterial diversity between term and preterm cohorts in 
the Romero study. 
Contrary to our overall findings, DiGiulio and colleagues (DiGiulio et al., 2015) found a 
strong association between the non-Lactobacillus-dominated CST IV and preterm birth in a case-
control study based on the 16S rRNA amplicon sequencing. Pregnant women (preterm n=34, term 
n=15), mostly of white ethnicity, were sampled weekly throughout gestation. Interestingly, the 
authors pointed out that if samples had been collected less frequently, short-term “excursions” to 
CST IV would have been missed and probably the association between CST IV and preterm birth 
would have been less obvious. The detection of a temporary microbiota disturbance represented 
by a change from a Lactobacillus-dominated CST to CST IV may have been missed in our study 
since samples were not collected longitudinally.  
Most samples in the preterm group were dominated by Lactobacillus, yet, they collectively 
had higher richness and diversity compared to samples from the term group. The increased 
microbiota richness/diversity might indicate a transient state between Lactobacillus-dominated 
CST and non-Lactobacillus-dominated, i.e., CST IV (A, C or D). In other words, the increased 
richness and diversity we observed might be a remnant characteristic of the previous disturbed 
microbiota. In summary, although we did not “detect” a specific microbial community structure 
that is associated with preterm birth, the increased microbiota richness/diversity might be an 
indication that the bacterial community overwhelmed placental and amniotic defences and 
permitted ascending bacterial contamination of the chorioamnion, which could still lead to preterm 
birth. In addition, the association with differences in types of Prevotella species and Mycoplasma 
presence may point to signature species associated with preterm birth. 
 
3.6. Conclusions 
Taken together, our results suggest that the differences in the microbiota of women who 
had preterm deliveries, such as increased microbiota richness and diversity and greater prevalence 
of Mollicutes and other bacteria, may have a role in sPTB. Other differences between cohorts 
might have been masked by the presence of highly dominant bacteria like Lactobacillus. At the 
overall level, we did not identify a specific vaginal microbial community structure at 11-16 weeks 
gestation age that predicts sPTB. Also, differences in relative abundance of bacterial species 
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between term and preterm groups were only significant for a few low abundance species. Although 
a causal relationship remains to be determined, our results confirm previous reports of an 
association between Mollicutes and preterm birth, and further suggest that a diverse bacterial 
community may contribute to the microbiome’s role in sPTB. Alternatively, the more rich and 
diverse microbiotas of the preterm group may reflect physiological differences between the groups 
that affect selection of bacteria. This study provides valuable evidence of subtle alterations in the 
microbiome associated with preterm birth that requires further study utilizing sequencing 
methodology. In addition, future study should include evaluation of the microbial metabolite 
production and host response might further elucidate factors leading to sPTB and identify women 
at risk early in pregnancy.  
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Chapter transition 
Several studies have investigated the causes of microbiome dysbiosis with limited success, 
regardless of pregnancy status. Researchers have also tried to understand the association between 
the microbiota and preterm birth, but still there is no consensus regarding which bacteria within 
the microbiome, if any, specifically lead to preterm birth. One difficulty in studying such complex 
biological system is the limited and poor definition of “healthy” and “unhealthy” microbiome. The 
current definition of a healthy microbiome is to be dominated by lactobacilli, which is not observed 
in many clinically healthy women. To better understand the relationship among the microbiota, 
host and reproductive outcomes, an improved definition of healthy microbiome is needed. In this 
chapter I described several vaginal microbial profiles in “healthy” women dominated by 
bifidobacteria. Bifidobacteria are a common member of the gut microbiome and have been 
associated with several health promoting effects in the gastrointestinal tract. The first goal was to 
confirm that bifidobacteria are the dominant bacteria in the microbiome of some women. My 
second objective was to characterize vaginal bifidobacteria isolates with a focus on phenotypic 
characteristics common to lactobacilli, and associated with a protective microbiome. Improving 
the understanding the role of these organisms in the vaginal microbial community contributes to 
an improved definition of "healthy", which focuses on the phenotypic properties of bacteria and 
not only in the presence/absence of specific taxa.  
 
 
 
 
 
 
 
 
 87 
4.1. Abstract 
The vaginal microbiome plays an important role in women’s reproductive health. 
Imbalances in this microbiota, such as the poorly defined condition of bacterial vaginosis, are 
associated with increased susceptibility to sexually transmitted infections and negative 
reproductive outcomes. Currently, a “healthy” vaginal microbiota in reproductive aged women is 
understood to be dominated by Lactobacillus, although “atypical” microbiomes, such as 
Bifidobacterium-dominated profiles, have been described. Despite these observations, vaginal 
bifidobacteria remain relatively poorly characterized and questions remain regarding their actual 
abundance in the microbiome. In this study, we used quantitative PCR to confirm the relative 
abundance of Bifidobacterium in the vaginal microbiomes of healthy reproductive aged women, 
previously determined by deep sequencing. We also isolated and phenotypically characterized 
vaginal bifidobacteria (n=40) in the context of features thought to promote reproductive health. 
Most isolates were identified as B. breve or B. longum based on cpn60 barcode sequencing. 
Fermentation patterns of vaginal bifidobacteria did not differ substantially from corresponding 
type strains of gut or oral origin. Lactic acid was produced by all vaginal isolates, with B. longum 
strains producing the highest levels, but only 32% of isolates produced hydrogen peroxide. Most 
vaginal bifidobacteria were also able to tolerate high levels of lactic acid (100 mM) and low pH 
(4.5 or 3.9), conditions typical of vaginal fluid of healthy women. Most isolates were resistant to 
metronidazole but susceptible to clindamycin, the two most common antibiotics used to treat 
vaginal dysbiosis. These findings demonstrate that Bifidobacterium is the dominant member of 
some vaginal microbiomes and suggest that bifidobacteria have the potential to be as protective as 
lactobacilli according to the current understanding of a healthy vaginal microbiome. 
Keywords: Bifidobacterium, vaginal microbiome, fermentation pattern, hydrogen peroxide, lactic 
acid, antibiotic. 
 
4.2. Introduction 
Bifidobacteria were first described by Tissier in 1899, who isolated a bacterium from 
breast-fed infant feces and named it Bacillus bifidus (Poupard et al., 1973). In 1924, Orla-Jensen 
proposed the genus Bifidobacterium as a separate taxon for these organisms (Orla-Jensen, 1924), 
which currently includes more than 30 species (Biavati and Mattarelli, 2012). Bifidobacteria are 
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Gram-positive, anaerobic, non-motile, non-spore forming rod-shaped bacteria, with varied 
branching. They belong to the Bifidobacteriaceae family and have high genomic G+C content (55-
67 mol%) (Biavati and Mattarelli, 2012). Bifidobacteria are known to colonize the human vagina, 
oral cavity and, more abundantly, the gastrointestinal tract (GIT) (Biavati and Mattarelli, 2006).  
Several studies have shown their influence on human physiology and nutrition (Arboleya 
et al., 2011; Fukuda et al., 2011; Martinez et al., 2013; Sugahara et al., 2015; Meyer and Stasse-
Wolthuis, 2009). In newborns, bifidobacteria play an important role as one of the primary 
colonizers of the GIT, representing 60 to 91% of fecal bacteria in breast-fed infants (Harmsen et 
al., 2000; Turroni et al., 2012). This proportion decreases with age and it may represent less than 
10% of the adult fecal microbiota (Yatsunenko et al., 2012; Turroni et al., 2008). Bifidobacteria 
provide protection from pathogens in the GIT through the production of bacteriocins (Martinez et 
al., 2013), inhibition of pathogen adhesion (Arboleya et al., 2011) and modulation of the immune 
system (Hart et al., 2004; Fanning et al., 2012). Due to these health-promoting effects, 
bifidobacteria have been extensively studied as probiotics (Sugahara et al., 2015; Zinedine and 
Faid, 2007; Chenoll et al., 2011; Heuvelin et al., 2010). 
Early microbial colonization is an essential process in the maturation of the immune system 
(Rautava et al., 2012). This initial colonization may be affected by many factors, such as the mode 
of delivery (vaginal or caesarean section), feeding type (breast-fed or formula-fed), exposure to 
antibiotics and hygiene (Fanaro et al., 2003). However, the relative contributions of maternal 
microbiota (gut, breast milk, vaginal) and environmental sources to the bifidobacteria population 
of the neonatal gut remain unresolved.  
While Bifidobacterium spp. present in the gut are well described, vaginal bifidobacteria 
remain relatively poorly characterized, and it is not known if vaginal adaptation has resulted in 
distinct phenotypic features that distinguish them from gut populations. Although a healthy vaginal 
microbiota is defined as Lactobacillus-dominated, several studies have identified vaginal 
Bifidobacterium-dominated profiles in 5-10% of healthy, reproductive aged women (Chaban et 
al., 2014; Hyman et al., 2005; Shipitsyna et al., 2013; Sundquist et al., 2007). Furthermore, some 
vaginal bifidobacteria are able to produce lactic acid and hydrogen peroxide; attributes of vaginal 
lactobacilli credited with maintaining homeostasis in the vaginal microbiome (Schellenberg et al., 
2012).  
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Culture-independent techniques are useful tools in microbiome characterization, but 
methods based on amplification and sequencing of 16S rRNA genes, have been reported to 
underrepresent Bifidobacterium in microbial communities (Hill et al., 2010). The abundance of 
Bifidobacterium in the vaginal microbiota may also be underestimated due to the similarity of their 
16S rRNA sequences to those of Gardnerella vaginalis. G. vaginalis is also a member of the 
Bifidobacteriaceae family and is a commonly detected microorganism associated with bacterial 
vaginosis (BV) (Burton et al., 2003b). The use of the cpn60 “universal target” (UT) region as a 
barcode for microbiome profiling results in better resolution of closely related species, including 
those within Bifidobacteriaceae (Links et al., 2012), and cpn60 based human fecal microbiome 
profiles have been shown to more accurately represent Bifidobacterium content than a 16S rRNA 
based approach (Hill et al., 2010). Previous studies of the vaginal microbiome (Chaban et al., 2014) 
or synthetic mixtures of vaginal organisms (Schellenberg et al., 2017) have demonstrated a strong 
correlation between cpn60 sequence read abundance and organism abundance determined by 
quantitative PCR. However, regardless of the target used, relative abundance of specific organisms 
within complex communities may not be represented accurately by methods that rely on 
polymerase chain reaction (PCR) amplification and its inherent biases.  
Considering the lack of information about Bifidobacterium spp. of vaginal origin, their 
importance as a potential source for the neonatal gut microbiome, and their potential health-
promoting effects in the vagina, a better understanding of the properties of vaginal bifidobacteria 
is needed. In this study, our main objectives were: 1) to apply species-specific quantitative PCR to 
confirm the relative abundance of Bifidobacterium in the vaginal microbiomes of reproductive 
aged women previously determined based on high-throughput DNA sequencing methods, and 2) 
to characterize vaginal Bifidobacterium isolates based on carbohydrate fermentation patterns, 
hydrogen peroxide production, lactic acid production, resistance to low pH and lactic acid, and 
susceptibility to antibiotics. 
 
4.3. Methods 
Samples and microbiome profiles 
Vaginal microbiome profiles from 492 healthy women were previously published by our 
research group (Albert et al., 2015; Freitas et al., 2017). Profiles were created by PCR amplification 
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and deep sequencing of the cpn60 UT region. Total bacterial load in each sample was also 
estimated as part of these studies using a SYBR Green assay based on the amplification of the V3 
region of the 16S rRNA gene. The remaining vaginal swabs and DNA extracts from these studies, 
archived at -80 ˚C, were available for use in the current study. 
 
Bifidobacterium quantitative PCR assays 
Sequences with similarity to Bifidobacterium breve, Bifidobacterium dentium and 
Alloscardovia omnicolens (Bifidobacteriaceae family) that were detected at high frequency in the 
previously published studies (Albert et al., 2015; Freitas et al., 2017) were selected as targets for 
quantitative PCR. Signature regions within the cpn60 UT unique to each target were determined 
using Signature Oligo software (LifeIntel Inc., Port Moody, BC, Canada) and primers were 
designed using Primer-blast software (Ye et al., 2012) and Primer3 (Rozen and Skaletsky, 2000) 
(Table 4.1). 
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Table 4.1. Primers used in the bifidobacteria qPCR assays. 
Target Primer 
name 
Sequence (5'->3') Product 
size (bp) 
Annealing 
Temperature 
(˚C) 
B. breve JH0472 (F) AACCGTGCTCGCCCAGTC 150 65 
 JH0473 (R) TCCTTGGTCTCAACGTCCTT   
B. dentium JH0474 (F) GTGCTCGAAGACCCGTACAT 163 65 
  JH0475 (R) GGATGGTGTTCAGGATCAGG    
A. omnicolens JH0470 (F) GCACGAAGGCTTGAAGAACG 197 65 
  JH0471 (R) CCAAAGCCTCAGCAATACGC    
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To create plasmids for use in standard curves, target sequences were amplified from vaginal 
swab DNA extracts. The resulting PCR products were purified and ligated into cloning vector 
pGEM-T-Easy (Promega, Madison, WI) and used to transform competent E. coli DH5α. Insertion 
of the intended target sequence was confirmed by DNA sequencing. Optimal annealing 
temperature for each assay was determined using an annealing temperature gradient, and 
specificity of each primer set was confirmed by using plasmids containing cpn60 UT sequences 
from closely related species as template. 
All qPCR reactions were performed in duplicate and each batch of reactions included a no 
template control and a standard curve consisting of serial dilutions of plasmids containing targets. 
Each reaction consisted of 2 µL of template DNA, 1´ iQ SYBR Green Supermix (BioRad, 
Mississauga, ON, Canada) and 400 nM each primer, in a final volume of 25 µL. A MyiQ 
thermocycler (BioRad) was used for all reactions with the following protocol: 95 °C for 3 m, 
followed by 40 cycles of 95 °C for 15 s, 65 °C for 15 s, 72 °C for 15 s. A dissociation curve was 
subsequently performed for 81 cycles at 0.5 °C increments from 55 °C to 95 °C to confirm the 
purity of PCR products. 
 
Calculation of proportional abundance of Bifidobacterium in vaginal samples 
Vaginal microbiome profiles (n=492) were ranked according to the proportional abundance 
of Bifidobacterium (all Bifidobacterium species and Alloscardovia combined), based on the 
previously determined cpn60 sequence read counts (Albert et al., 2015; Freitas et al., 2017). B. 
breve, B. dentium and A. omnicolens DNA was quantified in vaginal swab DNA extracts from 
selected samples using the SYBR Green qPCR assays described in the previous section. Previously 
determined total 16S rRNA copy number per sample (Albert et al., 2015; Freitas et al., 2017) was 
used an as estimate of total bacterial population. The ratio between log10 copy number of 
Bifidobacterium and 16S rRNA log10 copy number was used as an estimate of the proportional 
abundance of each target species in the selected vaginal microbiome samples. 
Proportional abundance determined from deep sequencing of cpn60 UT amplicons (percent 
of sequence reads) and by quantitative PCR for each of the three targets evaluated (B. breve, B. 
dentium and A. omnicolens) were compared using Spearman rank correlation in IBM SPSS 
(Statistical Package for the Social Sciences, version 21). 
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Isolation of vaginal Bifidobacterium 
A complete list of isolates used in the study and their sources is provided in Table 4.2. 
Bifidobacteria were isolated from vaginal swabs, which were collected in previous studies and had 
been stored at -80 °C. For one group of samples (healthy pregnant and non-pregnant Canadian 
women from Vancouver, BC and Toronto, ON), 12 Bifidobacterium-dominated samples were 
selected based on the previous microbial profiling data (Albert et al., 2015; Freitas et al., 2017). 
Eluted material from these 12 vaginal swabs was plated on Columbia agar containing 5% sheep 
blood (CSB, BD Canada, Mississauga, ON). For the second group of samples (Adolescent women, 
Winnipeg, MB) (Schellenberg et al., 2012), material from 27 vaginal swabs was plated on a Bifidus 
selective medium agar (BSM agar, Sigma-Aldrich, Oakville, ON); no information about the 
microbiome was available. Frozen swabs were thawed and sample was eluted from each swab by 
vortexing in phosphate-buffered saline (PBS). Dilutions were prepared from the eluted sample and 
spread onto CSB agar or BSM agar followed by incubation using the GasPak EZ anaerobic system 
(BD Canada, Mississauga, ON) at 37 °C for 72 h. After isolating pure colonies, a freezing buffer 
(4% (v/v) skim milk, 1% (w/v) glucose, 20% (v/v) glycerol) was added to the isolates for long-
term storage at -80 °C. DNA preparations from isolates were made using Chelex 100 (Bio-Rad 
Laboratories, Inc., Mississauga, ON).  
Bifidobacteria (n=16) previously isolated in a study of commercial sex workers in Nairobi, 
Kenya (Schellenberg et al., 2012), were also included in the study. Bifidobacterium spp. and 
Lactobacillus crispatus type strains (B. breve ATCC 15700, B. longum subsp. infantis ATCC 
15697, B. dentium ATCC 27534 and L. crispatus ATCC 33820) were acquired from the American 
Type Culture Collection (Manassas, VA). Lactobacillus crispatus vaginal isolates 67-1, B12-1 and 
N4D05 were from our lab culture collection. 
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Table 4.2. Complete list of vaginal isolates used in this study. 
cpnDB nearest type strain match Isolate ID ID (%) Origin 
Bifidobacterium breve (I)30-1 99.5 Canada 
 (I)30-2 99.5 Canada 
 (IV)30-1A 99.5 Canada 
 (I)91-1 98.9 Canada 
 (I)91-2 99.1 Canada 
 (I)91-3 99.1 Canada 
 (I)322-1 99.5 Canada 
 (I)322-2 99.5 Canada 
 (IV)322 99.5 Canada 
 12-4 99.8 Canada 
 (W)20-13 99.3 Canada 
 (W)20-15 99.3 Canada 
 (W)20-17 99.3 Canada 
 (W)56 99.3 Canada 
 N6D12 99.1 Kenya 
Bifidobacterium longum subsp. longum (I)239-2 99.3 Canada 
 (I)239-4 99.3 Canada 
 (IV)239 99.1 Canada 
 (W)35-1 100.0 Canada 
 N2E12 100.0 Kenya 
 N2F05 100.0 Kenya 
 N2G10 100.0 Kenya 
 N3A01 100.0 Kenya 
 N3E01-2 100.0 Kenya 
 N5E04 100.0 Kenya 
 N6D05 100.0 Kenya 
Bifidobacterium dentium (VI)131-1 99.5 Canada 
 (W)90-1 99.1 Canada 
 N3E11 99.5 Kenya 
 N5E10 99.1 Kenya 
Bifidobacterium bifidum (W)15 100.0 Canada 
 (W)27-1 100.0 Canada 
 (W)86-2 100.0 Canada 
Bifidobacterium adolescentis N1D05 95.1 Kenya 
 N5F04 94.4 Kenya 
Bifidobacterium kashiwanohense N4G05 97.8 Kenya 
 N5G01 97.6 Kenya 
Bifidobacterium catenulatum N3F01 99.1 Kenya 
Bifidobacterium pseudocatenulatum N4E05 99.3 Kenya 
Alloscardovia omnicolens (IV)256-6 99.5 Canada 
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cpn60 PCR, sequencing and phylogenetic analysis 
The cpn60 UT region was used for species identification of isolates. The target region was 
amplified from genomic DNA using modified versions of the cpn60 “universal” primers, 
optimized for high G+C templates: H1594 (5'-CGC CAG GGT TTT CCC AGT CAC GAC GAC 
GTC GCC GGT GAC GGC ACC ACC AC-3') and H1595 (5'-AGC GGA TAA CAA TTT CAC 
ACA GGA CGA CGG TCG CCG AAG CCC GGG GCC TT-3'). The M13 (-40)F and M13 (-
48)R sequencing primer landing sites are underlined. 
PCR was carried out with 2 µL template DNA in a reaction mixture containing 1× PCR 
buffer (0.2 M Tris-HCl at pH 8.4, 0.5 M KCl), 2.5 mM MgCl2, 200 µM dNTP mixture, 400 nM 
each primer, 2 U AccuStart Taq DNA polymerase and water to a final reaction volume of 50 µL. 
Cycling conditions were as follows: 94 °C for 3 m, 40 cycles of 94 °C for 30 s, 57 °C for 60 s, 72 
°C for 60 s, and a final extension at 72 °C for 10 m. Amplification was confirmed by resolving the 
PCR products in 1% agarose gel (expected cpn60 UT amplicon is ~652 bp). Purified PCR products 
were sequenced with primers M13(-40)F or M13(-48)R. Following assembly of the forward and 
reverse sequences and removal of amplification primer sequences, the resulting 552 bp sequences 
were compared to the cpnDB reference database (www.cpndb.ca) (Hill et al., 2004) for 
identification.  
Phylogenetic analysis of isolates was done using PHYLIP (Phylogeny Inference Package) 
version 3.5 (Felsenstein, 1993). The cpn60 sequences of the isolates and reference strains from the 
cpnDB reference database were aligned with ClustalW (Thompson et al., 1994). Alignments were 
bootstrapped with seqboot; distances were calculated with the maximum likelihood option of 
dnadist. Dendrograms were constructed from distance data by neighbor-joining with neighbor. 
Consensus trees were calculated with consense, and branch lengths were superimposed on 
consensus trees using dnaml.  
 
Carbohydrate fermentation patterns 
The ability of vaginal Bifidobacterium isolates to metabolize 49 different carbohydrates 
was tested using the API 50 CH kit and API 50 CHL broth (bioMérieux, France) according to 
manufacturer’s instructions. Assay strips were incubated anaerobically at 37 °C for 8 days. Type 
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strains B. breve ATCC 15700, B. longum subsp. infantis ATCC 15697 and B. dentium ATCC 
27534 were included in the assay for comparison with vaginal isolates. Previously published 
descriptions of carbon source utilization by other type strains were also used for comparison (B. 
longum subsp. longum (Reuter, 1971), B. bifidum (Scardovi et al., 1971), B. adolescentis (Reuter, 
1971), B. kashiwanohense (Morita et al., 2011), B. catenulatum (Scardovi and Crociani, 1974), B. 
pseudocatenulatum (Scardovi et al., 1979) and A. omnicolens (Huys et al., 2007)). 
Results for each isolate were recorded as positive or negative for acid production from each 
carbon source based on colour reaction. Acid production (colour change) after 2 days of incubation 
was considered a delayed reaction. A Jaccard index was used to measure pairwise distances 
between isolates based on their fermentation patterns by using the vegan package (function 
‘vegdist’) in R (Oksanen et al., 2015). This distance matrix was used for hierarchical clustering 
using the ‘hclust’ function in R, with UPGMA (Unweighted Pair Group Method with Arithmetic 
Mean).  
 
Hydrogen peroxide assay 
A modified Brucella agar media (mB) containing 0.25% (w/v) tetramethylbenzidine (TMB, 
Sigma-Aldrich, Oakville, ON) and 0.01% (w/v) horseradish peroxidase (HRP, Sigma-Aldrich, 
Oakville, ON) was used for chromogenic detection of hydrogen peroxide (H2O2) production (Rabe 
and Hillier, 2003). Isolates grown on CSB agar were streaked onto mB agar plates. Alternatively, 
1 mL of sterile PBS was used to wash colonies off the CSB plate and the resulting suspension was 
adjusted to 1 McFarland and spotted on to mB plates using a sterile replicator. mB plates were 
incubated anaerobically at 37 °C for 72 h, removed from the incubator and held at room 
temperature in air for 30 minutes for colour development. Hydrogen peroxide production was 
reported as positive or negative based on the colour of the colonies (no colour/pale beige = 
negative, green/blue = positive).  
 
Lactic acid assay 
Isolates were grown overnight in Modified Reinforced Clostridial broth (for 
Bifidobacterium and Alloscardovia) or deMan, Rogosa and Sharpe broth (MRS) (for 
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Lactobacillus). All cultures were adjusted to an initial optical density (OD600) ≈ 0.1. After 
incubation, broth cultures were pelleted and supernatants were heat-treated at 80 °C for 15 minutes 
to stop enzymatic reactions. Lactic acid quantification was conducted using the D- and L-lactic 
acid Enzymatic BioAnalysis/Food Analysis UV method kit (R-Biopharm, Darmstadt, Germany). 
Results were reported as concentration of lactic acid per OD600. Each experiment was repeated at 
least three times. Concentration of lactic acid produced by different species was compared by 
Kruskal-Wallis test using IBM SPSS (Statistical Package for the Social Sciences, version 21). 
 
Tolerance of bifidobacteria to low pH and lactic acid  
Experiments to test tolerance of bifidobacteria to lactic acid and low pH were based on 
O’Hanlon, Moench and Cone (2011) (O’Hanlon et al., 2011) with minor modifications. A subset 
of Bifidobacterium spp. (n=18) and Gardnerella vaginalis (n=3) isolates were grown overnight in 
Modified Reinforced Clostridial broth (pH 6.8) or NYC III broth (pH 7.3), respectively. An aliquot 
(50 µL) of the overnight inoculum was added to each control or experimental medium (final 
volume 5 mL) and then incubated anaerobically at 37 °C for 2 hours. Control media was prepared 
at pH 6.8. Experimental media was prepared at pH 4.5 with the following concentrations of lactic 
acid: 0 mM, 1 mM, 10 mM, 100 mM and 1000 mM, and at pH 3.9 with (100 mM) and without 
lactic acid (0 mM). After 2 hours exposure, each sample was serially diluted with the appropriate 
medium containing 200 mM HEPES and track-plated (Jett et al., 1997). The pH of each 
experimental or control medium was re-measured after the 2 hours incubation to confirm it had 
remained within 0.2 pH units of the starting pH. Agar plates were incubated anaerobically at 37 
°C for 48 h and colony forming units (cfu/mL) were counted. Each experiment was repeated at 
least three times.  
The percent bacterial survival was calculated based on the ratio of colony counts (log10 
cfu/mL) of bacteria that had been incubated in experimental media (treatment) compared to colony 
counts (log10 cfu/mL) of bacteria that had been incubated in control media (control), according to 
the following formula: 
!"#$"%&	()#*+*,- = -/012 $3) 456 &#",&4"%&-/012 $3) 456 $/%&#/- × 	100 
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Susceptibility to antibiotics  
Susceptibility of bifidobacteria to clindamycin and metronidazole was evaluated using 
Etest strips (bioMérieux, France). Overnight cultures grown in Modified Reinforced Clostridial 
broth were adjusted to 1 McFarland. The suspension was spread evenly on Columbia sheep blood 
agar plates and Etest strips were placed on the agar surface. Plates were incubated anaerobically 
at 37 °C for 48 h. The minimum inhibitory concentration (MIC) for each antibiotic was read as the 
lowest antibiotic concentration at which growth was inhibited. 
 
4.4. Results 
Confirmation of Bifidobacterium-dominated vaginal microbial profiles 
We identified 21/492 (4.2%) of the previously published vaginal microbiome profiles that 
were dominated (>50% of sequence reads) by Bifidobacterium-like sequences, of which eight were 
dominated by B. breve, five by B. longum, three by B. dentium and five by A. omnicolens. An 
additional 6% (29/492) of microbiome profiles had intermediate (1-50%) levels of 
Bifidobacterium-like sequences and 59.5% (293/492) of profiles had low (<1%) levels. 
Bifidobacterium-like sequences were undetected in 30.3% (149/492) of samples. 
All samples (n=492) were ranked based on the total Bifidobacterium-like relative 
abundance, previously determined by cpn60 amplicon sequencing. A total of forty-two samples 
with high (>50%, n=11), medium (1-50%, n=11), low levels (<1%, n=10) and undetected 
Bifidobacterium-like sequences (n=10) (i.e., samples with ≤ 2 reads) were randomly selected from 
the 492 samples for qPCR analysis. This sample set (n=42) was assayed for each of the three 
targets (B. breve, B. dentium and A. omnicolens) by species-specific qPCR. The copy number for 
each target determined by qPCR was expressed as a proportion of the total bacterial load, estimated 
by 16S rRNA gene copy number (Albert et al., 2015; Freitas et al., 2017). Sequence read numbers 
(% abundance), qPCR results for B. breve, B. dentium and A. omnicolens, and previously 
determined total 16S rRNA copy numbers are provided in Supplementary Table 4.4S, and results 
are summarized in Figure 4.1.  
For samples in the high category, the three targets analyzed (B. breve, B. dentium and A. 
omnicolens) comprised approximately 100% of the estimated total bacterial load (Figure 4.1, left 
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panel). In two of the B. breve dominated samples where A. omnicolens was also detected in the 
microbiome profiles, both targets were detected by qPCR. B. breve and B. dentium were also 
detected by qPCR in two of the three high category samples where the microbiome profiles were 
dominated by other Bifidobacterium species not targeted by any of the qPCR assays. All five 
samples with medium levels (1-50% of sequence reads) of B. breve based on cpn60 amplicon 
sequencing, had detectable B. breve sequences by qPCR (Figure 4.1, middle panel). Estimates of 
proportional abundance of B. breve in these samples based on qPCR (77-113%), however, were 
much higher than the proportional abundance of corresponding sequence reads in the cpn60 
sequence-based microbiome profiles (all <10%). Two of the three samples with medium levels of 
B. dentium were qPCR positive for this target, but again the qPCR based estimate of proportional 
abundance (82-102%) was much higher than that predicted by sequence read numbers (both 
<25%). Samples with medium levels of A. omnicolens were negative by species-specific qPCR, 
but A. omnicolens was detected by qPCR in other samples in the medium category that were 
dominated by B. breve, B. dentium or other bifidobacteria. Samples in the low and undetected 
categories were negative for all three qPCR assays (Figure 4.1, right panel).  
When all samples (n=42) were considered, regardless of abundance category, there was a 
positive correlation between cpn60 amplicon sequencing data (% of sequence reads) and qPCR 
values (log10 copies per swab) for all three targets (B. breve ρ=0.671, p<0.0001; B. dentium 
ρ=0.502, p=0.001; A. omnicolens ρ=0.784, p<0.0001). The correlations remained significant when 
samples with zero values were removed from analysis. 
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Figure 4.1. Detection of B. breve, B. dentium and A. omnicolens by sequencing and qPCR, in 
42 vaginal microbiomes. 
Results are shown for samples in the high (n=11, left panel), medium (n=11, middle panel) and 
low/undetected (n=20, right panel with *) bifidobacteria abundance categories as determined by 
cpn60 amplicon sequencing. All samples in the “low” (n=10) and “undetected” (n=10) categories 
had identical results so only one example is shown. The bar charts illustrate the proportion of 
sequences assigned to each species detected, indicated by colour according to the legend. The 
lower table shows the percentage of Bifidobacterium (B. breve, B. dentium or A. omnicolens log10 
copies) out of the total bacterial load (estimated by 16S rRNA gene log10 copies) (%Bif/16S 
(qPCR)).  
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Vaginal Bifidobacterium isolates 
A total of 40 isolates from the vaginal swabs of 26 women from Canada and Kenya were 
included in the study (Table 4.2). Based on the cpn60 gene PCR amplification, sequences of the 
40 isolates were compared to cpnDB and the nearest type strain sequence was identified as B. 
breve n=15 (98.9-99.8% sequence identity over 552 bp), B. longum n=11 (99.1-100%), B. dentium 
n=4 (99.1-99.5%), B. bifidum n=3 (100%), B. adolescentis n=2 (94.4-95.1%), B. kashiwanohense 
n=2 (97.6-97.8%), B. catenulatum n=1 (99.1%), B. pseudocatenulatum n=1 (99.3%) and 
Alloscardovia omnicolens n=1 (99.5%). A phylogenetic tree based on the cpn60 UT sequences of 
the 40 vaginal isolates and 12 reference sequences from type strains of human origin is shown in 
Figure 4.2. B. adolescentis and B. kashiwanohense isolates clustered separately from their 
respective type strains with good bootstrap support. 
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Figure 4.2. Phylogenetic tree based on cpn60 UT sequences of vaginal bifidobacteria and 
reference strainsT. 
The tree was rooted with Gardnerella vaginalis ATCC 14018T and constructed using the Dnaml 
method with bootstrap values calculated from 100 trees. The number at each node represents the 
percentage bootstrap support.  
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Carbohydrate fermentation patterns 
Vaginal bifidobacteria isolates were tested for their ability to metabolize 49 different 
carbon sources. The relatedness of the fermentation patterns of vaginal bifidobacteria (n=39) and 
three available type strains (n=3) was visualized by UPGMA clustering (Figure 4.3). As expected, 
most strains clustered based on species identity, except for the two B. kashiwanohense-like isolates 
(N4G05 and N5G01) and three B. longum isolates ((W)35-1, (I)239-2 and (IV)239). (I)239-2 and 
(IV)239 were the only B. longum isolates that metabolized glycogen, gentiobiose and L-fucose, 
and (W)35-1 was the only B. longum strain not able to metabolize D-ribose. Also, most B. longum 
isolates (7/11) did not cluster with the type strain (B. longum subsp. infantis ATCC 15697) based 
on their fermentation patterns. The use of trehalose by B. breve differed between the type strain 
and most vaginal isolates (type strain was negative and 13/15 vaginal isolates were positive). 
Vaginal B. dentium isolates mainly differed from the type strain due to their ability to use D-
cellobiose (4/4). Overall, for B. breve isolates (n=15), there was a complete agreement between 
vaginal isolates and the type strain ATCC 15700 (gut origin) for utilization of 71% (35/49) of 
carbon sources tested. For B. longum (n=10), vaginal isolates and type strain ATCC 15697 (gut 
origin) had a complete agreement for 51% (25/49) of carbon sources. For B. dentium (n=4), a 
complete agreement of 84% (41/49) was observed between vaginal isolates and type strain ATCC 
27534 (oral cavity origin). Overall, there were no remarkable differences in the fermentation 
patterns between vaginal bifidobacteria and their respective type strains of gut or oral cavity origin.  
A second analysis was performed considering the percentage of vaginal isolates that were 
positive for each carbon source in comparison to the literature description of the type strains 
(Supplementary Table 4.5S). This analysis enabled the comparison of isolates for which the type 
strain was not available for inclusion in our fermentation assays. For B. adolescentis, vaginal 
isolates (2/2) did not utilize D-sorbitol and D-melezitose, unlike the type strain (Scardovi et al., 
1971). B. kashiwanohense isolates (2/2) differed from their type strain due to the ability to 
metabolize D-trehalose and D-melezitose (Morita et al., 2011). Regarding B. bifidum, the main 
difference was the fermentation of D-raffinose by all vaginal isolates (3/3), which differs from the 
type strain and other gut B. bifidum strains (Biavati and Mattarelli, 2012). Also, vaginal B. bifidum 
did not ferment D-cellobiose, diverging from its type strain (Biavati and Mattarelli, 2012). Despite 
these few differences, overall utilization patterns of vaginal isolates did not differ substantially 
from literature descriptions of the type strains. 
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Figure 4.3. Carbohydrate fermentation pattern. 
(A) UPGMA dendrogram derived from Jaccard’s similarity coefficients calculated among isolates 
based on their fermentation patterns (isolates n=39, type strainsT n=3). (B) Heatmap representing 
the fermentation of 49 carbon sources. Black = positive reaction; Grey = weak reaction; White = 
no growth/fermentation; * = Delayed reaction. 
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Production of hydrogen peroxide 
Hydrogen peroxide production was detected in 32.5% (13/40) of the vaginal bifidobacteria. 
All B. dentium (n=4) strains were positive and all B. kashiwanohense (n=2), B. catenulatum (n=1), 
B. pseudocatenulatum (n=1) and A. omnicolens (n=1) were negative. Production of hydrogen 
peroxide by B. breve (3/15), B. longum (4/11), B. bifidum (1/3) and B. adolescentis (1/2) was 
variable (Figure 4.4).  
 
Production of lactic acid  
Lactic acid production was measured for all vaginal bifidobacteria isolates using a 
commercial assay. Four vaginal isolates of L. crispatus, a species associated with high lactic acid 
production in the vagina, were included for comparison. All vaginal bifidobacteria produced lactic 
acid (n=40) (Figure 4.5). While bifidobacteria produced L-lactic acid only, L. crispatus produced 
both D and L lactic acid isomers. As expected, there was significant correlation between the 
absolute values of total lactic acid concentration (mM) and supernatant pH (p < 0.01, Pearson = 
1), and culture OD600 (p < 0.0001, Pearson = 1) (data not shown). A Kruskal-Wallis test was 
conducted to evaluate differences in the production of lactic acid among species (only species with 
two or more isolates were included in the statistical analysis). The overall test was significant (χ2 
(6, n=30) = 24.7, p ≤ 0.0001), hence pairwise comparisons among the groups were conducted with 
Mann-Whitney test. The highest concentration of lactic acid among the bifidobacteria was 
produced by B. longum isolates, which did not differ from the L. crispatus strains (Mann-Whitney, 
p=0.240) (Figure 4.5).  
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Figure 4.4. Hydrogen peroxide production indicated by blue colour on TMB medium. 
Species designation of each isolate is indicated by coloured dot according to the legend. Positive 
controls (+). Negative control (-).  
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Figure 4.5. Total lactic acid concentration in culture supernatant of vaginal isolates and type 
strains. 
Grey boxes below the chart indicate species identification for each isolate. Numbers at the top are 
the average lactic acid concentrations (mM/OD600 ± standard deviation) produced by each species 
group (excluding type strainsT). 
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Tolerance to low pH and lactic acid 
A subset of vaginal bifidobacteria isolates (15/40) and three type strains were selected for 
testing tolerance of low pH and high lactic acid concentrations and the percent survival values for 
each isolate under different conditions are shown in Figure 4.6. All bifidobacteria tested were able 
to survive at pH 4.5 with up to 100 mM lactic acid; conditions typical of vaginal fluid of healthy 
women with a Lactobacillus dominated microbiome and that have been shown to be lethal to many 
vaginosis associated bacteria (O’Hanlon et al., 2011). Survival of a few isolates was affected by 
1000 mM lactic acid, which is ten times more concentrated than physiologic levels. Surprisingly, 
pH 4.5 and 100 mM lactic acid did not affect G. vaginalis. The experiment was repeated using 
media at pH 3.9 (pKa of lactic acid), which resulted in drastic reduction in G. vaginalis survival, 
regardless of the inclusion of lactic acid. Most bifidobacteria were tolerant to this more acidic 
condition, with or without lactic acid (Figure 4.6). A. omnicolens and B. kashiwanohense (n=2) 
were the isolates most affected by lactic acid, with survival declining considerably when incubated 
with 100 mM lactic acid (pH 3.9). Two bifidobacteria type strains, B. breve ATCC 15700 and B. 
longum subsp. infantis ATCC 15697, were also affected by this condition, with only 45% survival 
compared to the culture incubated at neutral pH.  
 
Susceptibility to antibiotics 
Selected representative isolates were tested for susceptibility to clindamycin and 
metronidazole, the two antibiotics most widely used to treat vaginal dysbiosis (Table 4.3). Only 
one isolate (B. breve (I)30-1) presented a MIC higher than 8 µg/mL for clindamycin, which is the 
breakpoint of resistance for anaerobic bacteria according to The National Committee for Clinical 
Laboratory Standards (CLSI, 2014). For metronidazole, 15/22 isolates had a MIC higher than ≥ 
32 µg/mL, the breakpoint for metronidazole resistance (CLSI, 2014). All fifteen of these isolates 
had a MIC ≥ 256 µg/mL, the maximum antibiotic concentration in the Etest strip.  
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Figure 4.6. Survival (% log cfu/mL) of vaginal bifidobacteria after incubation at low pH and 
high lactic acid concentrations in comparison with bacteria cultured at pH 6.8. 
Results shown are the average of at least three replicate experiments. 
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Table 4.3. Susceptibility of bacteria to metronidazole and clindamycin. 
  
Minimum inhibitory concentration 
(MIC µg/mL) 
Species isolate Metronidazole Clindamycin 
B. breve (I)30-1 8.0 32.0 
 (I)91-1 >256 ≤0.016 
 (I)322-1 >256 0.035 
 (W)56 >256 0.032 
B. longum (I)239-2 >256 ≤0.016 
 N2E12 >256 0.056 
 (W)35-1 2.0 0.047 
 N2F05 >256 0.125 
B. dentium (VI)131-1 4.0 ≤0.016 
 N3E11 >256 0.250 
 N5E10 4.0 ≤0.016 
 (W)90-1 >256 ≤0.016 
B. bifidum (W)15 2.0 0.032 
 (W)27-1 2.0 0.032 
 (W)86-2 4.0 0.056 
B. adolescentis N1D05 >256 0.158 
 N5F04 >256 0.028 
B. kashiwanohense N4G05 >256 0.047 
 N5G01 >256 0.028 
B. catenulatum N3F01 >256 0.040 
B. pseudocatenulatum N4E05 >256 0.040 
A. omnicolens (VI)258-6 >256 0.035 
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4.5. Discussion 
As a result of microbiome characterization by culture-independent, DNA sequence based 
methods there is a growing appreciation of “atypical” vaginal microbiomes in healthy women, 
such as the Bifidobacterium-dominated profiles. However, it is known that DNA extraction 
methods and PCR amplification biases affect the sequencing outcome, resulting in a view of the 
abundances of species within the community that is inevitably distorted to some degree. Thus, for 
a careful investigation of the microbial composition, further evaluation using alternative 
techniques is recommended. Bifidobacteria present a particularly interesting and important subject 
for this type of investigation due to their recognized importance in the neonatal gut, their probiotic 
potential, and their frequent underrepresentation in PCR based microbiome profiles. Furthermore, 
the current diagnostic definition of a healthy vaginal microbiome is limited to a Lactobacillus-
dominated community, and the available gold standard diagnostic method (Gram stain and Nugent 
scoring (Nugent et al., 1991)) is interpreted based on this restrictive definition. 
In this study, we used species-specific qPCR to quantify bifidobacteria DNA in vaginal 
samples showing a wide range of proportional abundances of bifidobacteria based on cpn60 
amplicon sequencing. Our results showed a strong positive correlation between sequence read 
abundance and qPCR values for the three species tested (Supplementary Table 4.4S). However, 
when we expressed bifidobacteria abundance as a proportion of the estimated total bacterial 
population, the values calculated for the medium abundance category (1-50% bifidobacteria 
sequences in the cpn60 microbiome profile), estimates were much higher than expected. One 
possible explanation for this is that the 16S rRNA based estimates were biased (underestimated) 
due to the composition of the samples, resulting in a corresponding overestimation of proportional 
abundance of bifidobacteria DNA. The biases of “universal” 16S rRNA gene primers are well 
recognized (Walker et al., 2015; Brooks et al., 2015), making estimates of total bacterial population 
size challenging using this approach. Better approaches include flow cytometry (Schellenberg et 
al., 2008), which counts bacterial cells rather than relying on detection of sequences. However, 
fresh samples are preferred for this approach, which were not available for our study. While it is 
also possible that the cpn60 amplicon sequencing method underestimated the abundance of 
bifidobacteria due to preferential amplification of other sequences present in the samples, this 
seems unlikely given the abundance of Bifidobacterium sequence reads in other libraries within 
the same studies (i.e. the high category) and previous demonstrations of the efficient amplification 
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of Bifidobacterium cpn60 sequences from complex samples (Hill et al., 2010). A few samples with 
medium levels of bifidobacteria sequence reads were qPCR negative for targets expected to be 
present. The medium category included samples containing a wide range (1-50%) of bifidobacteria 
abundance, and the lack of qPCR detection in samples with bifidobacteria levels near the 1% cut 
off may be due to the detection limit of the assays. Taken together, our results confirm that cpn60 
amplicon sequencing reflects relative abundance of bifidobacteria and that Bifidobacterium spp. 
can be the dominant component of the vaginal microbiome. Future studies using more accurate 
methods for total bacterial population quantification will be needed to better describe this 
relationship in the context of overall community size. 
To learn more about the characteristics of vaginal bifidobacteria detected in sequence-
based microbiome studies, we collected 40 isolates from vaginal swabs of clinically healthy 
women, with most isolates being identified as B. breve or B. longum (Figure 4.2). A few 
differences were observed in carbon source utilization patterns between vaginal isolates and type 
strains, however, most of those differences have also been described among other bifidobacteria 
of gut or oral cavity origin. For example, unlike the type strain, vaginal B. bifidum isolates did not 
ferment D-cellobiose, but this characteristic is also absent in some gut B. bifidum (Biavati and 
Mattarelli, 2012). Similarly, our vaginal B. dentium isolates and other oral cavity isolates utilize 
D-cellobiose, which is not done by the type strain (Biavati and Mattarelli, 2012). Thus, this lack 
of agreement in carbon source utilization between vaginal isolates and type strains does not 
necessarily indicate that there is a distinctive fermentation profile of vaginal bifidobacteria. Our 
results support the idea that different body sites, such as gut and vagina, host similar strains of 
bifidobacteria. However, a more detailed examination of the utilization of nutrients that 
differentiate these environments and the genome contents of vaginal and gut isolates of 
Bifidobacterium spp. may yet reveal signs of niche specialization that are not apparent in 
examinations of housekeeping functions. 
Hydrogen peroxide and lactic acid production have been associated for decades with the 
protective role of vaginal Lactobacillus, but more recent findings have called into question the 
significance of the physiological concentrations of H2O2 produced by Lactobacillus. Vaginal 
H2O2-producing lactobacilli are claimed to inhibit growth of opportunist bacteria, which share the 
same niche with lactobacilli and may not have protective mechanisms like production of catalase 
or peroxidase (Strus et al., 2006). However, it is unclear whether Lactobacillus is able to produce 
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H2O2 under the hypoxic condition of the vagina (Hill et al., 2005a), since oxygen is required for 
its production. Additionally, cervicovaginal fluid and semen contain proteins, glycoproteins, 
polysaccharides, and lipids that react with and inactivate H2O2 (O’Hanlon et al., 2010). O’Hanlon, 
Moench, & Cone (2011) also reported that physiological concentrations of H2O2 had no 
microbicidal activity, while a supraphysiologic concentration of H2O2 that was sufficient to 
inactivate bacterial vaginosis associated bacteria, also inactivated vaginal lactobacilli. We decided 
to test our bifidobacteria isolates for H2O2 production considering the wealth of previous studies 
and descriptions of H2O2 production for Lactobacillus, the presumed indicator of a healthy vaginal 
microbiome. Our results indicate that in vitro H2O2 production is not widespread in vaginal 
bifidobacteria (Figure 4.4). 
Lactic acid is a key element in promoting a healthy vaginal environment by preventing the 
overgrowth of bacterial vaginosis-associated microorganisms (O’Hanlon et al., 2011). One of the 
protective mechanisms attributed to lactic acid is lowering the vaginal pH (Boskey et al., 2001, 
1999). It has also been demonstrated that lactic acid is able to disrupt the outer membrane of Gram 
negative bacteria (Alakomi et al., 2000). Bacteria are known as the primary source of lactic acid 
in the vagina, with some species being able to produce both lactic acid enantiomers (D and L), as 
opposed to human cells that only make the L form (Boskey et al., 2001). Here, we confirmed that 
vaginal Bifidobacterium produced only L-lactic acid, as previously described for other 
bifidobacteria (Kandler, 1983). While L. crispatus and L. gasseri are both able to produce a 
mixture of DL-lactic acid, other Lactobacillus spp. have been shown to produce only L- (L. iners) 
or D-lactic acid (L. jensenii) (Witkin et al., 2013). At physiological concentrations (~56 to 111 
mM), both forms of lactic acid are effective in decreasing HIV infectivity in vitro; at lower 
concentrations, L-lactic acid has greater virucidal activity than D-lactic acid (Aldunate et al., 
2013). L-lactic acid has also been shown to have greater antibacterial effect against E. coli (O157 
and non-O157) than D-lactic acid (Leitich et al., 2003). Although the biological significance of 
producing different amounts of D and L forms remains unclear, the results of these studies suggest 
that the microbicidal effect of lactic acid involves more than acidity alone. Since bifidobacteria in 
general are known lactic acid producing bacteria, our observation of its production is far from 
surprising. However, what is noteworthy is that the levels of lactic acid produced by vaginal 
bifidobacteria, especially B. longum, are comparable to those of L. crispatus, the organism most 
often associated with a healthy vaginal microbiome (Petrova et al., 2015). 
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Considering that lactic acid is a hallmark of a healthy vagina, knowing the levels of acid 
produced by different bifidobacteria is of interest when evaluating whether a vaginal microbiome 
dominated by Bifidobacterium should be considered as protective as a microbiome dominated by 
Lactobacillus. Moreover, assessing the ability of bifidobacteria to persist in high levels of lactic 
acid and low pH, conditions typical of the vaginal fluid of healthy women, was an important step 
in improving knowledge of bifidobacteria ecology. Other studies have shown that protonated lactic 
acid rather than lactate anion is the microbicidal form of lactic acid (O’Hanlon et al., 2011; 
Aldunate et al., 2013), which emphasizes the role of pH in mediating lactic acid activity. We 
initially conducted our experiments at pH 4.5, recreating conditions used in previous investigations 
of microbicidal activity of lactic acid against vaginosis-associated bacteria (O’Hanlon et al., 2011). 
However, these conditions did not kill any of the three G. vaginalis isolates included in our study. 
We repeated the experiments at pH 3.9, a value of which is now understood to be within the range 
of expected pH for the cervicovaginal fluid of clinically healthy women (~3.5 - 4.5) (O’Hanlon et 
al., 2013) and observed differential survival of G. vaginalis and the bifidobacteria. Bifidobacteria 
resistance to low pH and high concentrations of lactic acid may be species specific, as isolates 
from the same species behaved similarly in most cases (Figure 4.6). B. kashiwanohense-like 
isolates, for example, were clearly less tolerant to these acidic conditions than B. breve, B. dentium, 
B. bifidum or B. adolescentis isolates. Further studies of larger numbers of isolates will be required 
to test this observation.  
The normal microbiota plays an important role in the recovery of the microbiome after 
antibiotic treatment. While most vaginal bifidobacteria were susceptible to clindamycin, we 
observed high rates of metronidazole resistance. Metronidazole and clindamycin are the two 
antibiotics recommended by CDC to treat bacterial vaginosis, and can be administrated either 
orally or intravaginally (CDC - Centers for Disease Control and Prevention, 2015b). Although 
metronidazole is the first-line treatment against bacterial vaginosis (Hay, 2009), many non–spore-
forming, Gram-positive anaerobic rods are resistant to it, including Propionibacterium, 
Atopobium, Mobiluncus, Bifidobacterium and Lactobacillus (Hall and Copsey, 2015). Gardnerella 
vaginalis, a hallmark microorganism in BV, and Prevotella have also been demonstrated to be 
resistant to metronidazole (Alauzet et al., 2010; Aroutcheva et al., 2001). Since G. vaginalis, 
Atopobium, Mobiluncus and Prevotella are considered vaginosis associated bacteria, this might 
explain the high rates of BV recurrence after metronidazole treatment (Hay, 2009). Although 
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antimicrobial resistance is a concern in BV treatment, bifidobacteria resistance might be a 
beneficial factor by facilitating the microbiota recovery after antibiotic administration.  
In this study we confirmed that a subset of healthy, reproductive aged women have vaginal 
microbiomes dominated by Bifidobacterium spp. We also demonstrated that vaginal bifidobacteria 
have the potential to be as protective as lactobacilli according to the current understanding of a 
“healthy” vaginal microbiome. These results have significant implications for women’s health 
diagnostics since current protocols based on Gram staining and Nugent score would likely result 
in a diagnosis of “intermediate” or “consistent with BV” if a vaginal smear was dominated by 
Bifidobacterium rather than Lactobacillus. We expect our findings will help to guide clinicians 
and researchers to better assess a healthy vaginal microbiome, and avoid unnecessary 
interventions. 
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Chapter transition 
Bifidobacteria are found in the human gut (adult and infant), vaginal and milk 
microbiomes, and although they have been the subject of numerous studies due to their gut health-
promoting effects, the mechanisms of mother-infant transmission remain in discussion. 
Considering their potential importance in the vaginal and infant-gut microbiome, I have 
investigated several aspects of vaginal bifidobacteria in the previous study chapter. First, I 
confirmed that bifidobacteria can be the dominant bacteria in the vaginal microbiome of a 
subpopulation of women. Second, I described bifidobacteria characteristics that are consistent with 
the phenotypic properties of lactobacilli, the “healthy” gold standard bacteria. Although the results 
indicated that bifidobacteria may play a similar role as lactobacilli, it is unknown if the vaginal 
bifidobacteria are an adapted subpopulation or if they are ubiquitous bacteria that have health 
promoting effects in both the gut and the vagina. To elucidate some aspects of these possible 
adaptations and indirectly infer aspect of mother-infant bifidobacteria transmission, I assessed the 
genetic variability of B. breve and B. longum isolated from two different microbiomes: vaginal 
and gut. These two bifidobacteria species are the most common bifidobacteria species found in the 
gut (adult and infant) and genital tract. The results of this study demonstrated that gut and vaginal 
bifidobacteria have very similar genome repertoires indicating they represent the same bacterial 
population. 
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5.1. Abstract  
Bifidobacteria colonize the human gastrointestinal tract, vagina, oral cavity and breast 
milk. They influence human physiology and nutrition through health-promoting effects, play an 
important role as primary colonizers of the newborn gut, and contribute to vaginal microbiome 
homeostasis by producing lactic acid. Nevertheless, the mechanisms by which bifidobacteria are 
transmitted from mother to infant remains in discussion. Moreover, studies have suggested that 
Bifidobacterium spp. have specializations for gut colonization, but comparisons of strains of the 
same bifidobacteria species from different body sites are lacking. Here, our objective was to 
compare the genomes of Bifidobacterium breve (n = 16) and Bifidobacterium longum (n = 26) to 
assess whether gut and vaginal isolates of either species were distinguishable based on genome 
content. Comparison of the general genome features showed that vaginal and gut isolates did not 
differ in size, GC content, number of genes and CRISPR, either for B. breve or B. longum. Average 
nucleotide identity and whole genome phylogeny analysis revealed that vaginal and gut isolates 
did not cluster separately. A few differences in the accessory genes between vaginal and gut strains 
were observed, but were not sufficient to distinguish isolates based on their origin. Vaginal and 
gut isolates also had a similar COG (Cluster of Orthologous Group) category distribution, and no 
evidence of differential adaptation to either body site was identified. The results of this study 
support the hypothesis that the vaginal and gut microbiomes are colonized by a shared community 
of Bifidobacterium, and further emphasize the potential importance of the maternal vaginal 
microbiome as a source of infant gut microbiota.  
Keywords: Bifidobacterium, gut, vagina, genome, microbiome, adaptation, specialization, 
comparative genomics 
 
5.2. Introduction 
Bifidobacterium are Gram-positive, non-motile, anaerobic, non-spore forming rod-shaped 
bacteria. They belong to the Bifidobacteriaceae family and are characterized by high genomic 
G+C content (55-67 mol%) (Biavati and Mattarelli, 2006). Bifidobacteria are common members 
of the microbiota of the gastrointestinal tract (GIT), and they also colonize the human vagina, oral 
cavity, and breast milk (Gomez-Gallego et al., 2016; Biavati and Mattarelli, 2006). Beyond the 
human microbiome, they can be found in sewage, fermented milk products, and the gastrointestinal 
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tracts of animals including insects (Biavati and Mattarelli, 2012). Although members of the genus 
inhabit a wide range of habitats, most Bifidobacterium spp. are host-specific (Biavati and 
Mattarelli, 2006). 
Bifidobacteria have been the subject of numerous studies due their probiotic potential and 
health promoting characteristics, such as immune modulation (Fanning et al., 2012; Hart et al., 
2004), production of bacteriocins (Martinez et al., 2013) and inhibition of pathogens (Bernet et al., 
1993; Arboleya et al., 2011; Fukuda et al., 2011). The precise mechanisms by which bifidobacteria 
provide these benefits, however, are not fully understood. Bifidobacteria also play an important 
role as one of the primary colonizers of the neonatal gut, representing 60-91% of fecal bacteria in 
breast-fed infants (Harmsen et al., 2000; Turroni et al., 2012). This early microbial colonization is 
an essential step in the modulation of the neonatal immune system (Rautava et al., 2012; Olszak 
et al., 2012) and may be influenced by mode of delivery (vaginal or C-section) and feeding type 
(breast milk or formula) (Penders et al., 2006; Dominguez-Bello et al., 2010; Bäckhed et al., 2015). 
Studies of the vaginal microbiota using deep sequencing methods have shown that 
bifidobacteria are the dominant bacteria in the vaginal microbiomes of some reproductive aged 
women (Freitas and Hill, 2017). Culture-based studies have subsequently confirmed that some 
vaginal Bifidobacterium spp. are able to perform a protective role similar to the beneficial 
lactobacilli, which includes the production of lactic acid and hydrogen peroxide (Schellenberg et 
al., 2012; Freitas and Hill, 2017). These features prevent the overgrowth of unwanted bacteria and 
help to maintain the homeostasis of the vaginal microbiome. Common species detected in the 
vaginal microbiome, based on sequencing (Chaban et al., 2014; Freitas et al., 2017; Freitas and 
Hill, 2017) and culture methods (Freitas and Hill, 2017; Verhelst et al., 2005), include 
Bifidobacterium breve, B. longum, B. bifidum, and B. dentium. Based on the recognition that both 
the gut and vagina harbour bifidobacteria, a large number of studies have been conducted to 
investigate and demonstrate the influence of maternal microbiota on the neonatal gut microbiome 
(Matamoros et al., 2013; Bäckhed et al., 2015; Makino et al., 2013; Dominguez-Bello et al., 2010; 
Gabriel et al., 2017; Gomez-Gallego et al., 2016; Hunt et al., 2011; Milani et al., 2015; Duranti et 
al., 2017; Pannaraj et al., 2017), but the specific contribution of each microbial community 
(vaginal, gut and to a smaller extent, milk) in the mother-to-infant bifidobacteria transmission 
remains in discussion. 
 121 
Comparison of Bifidobacterium spp. genome sequences has revealed a high degree of 
conservation and synteny across their genomes (Ventura et al., 2007). Nevertheless, phenotypic 
differences have been described among bifidobacteria, suggesting that niche adaptation has led to 
some degree of specialization (Ventura et al., 2009a). One indication of these adaptations is the 
greater percentage of the bifidobacteria genome involved in carbohydrate metabolism in 
comparison with the genomes of other members of the gut microbiota. Specifically, genome 
analysis has demonstrated that B. longum has the ability to metabolize a variety of complex sugars 
which gives an ecological advantage in the GIT and evidently reflects its gut adaptation (Schell et 
al., 2002). It has also been shown that B. longum subsp. infantis has adaptations for milk utilization 
(Sela et al., 2008), and that B. dentium is adapted for the colonization of the human oral cavity 
(Ventura et al., 2009b). These observations of niche specialization, however, are mostly based on 
the examination of a single genome, or reflect the differences among different bifidobacteria 
species (from the same niche or not) rather than among isolates of the same species from different 
ecological niches. B. longum, for example, possess a large number of genes related to carbohydrate 
transport and metabolism indicating an adaption to the diversity of nutrients available in the gut 
(Schell et al., 2002), but since B. longum also colonizes the human vagina, it is not clear whether 
these specializations are broadly present in all B. longum or only those strains present in the gut.   
The importance of bifidobacteria in adult and neonatal health is evident, although evidence 
supporting the importance of vertical transmission of maternal microbiota in establishing these 
populations remains inconclusive. The overlapping occurrence of bifidobacteria species, among 
other microorganisms, in different body sites is one of the challenges in studying vertical 
transmission. For example, are vaginal bifidobacteria transferred to the infant gut microbiome, or 
are they a distinct population adapted to life in the vaginal microbiome? Answers to questions like 
this are not yet resolved due the lack of studies comparing isolates of the same species from 
different body sites. Furthermore, while several bifidobacteria adaptations for survival in the GIT 
and oral cavity have been proposed, no study has addressed possible adaptations to the particular 
features of the vaginal microbiome. Here, we compared the genomes of gut and vaginal isolates 
of B. breve and B. longum to identify evidence of specialization that could indicate if vaginal and 
gut strains represent two distinct, adapted subpopulations or if they are ubiquitous bacteria able to 
colonize both gut and vagina. Improved knowledge of bifidobacteria ecology is necessary for a 
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better understanding of mother-to-infant bifidobacteria transmission, a potentially important 
determinant of infant health. 
 
5.3. Material and Methods 
Bacterial strains  
A total of 16 bifidobacteria (7 Bifidobacterium breve and 9 Bifidobacterium longum) were 
sequenced in this study. Genome sequences from an additional 27 Bifidobacterium spp. were 
acquired from GenBank for comparative analysis (Table 5.1). All 16 genomes sequenced in this 
study were from strains originally isolated from human vaginal microbiota as part of previous 
studies (Freitas and Hill, 2017; Schellenberg et al., 2012). Genomic DNA was isolated from 
cultures grown in Modified Reinforced Clostridial broth using a modified salting out procedure 
(Martín-Platero et al., 2007). The integrity of DNA was verified by electrophoresis on 1% agarose 
gels. Genomic DNA was quantified using Qubit dsDNA BR assay kit (Invitrogen, Burlington, 
Ontario) and DNA quality was assessed by the A260/A280 ratio using a spectrophotometer. 
 
Genome sequencing and assembly 
Libraries were prepared with 1 ng of genomic DNA using the Nextera XT DNA Library 
Preparation Kit (Illumina Inc., San Diego, CA) according to the manufacturer’s instructions. After 
PCR amplification and clean up, the fragment size distribution of the tagmented DNA was 
analyzed using the High Sensitivity DNA Analysis Kit on Agilent 2100 Bioanalyzer (Agilent 
Technologies, Santa Clara, CA). PhiX DNA (15% (v/v)) was added to the pooled indexed libraries 
prior to loading onto the flow cell. The libraries were sequenced using Reagent Kit V2 (500 cycles) 
on Illumina Miseq platform (Illumina Inc., San Diego, CA). 
Raw sequence reads were trimmed for quality using Trimmomatic (Bolger et al., 2014) 
with a minimum read length of 40 and quality cut-off of Phred score of 20. To estimate genome 
coverage and calculate average insert size, reads were mapped on to the reference genome of B. 
breve (Genbank Accession AP012324) or B. longum (Genbank Accession NC_015067.1) using 
Bowtie2 (Langmead and Salzberg, 2012) and the results were converted to BAM format for 
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viewing in Qualimap v2.2.1 (Okonechnikov et al., 2015). High quality reads were assembled with 
SOAPdenovo2 (Luo et al., 2012) using the estimated average insert size from Qualimap analysis.  
 
Genome analysis 
Genomes were annotated using the NCBI (National Center for Biotechnology Information) 
Prokaryotic Genome Automatic Annotation Pipeline (PGAAP). CRISPRFinder 
(http://crispr.i2bc.paris-saclay.fr/) was used to identify CRISPR (clustered regularly interspaced 
short palindromic repeats) within the genome sequences (Grissa et al., 2008). Annotated genomes 
were submitted to the Joint Genome Institute (JGI - http://jgi.doe.gov/) for COG (Clusters of 
Orthologous Groups) category assignment.  
Overall genome similarities were assessed by calculating the Average Nucleotide Identity 
by Mummer (ANIm) and tetranucleotide scores (tetra) within JSpecies (Richter et al., 2016). 
ANIm values were visualized as heatmap, generated in R. The vegdist() function was used to 
calculate the Euclidean distance between the ANI divergence values, and hclust() function was 
used to calculate the complete linkage on the distance matrix, in R. 
Pangenome analysis was conducted using GView server with the following settings: 
genomes were compared to each other using tblastn with expect value cutoff of 1×10-10; CDS were 
translated into amino acid sequence using the genetic code of Bacteria; minimum alignment length 
cutoff value of 100 and minimum percentage identity cutoff value of 80% (Petkau et al., 2010). 
Core and accessory genomes were identified using the Nucmer alignment within Spine and 
the distribution of each accessory genomic element among the genomes was determined with 
ClustAge (Ozer et al., 2014). A heatmap and neighbour joining tree were created based on the 
Bray-Curtis distance matrix of the accessory element distribution patterns from the 100 bootstrap 
replicates.  
CSI Phylogeny was used to call SNPs (single-nucleotide polymorphisms) and infer 
phylogeny based on the concatenated alignment of SNPs. The following settings were used: 
minimum depth at SNP positions of 10; relative depth at SNP positions of 10; minimum distance 
between SNPs (prune) of 10; minimum SNP quality of 30; minimum read mapping quality of 25; 
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minimum Z-score: 1.96. A maximum likelihood tree indicating the whole genome phylogeny was 
also computed within CSI Phylogeny (Kaas et al., 2014). 
 
5.4. Results and Discussion 
General genome features  
We performed a comparative genomic analysis of gut and vaginal isolates for two 
Bifidobacterium species commonly found in the human gut and vagina: B. breve and B. longum. 
All analysis comparing vaginal and gut strains was performed in parallel for these two species. 
The general features of all genomes included in this study are listed in Table 5.1. Seventeen B. 
breve genomes were analyzed, seven of which were sequenced in this study. We also analyzed the 
genome sequences of twenty-six B. longum strains, nine of which were sequenced as part of this 
study. Genome sequence data and annotated assemblies have been deposited in GenBank under 
BioProject PRJNA387952. The B. breve genomes were sequenced to an average of 97-fold 
coverage ± 47 (range 14-270), and B. longum genomes were sequenced to an average of 57-fold 
coverage ± 34 (range 11-182).  
 
 
 
 
 
 
 
 
 
 
 
 125 
Table 5.1. General features of the bifidobacteria genomes included in this study. 
Strain Ecological origin 
Size 
(Mb) 
GC 
(%) 
Total 
genes tRNA CRISPR N50 / N90 GenBank 
Status (n. 
scaffolds/ 
contigs) 
B. breve (n=17)          
B.b.# 30-1 Vagina 2.54 59.8 2346 67 1 125268 / 38442 * D (32/5) 
B.b. 91-1 Vagina 2.24 58.0 2215 50 0 188169 / 56499 * D (21/1) 
B.b. 322-1 Vagina 2.24 58.5 2026 47 1 29270 / 9437 * D (67/36) 
B.b. W20-13 Vagina 2.30 58.3 2113 50 1 43276 / 19775 * D (49/16) 
B.b. W56 Vagina 2.36 57.8 2207 49 2 126027 / 46295 * D (24/13) 
B.b. N6D12 Vagina 2.29 58.5 2097 50 1 119740 / 29243 * D (30/12) 
B.b. 12-4 Vagina 2.26 58.7 2148 48 3 148702 / 48178 * D (25/7) 
B.b. ACS-071-V-
Sch8b Vagina 2.33 58.7 2046 53 4 NA CP002743 C 
B.b. JCM 1192T Infant feces 2.27 58.9 2039 53 0 NA AP012324 C 
B.b. UCC2003 Infant feces 2.42 58.7 2131 54 3 NA CP000303 C 
B.b. JCM 7017 Infant feces 2.29 58.7 1995 54 2 NA CP006712 C 
B.b. JCM 7019 Adult feces 2.36 58.6 2133 56 2 NA CP006713 C 
B.b. NCFB 2258 Infant feces 2.32 58.7 2036 53 2 NA CP006714 C 
B.b. 689b Infant feces 2.33 58.7 2052 53 0 NA CP006715 C 
B.b. S27 Infant feces 2.29 58.7 2005 53 2 NA CP006716 C 
B.b. CBT BR3 Infant feces 2.43 59.1 2195 54 2 NA CP010413 C 
B.b. LMC520 Infant feces 2.40 59.0 2146 55 1 NA CP019596 C 
B. longum (n=26)          
B.l.# 239-2 Vagina 2.28 59.1 2060 50 8 33459 / 10497 * D (60/56) 
B.l. W35-1 Vagina 2.30 60.3 2133 49 1 17831 / 5459 * D (81/132) 
B.l. N2E12 Vagina 2.34 59.1 2114 51 5 80659 / 26287 * D (43/12) 
B.l. N2F05 Vagina 2.33 59.6 2076 55 2 105634 / 41749 * D (30/13) 
B.l. N2G10 Vagina 2.28 59.6 2200 38 0 9284 / 3230 * D (165/186) 
B.l. N3A01 Vagina 2.31 59.7 2056 51 5 82928 / 40450 * D (33/13) 
B.l. N3E01-2 Vagina 2.34 59.6 2167 51 3 202175 / 50971 * D (23/1) 
B.l. N5E04 Vagina 2.46 58.3 2219 45 0 154725 / 47782 * D (27/3) 
B.l. N6D05 Vagina 2.72 60.4 2641 77 3 25630 / 6992 * D (80/105) 
B.l.l. JCM 1217T Infant feces 2.39 60.3 2090 73 1 NA AP010888 C 
B.l.l. JDM301 Gut 2.48 59.8 2156 55 1 NA CP002010 C 
B.l.l. BBMN68 Elderly feces 2.27 59.9 1959 54 3 NA CP002286 C 
B.l.l. KACC 91563 Infant feces 2.40 59.8 2064 56 1 NA CP002794 C 
B.l.l. GT15 Adult feces 2.34 60.0 2021 56 1 NA CP006741 C 
B.l.l. NCIMB 8809 Human feces 2.34 60.1 2037 56 1 NA CP011964 C 
B.l.l. CCUG 30698 Gut 2.46 60.2 2184 72 1 NA CP011965 C 
B.l.l. AH1206 Infant feces 2.42 60.2 2179 60 2 NA CP016019 C 
B.l. NCC2705 Infant feces 2.26 60.1 1799 57 1 NA AE014295 C 
B.l. DJO10A Adult feces 2.39 60.1 2105 58 2 NA CP000605 C 
B.l. 105-A Human feces 2.29 60.1 1950 56 2 NA AP014658 C 
B.l. BXY01 Gut 2.48 59.8 2158 55 1 NA CP008885 C 
B.l. BG7 Infant feces 2.46 60.0 2128 57 1 NA CP010453 C 
B.l. 35624 Gut 2.26 60.0 1942 57 2 NA CP013673 C 
B.l.i. JCM 1222T Infant feces 2.83 59.9 2673 77 0 NA CP001095 C 
B.l.i. 157F Infant feces 2.41 60.1 2147 59 1 NA AP010890 C 
B.l.i. BT1 Infant feces 2.58 59.4 2308 56 1 NA CP010411 C 
# B.b. = B. breve; B.l. = B. longum; B.l.l. = B. longum subsp. longum; B.l.i. = B. longum subsp. infantis. * Genome sequenced 
as part of this study.  T = type strain. NA = not applicable. C = complete, D = draft. 
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Currently, B. longum encompass three subspecies: -longum, -infantis and -suis, but it has 
been previously considered as three separate species (B. longum, B. infantis and B. suis) or as a 
unified species (B. infantis and B. suis were published as synonyms of B. longum) (Mattarelli et 
al., 2008; Sakata et al., 2002). Considering this controversial taxonomic history of B. longum, we 
opted to include in our analysis publicly complete genomes of all subspecies of B. longum of gut 
origin. 
The average genome size of vaginal and gut B. breve was 2.32 ± 0.09 Mb and 2.34 ± 0.05 
Mb, respectively; where vaginal strains 91-1 and 322-1 were the smallest (2.24 Mb) and the 
vaginal strain 30-1 was the largest (2.54 Mb). For B. longum, the average genome sizes of vaginal 
and gut isolates were 2.37 ± 0.14 Mb and 2.41 ± 0.13 Mb, respectively; the smallest genomes were 
represented by gut isolates NCC2705 and 35624 (2.26 Mb) and the largest genome was from JCM 
1222T (2.83 Mb). All genomes analyzed had high GC content, a known characteristic of the genus 
Bifidobacterium and previously reported as 55-67 mol% (Biavati and Mattarelli, 2012). Vaginal 
and gut B. breve have 58.5% and 58.8% genomic GC content, respectively; and vaginal and gut 
B. longum have 59.5% and 60% of GC content, respectively. There were no differences in genome 
size and GC content between gut and vaginal isolates, either for B. breve or B. longum (t-test, all 
p>0.05) (Figure 5.1).  
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Figure 5.1. Genome features. 
Genome size and GC content of B. breve and B. longum of gut and vaginal origin. 
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The genomes of B. breve and B. longum contained an average of 2113 and 2137 genes, 
respectively, which is within the range of number of predicted genes previously reported for 
Bifidobacterium spp. (1369-2564 genes) (Sun et al., 2015). Also, B. breve and B. longum contained 
an average of 1.6 (range 0-4) and 1.8 (range 0-8) CRISPR, respectively. There was no difference 
in the number of genes and CRISPR between gut and vaginal isolates of either B. breve or B. 
longum (t-test, all p>0.05). CRISPR have been implicated in chromosomal rearrangement, 
modulation of expression of neighbouring genes, target for DNA binding proteins, and DNA repair 
(Horvath and Barrangou, 2010). It has been shown to act as the defense mechanism in bacteria 
against phages and plasmids by providing adaptive immunity (Barrangou et al., 2007). Notably, 
vaginal B. longum 239-2 and N2E12 had a total of 8 and 5 CRISPR, respectively, which suggest 
these strains had an active CRISPR immune system against potentially damaging foreign DNA. 
Previous studies have shown that CRISPR systems are frequent and diverse in the genus 
Bifidobacterium and differences in the frequency of CRISPR-Cas systems (CRISPR and CRISPR-
associated proteins) within species are an indicative that CRISPR distribution is strain-dependent 
(Briner et al., 2015; Milani et al., 2014).  
The overall sequence similarity between vaginal and gut strains was assessed based on 
average nucleotide identity (ANI). A hierarchal clustering based on the distance matrix of ANI 
divergence values was computed and visualized as a heatmap (Figure 5.2). All ANI values between 
isolates of the same species were >95%, consistent with their identification as members of the 
same species (Richter and Rossello-Mora, 2009). The genomes of vaginal B. breve did not cluster 
separately from the gut isolates (Figure 5.2A). Similarly, vaginal B. longum did not form a separate 
cluster from the gut isolates (Figure 5.2B). Therefore, vaginal and gut isolates could not be 
distinguished based on their overall nucleotide identity, either for B. breve or B. longum. The 
relatedness of isolates was also assessed by calculating the tetranucleotide scores (tetra), which led 
to similar results as ANI (data not shown). 
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Figure 5.2. Average Nucleotide Identity (ANI). 
Heatmap of ANI values between genomes of gut and vaginal origin. (A) B. breve; (B) B. longum. 
T = type strain. 
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Pangenome, core and accessory genome 
The pangenome is defined as the entire gene set of all isolates, including genes present in 
all isolates (core genome) and genes present in one or some isolates (accessory genome). The 
pangenome analysis revealed that genomes of B. breve and B. longum did not have major deletions 
or insertions related to the source of the isolates (Figure 5.3). In other words, at this overall level, 
there was no region within the genome specifically associated with gut or vaginal isolates.  
Interestingly, a few vaginal and gut B. breve isolates had several coding sequences in 
common that were mostly absent in other isolates (Figure 5.3A). The gut isolate JCM 1192T and 
the vaginal isolates 30-1 and N6D12 shared genes encoding several hypothetical proteins, a type 
IA DNA topoisomerase, a plasmid mobilization relaxosome protein MobC, a mobilization protein, 
a PsfB family protein, a conjugal transfer protein TraG, a glycosidase hydrolase, a transfer 
complex protein, and a Prgl family protein, all located within the 1300-1350 kbp region of the 
calculated pangenome (Figure 5.3A). In the same region, several hypothetical proteins, a cell wall 
anchor protein and a ParA family protein were also exclusively present in the gut strain JCM 1192T 
and vaginal strain 30-1. These two isolates also shared an integrase, a type I restriction 
modification protein subunit S, a SAM-dependent DNA methyltransferase, and a type I 
desoxyribonuclease HsdR, all of which were located within the 1650-1700 kbp region (Figure 
5.3A). 
Analysis of B. longum pangenome also revealed several sequence features shared by the 
vaginal and gut isolates (Figure 5.3B). In particular, the gut isolates JCM 1217T, CCUG 30698, 
KACC 91563, NCIMB 8809, 35624 and JCM 1222T, and the vaginal isolates 239-2 and N5E04 
shared several coding sequences within the region 1550-1555 Kbp (Figure 5.3B); among the 
shared sequences were numerous hypothetical proteins, a DUF262 domain containing protein, a 
cell division protein FtsZ, a DNA helicase UvrD, a ATP-dependent nuclease subunit B, and a DNA 
polymerase III subunit alpha. Notably, vaginal isolate 239-2 was missing several coding sequences 
in comparison with other isolates, which is consistent with its small size (2.28 Mb). Moreover, gut 
isolates JCM 1222T and BT1 had very similar genome patterns, where presence/absence of several 
sequences was in common between them. 
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Figure 5.3. Pangenome. 
(A) B. breve; (B) B. longum. Coloured horizontal bars represent different strains. Vertical grey blocks indicate origin of the isolate. 
T = type strain.
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We also investigated B. breve and B. longum core genomes, which represent the DNA 
coding sequences (CDS) that are present in all isolates of a species. For B. breve isolates, the core 
genome accounted for an average of 69.8% of the genome (1.6 Mb), for both vaginal and gut 
isolates, ranging from 63.3% (strain 30-1) to 73.2% (strain 91-1) for the vaginal isolates, and from 
66% (strain BR3) to 70.8% (strain JCM 1192T) for the gut isolates. For B. longum, the core genome 
accounted for an average of 55.7% (1.33 Mb) of the genome (vaginal isolates: 56.4%; gut isolates: 
55.3%), ranging from 49.1% (strain N6D05) to 58.3% (strain 239-2) for vaginal isolates, and from 
46.2% (strain JCM 1222T) to 58.9% (strain NCC2705) for the gut isolates. No significant 
differences in the proportional representation of the core genome of gut and vaginal isolates were 
detected either for B. breve or B. longum (t-test, all p>0.05). 
The accessory genome was defined in terms of presence or absence of CDS within the 
genome; a Bray-Curtis dissimilarity matrix was constructed based on the distribution of these 
accessory elements. The genomes of B. breve and B. longum did not cluster based on the origin of 
the strains (Figure 5.4), indicating that the presence/absence of accessory genes did not correlate 
according to the isolates source. Notably, the relationship of the isolates based on the accessory 
genome is consistent with observations in the pangenome analysis. Strain 30-1 and JCM 1192T, 
for example, clustered together based on the accessory elements (Figure 5.3A) and had several 
extra genes in common in the pangenome analysis. Also, vaginal strain 239-2 did not cluster with 
any other isolate based on the accessory genome analysis (Figure 5.3B), which is consistent with 
the fact that several coding sequences were missing in this strain in the pangenome analysis making 
it more different from the other isolates.  
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Figure 5.4. Accessory genome. 
Heatmap and neighbour joining tree based on Bray-Curtis distance matrix of the accessory genome 
elements. (A) B. breve; (B) B. longum. T = type strain. 
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Whole genome phylogeny  
Whole genome phylogeny of isolates was inferred based on the concatenated alignment of 
SNPs, and a maximum likelihood circular tree was created for phylogeny visualization (Figure 
5.5). The comparison of all genomes revealed a total of 1,616,032 and 1,350,284 SNPs in all B. 
breve and B. longum strains, respectively. Phylogenetic analysis indicated that vaginal B. breve 
isolates did not cluster separately from the gut isolates (Figure 5.5A). Similarly, the genomes of 
vaginal B. longum did not form a separate cluster from the genomes of gut strains (Figure 5.5B).  
 
COG distribution 
Predicted proteins were functionally categorized based on COG (Cluster of Orthologous 
Group) assignment and the proportions in each category were compared between vaginal and gut 
isolates (Figure 5.6). Most sequences in B. breve and B. longum were assigned to the ‘carbohydrate 
transport and metabolism’ category, followed by ‘amino acid transport and metabolism’ and 
‘translation, ribosomal structure and biogenesis’ categories (Figure 5.6A-B). Most importantly, 
vaginal and gut strains did not differ in terms of COG category distribution. Considering that 
carbohydrates are less abundant in quantity and variety in the vagina relative to the gut, we had 
anticipated that if vaginal isolates have genome adaptations, it would be mostly related to genes 
involved in metabolism. Previous studies have demonstrated that bifidobacteria isolated from 
different hosts have different COG distribution and are enriched with specific gene sets according 
to their niche. B. boum and B. asteroides, species usually isolated from bees, have a group of genes 
encoding oxidases involved in respiration metabolism, an adaptation for an environment richer in 
oxygen (Sun et al., 2015). Another study has shown that B. dentium isolated from the oral cavity 
has more COG assigned to the toxin-defense category relative to other enteric bifidobacteria 
(Ventura et al., 2009b). In this study, however, there was no indication that vaginal bifidobacteria, 
B. breve or B. longum, possess different proportions of genes across different COG functions. 
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Figure 5.5. Whole genome phylogeny. 
A maximum likelihood tree based on SNPs. (A) B. breve; (B) B. longum. T = type strain. 
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Figure 5.6. Clusters of Orthologous Groups (COG). 
COG function distribution among genomes of (A) B. breve and (B) B. longum. COG classification: 
[D] Cell cycle control, cell division, chromosome partitioning; [M] Cell wall/membrane/envelope 
biogenesis; [N] Cell motility; [O] Post-translational modification, protein turnover, and 
chaperones; [T] Signal transduction mechanisms; [U] Intracellular trafficking, secretion, and 
vesicular transport; [V] Defense mechanisms; [W] Extracellular structures; [Y] Nuclear structure; 
[Z] Cytoskeleton; [A] RNA processing and modification; [B] Chromatin structure and dynamics; 
[J] Translation, ribosomal structure and biogenesis; [K] Transcription; [L] Replication, 
recombination and repair; [C] Energy production and conversion; [E] Amino acid transport and 
metabolism; [F] Nucleotide transport and metabolism; [G] Carbohydrate transport and 
metabolism; [H] Coenzyme transport and metabolism; [I] Lipid transport and metabolism; 
[P] Inorganic ion transport and metabolism; [Q] Secondary metabolites biosynthesis, transport, 
and catabolism; [R] General function prediction only; [S] Function unknown; [X] Mobilome: 
prophages, transposons. 
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COG categories were also investigated in terms of number of shared and “unique” COG 
among isolates. B. breve isolates were represented by a set of 1016 COG, 489 of which were 
present in all strains (vaginal and gut origin). A total of 30 COG were exclusively present in vaginal 
isolates, i.e., they were absent in gut isolates and present in at least one vaginal isolate. Notably, 
the prevalence of these 30 “unique” COG among vaginal isolates was low, ranging from 12.5% 
(1/8) to 37.5% (3/8), suggesting it is unlikely that these rare COG represent a biologically 
significant vaginal adaptation. Similarly, a total of 34 COG were exclusively present in gut 
isolates, but their prevalence was also mostly low, ranging from 11.1% (1/9) to 33.3% (3/9), with 
only one exception: COG1396 (Transcriptional regulator, contains XRE-family HTH domain) that 
was present in 55.5% (5/9) of the gut isolates. Two additional COG showed substantial differences 
in distribution between vaginal and gut B. breve isolates. Glucan phosphorylase (COG0058) was 
present in only 12.5% (1/8) of vaginal isolates against 88.9% (8/9) of isolates of gut origin. On the 
other hand, the predicted ABC-type sugar transport system (permease component) (COG4158) 
was present in 87% (7/8) and 22.2% (2/9) of vaginal and gut isolates, respectively. 
For B. longum, a total of 1128 COG were identified, 451 of which were present in all strains 
(vaginal and gut). Although 26 COG were exclusively present in vaginal isolates, most of them 
were found in only one or two vaginal isolates, with one exception: COG3695 (Alkylated DNA 
nucleotide flippase Atl1), which was present in 55.5% (5/9) of vaginal isolates. On the other hand, 
a total of 113 COG were exclusively associated with isolates of gut origin, although their 
prevalence was also low, ranging from 5.8% (1/17) to 29.4% (5/17). The only exception was 
COG1672 (Predicted ATPase), which was found in 76.5% (13/17) of gut strains. Additionally, 5 
COG were more frequently found in gut isolates than vaginal isolates: COG0481 (Translation 
elongation factor EF-4, membrane-bound GTPase), COG0802 (tRNA A37 
threonylcarbamoyladenosine biosynthesis protein TsaE), COG1225 (Peroxiredoxin), COG0159 
(Tryptophan synthase alpha chain), and COG0732 (Restriction endonuclease S subunit). Four 
COG were more prevalent in vaginal isolates: COG1327 (Transcriptional regulator NrdR, contains 
Zn-riB.b.on and ATP-cone domains), COG0328 (Ribonuclease HI), COG1983 (Phage shock 
protein PspC (stress-responsive transcriptional regulator)), and COG0759 (Membrane-anchored 
protein YidD, putatitve component of membrane protein insertase Oxa1/YidC/SpoIIIJ). Although 
there were a few differences in COG distribution between vaginal and gut isolates, differences 
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were not systematically concentrated within function categories, and were insufficient to 
distinguish isolates from the two body sites.  
 
5.5. Conclusions 
In this study, we investigated the genomes of B. breve and B. longum from two different 
body sites of significant importance in neonatal health: gut and vagina. In all analyses, gut and 
vaginal strains of B. breve or B. longum were not distinguishable from each other based on their 
genomic content. Consistent with these observations, it has been previously demonstrated that 
several vaginal and gut Bifidobacterium spp. did not differ based on phenotypic characteristics 
related to their carbohydrate fermentation patterns, lactic acid production and tolerance to low pH 
(Freitas and Hill, 2017). Our results support the hypothesis that vaginal and gut isolates represent 
the same bacterial population with similar genetic repertoires that allow them to efficiently 
colonize both body sites. The genomes included in our study are from isolates recovered from 
individuals of different ages around the world over many years. While this provides an opportunity 
to look at these species very broadly, an obvious complementary study would be a comparison of 
gut and vaginal isolates from individual women, or paired samples from women and their babies. 
Both vaginal and gut microbiota are thought to contribute to mother-infant transmission of 
bifidobacteria, and recognition that vaginal and gut isolates represent the same population is an 
important step for future studies in maternal-neonatal health. 
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CHAPTER 6. General discussion and conclusions 
6.1. Summary and limitations of these works 
Pregnancy affects the vaginal microbiota by increasing relative abundance of lactobacilli, 
decreasing microbiota richness and diversity, and decreasing prevalence of Mollicutes 
The vaginal microbiome has been the subject of many studies over the years. These studies 
have clearly demonstrated that the vaginal microbial community influences women’s reproductive 
health. A disturbed microbiota is associated with increased susceptibility to sexually transmitted 
infections and negative reproductive outcomes. Despite advances in technology, the causes of 
disturbed microbiota are still poorly understood. In addition, most studies have focused in the 
microbiota of reproductive age, non-pregnant women. Pregnancy is associated with a variety of 
physiological events that may, or may not drive changes in the composition of the vaginal 
microbiota. Therefore, a better understanding of the vaginal microbiome in low risk pregnancy is 
necessary before further investigating the microbiota as a tool for prediction of adverse pregnancy 
outcomes. 
In the study described in Chapter 2, a baseline description of the vaginal microbiota in 
pregnant women at low risk for preterm birth was established, based on sequencing of the cpn60 
universal target. cpn60 provides higher resolution than 16S rRNA variable regions (Links et al., 
2012) and allowed the detection of novel CST that had been previously described based on the 
resolution of distinct subgroups of G. vaginalis, a hallmark bacteria in disturbed vaginal microbial 
communities (Albert et al., 2015). The relatively large sample size and the cpn60 approach are 
considered strengths that differentiate this work from other studies. Our results demonstrated that 
pregnancy was associated with decreased microbiota richness and diversity, decreased Mollicutes 
and Ureaplasma prevalence, and an increased relative abundance of lactobacilli and total bacterial 
load. These pregnancy-associated changes were hypothesized to be related to increased levels of 
estrogen that have been previously shown to increase deposition of glycogen in vaginal epithelial 
cells (BMJ, 1943; Cruickshank and Sharman, 1934). Glycogen is the main carbohydrate utilized 
by vaginal lactobacilli for the production of lactic acid (Cruickshank, 1934), which may provide a 
competitive advantage for vaginal lactobacilli and explain the greater dominance of these bacteria, 
and consequently lower prevalence of other bacteria such as Mollicutes, and overall lower richness 
and diversity in the vaginal microbiota of pregnant women in comparison to non-pregnant women. 
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One of the potential limitations of this study is the single time point collection since it does 
not provide information about possible changes in microbial composition as a function of 
gestational age. The results of this study are only applied to pregnant women early in gestation and 
it is possible that the changes in microbial composition reported here might be different for other 
gestation periods. Another limitation is the lack of information about the weight of vaginal swabs. 
The results indicated that microbiomes of pregnant women contained more total bacteria than the 
microbiomes of non-pregnant women. This might have a biological significance (increased 
glycogen may provide a more nutritious environment that supports growth of more bacteria) or 
might be simply the result of more material been collected from pregnant women in comparison 
with non-pregnant women. This question unfortunately remains unsolved since swabs were not 
weighed before DNA extraction steps. 
Increased microbiota richness and diversity is associated with preterm birth 
Imbalances in the vaginal microbiota have long been associated with negative reproductive 
outcomes such as spontaneous preterm birth, but the mechanisms underlying the association 
between a disturbed microbiota and preterm remain poorly understood. Preterm birth is a 
multifactorial condition in which an intrauterine infection ascending from the vagina is thought to 
be an important contributor to the onset of preterm labour. Nevertheless, no single bacterium or 
group of bacteria have yet been causally linked to prematurity, which demonstrates the complexity 
of this condition. 
In the study described in Chapter 3, the microbiota of women who had term and preterm 
deliveries (gestational age at delivery <37 weeks) were compared based on their microbial profiles 
generated by sequencing of the cpn60 universal target. The overall goal was to identify traits in 
the microbiota that could be further investigated as predictors of preterm birth. Results of this study 
demonstrated that the microbiota of women who experienced preterm birth had higher richness 
and diversity, and higher Mollicutes prevalence when compared to those of women who delivered 
at term. At an overall level, no specific microbial profile pattern was associated with preterm birth, 
which unfortunately does not contribute directly to the development of a diagnostic tool based on 
the microbiota for the prediction of preterm birth. Nevertheless, the increased richness and 
diversity (in the preterm cohort) might be a remnant characteristic of a previously disturbed 
microbiota, or an early indication of a microbiota shift from a healthy to a disturbed status. Either 
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way, this increased microbiota richness/diversity might be an indication that the bacterial 
community overwhelmed placental and amniotic defences and permitted ascending bacterial 
contamination of the chorioamnion, which probably led to preterm birth. 
One limitation of this study is related to single time point sample collection. Other studies 
have shown that changes in the microbiota based on microbial profile patterns are very transient 
(DiGiulio et al., 2015), which makes detection the non-Lactobacillus-dominated profiles more 
difficult if samples are not collected frequently. A longitudinal study would have provided the 
opportunity to capture transient, disturbed microbiomes that could be associated with preterm 
birth. Another limitation is the lack of extreme preterm cases. Most women in this study were 
considered late preterm (average gestational week was 34) and although this question cannot be 
addressed, it is possible that preterm driven by an ascending infection would be more evident in 
extreme preterm cases.  
Bifidobacteria can dominate the vaginal microbiota and have the potential to be as beneficial as 
lactobacilli in promoting a healthy vaginal microbiome 
The healthy vaginal microbiome is currently understood to be dominated by lactobacilli, 
and an overgrowth of any other species is often associated with unhealthy conditions. As a result 
of application of DNA sequencing based methods for microbiome characterization, an increasing 
appreciation of atypical microbiomes in healthy women has emerged, such as those dominated by 
bifidobacteria. Bifidobacteria are well known for their health promoting characteristics in the 
gastro-intestinal tract, but relatively little is known about vaginal bifidobacteria and their potential 
to promote a healthy vaginal environment.  
In the first part of this study (Chapter 4), quantitative PCR was used to confirm the relative 
abundance of Bifidobacterium in vaginal microbiomes of several women, previously determined 
by deep sequencing. Primer bias in PCR amplification for microbial profiling might 
over/underestimate specific groups of bacteria. Here, the results indicated that bifidobacteria are 
the dominant members of the vaginal microbiota in some women and that previous results based 
on deep sequencing were in fact valid. Thereafter, vaginal bifidobacteria were isolated and 
phenotypically characterized in the context of features believed to promote reproductive health. 
Most isolates were identified as B. breve or B. longum, based on identity of the cpn60 gene. Results 
demonstrated that some bifidobacteria produced levels of lactic acid similar to the beneficial 
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lactobacilli. While only 32% of isolates produced hydrogen peroxide, most vaginal bifidobacteria 
were able to tolerate high levels of lactic acid (100 mM) and low pH (4.5 or 3.9), conditions typical 
of a healthy vaginal microbiome. These results collectively demonstrated that Bifidobacterium 
spp. have the potential to be as protective as lactobacilli according to the current understanding of 
a healthy vaginal microbiome. The results also contributed to improving the definition of a healthy 
microbiome and may help to guide clinicians and researchers to better assess a healthy vaginal 
microbiome, avoiding unnecessary interventions. 
A major limitation of this study is the low number of isolates per species. A total of 8 
different bifidobacteria species were isolated and characterized, which was a good representation 
of the bifidobacteria species commonly detected in vaginal microbiome. However, only B. breve 
(n=15) and B. longum (n=11) had a significant number of isolates that could be analyzed 
statistically throughout the experiments, while results derived from remaining isolates were largely 
descriptive. Having more isolates per species would have provided more information about 
significant differences in the phenotypic characteristics among different vaginal bifidobacteria 
species. 
Vaginal and gut microbiomes are colonized by a shared community of Bifidobacterium 
Bifidobacteria colonize the human gastrointestinal tract, vagina, oral cavity and breast 
milk. They influence human physiology through gut health-promoting effects and play an 
important role as primary colonizers of the newborn gut, which contributes for the maturation of 
the neonatal immune system. Bifidobacteria are acquired both vertically (from the mother) and 
horizontally (from other humans or the environment) during and after birth. Nevertheless, the 
contribution of each maternal microbiome remains in discussion since the mere presence of 
common bacterial species does not necessarily indicate vertical transmission, and studies using 
high-resolution methods for strain characterization are still limited. 
B. breve and B. longum are both commonly detected in the human vaginal and gut 
microbiome, but it is not yet clear if they represent distinct, niche-adapted subpopulations. In this 
study (Chapter 5), the genomes of B. breve and B. longum from vaginal and gut microbiomes were 
investigated. The goal was to assess if vaginal and gut bifidobacteria represent the same 
population, which could have implications in understanding vertical transmission. Vaginal and gut 
isolates of either B. breve or B. longum did not differ in size, GC content, number of genes and 
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CRISPR. In addition, vaginal and gut isolates did not cluster separately based on average 
nucleotide identity or whole genome phylogeny analysis. They also had a similar COG category 
distribution with no evidence of differential adaptation to either body site. Therefore, the results 
of this study supported the hypothesis that the vaginal and gut microbiomes are colonized by a 
shared community of Bifidobacterium, and emphasized the importance of the maternal vaginal 
microbiome as a source of infant gut microbiota. 
Limitations of this study relate to the lack of gut and vaginal isolates from the same women 
or paired samples from women and their babies. This could provide more information about the 
contribution of each body site to bifidobacteria vertical transmission.  
 
6.2. Discussion of future prospects 
The vaginal microbiome has been studied over the past years mostly by applying culture 
dependent techniques. Advances in the development of high-throughput, next-
generation sequencing have revolutionized characterization of human vaginal microbiota. These 
culture-independent methods provide identification of bacteria at low taxonomic levels, such as 
genus and species, and allow detection of bacterial species that are difficult to culture. This 
represents a great advance for vaginal microbiome characterization studies in comparison with 
low-resolution methods like the Nugent score, which is based on Gram-stains of vaginal smears. 
Despite these technological advances, the causes of microbiome dysbiosis and its potential 
association with preterm birth are not completely understood. 
In Chapters 2 and 3 of this thesis, DNA sequencing based methods were used to investigate 
the vaginal microbiota of different cohorts. Results of these studies provided important information 
about the composition of the vaginal microbiomes of a Canadian population of healthy pregnant 
women, and pregnant women who experienced preterm birth. Nevertheless, it is known that the 
incidence of microbiome dysbiosis and preterm birth varies among women of different ethnicities 
suggesting that host factors may also play a role in influencing the microbiota and reproductive 
outcomes. Additional studies of the vaginal microbiomes of women from different geographical 
locations and ethnicities are essential to better understand the relationship among host factors, 
microbiota and reproductive outcomes. Gene-environment studies have also suggested that 
preterm birth following a bacterial infection might be host-response related. Some women may 
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hyper-respond to a uterine infection by releasing large amounts of inflammatory cytokines, which 
could potentially trigger premature labour (Hernandez-Guerrero et al., 2003; Crider et al., 2005). 
The carriage of specific maternal alleles of inflammation-related genes (e.g., TNF-2, tumour 
necrosis factor alpha gene) in combination with a disturbed vaginal microbiota has also been 
proposed as a synergistic mechanism for an higher risk of preterm birth in comparison with each 
risk factor alone (Macones et al., 2004; Gómez et al., 2010). Therefore, assessing microbiota 
composition is only one part of the equation in trying to understand what defines healthy and high-
risk microbiomes for preterm birth. Future studies investigating host and environmental factors in 
association with the microbiota could improve understanding of the causes of preterm birth and 
other negative reproductive outcomes. 
The definition of a healthy vaginal microbiota is also a limiting factor to successfully 
diagnosing women with a disturbed microbial community. The current definition is simplistic and 
out-dated, but evidence supporting a new and better definition is still limited. In Chapter 4 of this 
thesis, it was confirmed that bifidobacteria are the dominant members of some vaginal 
microbiomes and that bifidobacteria have ecological and phenotypic characteristics similar to the 
beneficial vaginal lactobacilli, such as high production of lactic acid and tolerance to low pH. In 
addition of acidifying the vaginal environment, lactobacilli have also been demonstrated to (i) be 
able to adhere to cervical and vaginal epithelial cells forming a biological barrier against 
colonization by pathogenic bacteria (Coudeyras et al., 2008), (ii) inhibit growth of urogenital 
pathogens (Atassi et al., 2006), and (iii) block pathogens adherence through process related to 
competition for vaginal epithelium receptors, displacement and co-aggregation (Osset et al., 2001; 
Castro et al., 2013; Kaewnopparat et al., 2013; Boris et al., 1998), (Kaewnopparat et al., 2013). 
Although less investigated, these characteristics represent important aspects of lactobacilli 
colonization that contribute to promoting a healthy vaginal microbiome. In vaginal bifidobacteria, 
these characteristics have not yet been assessed. In vitro studies investigating the ability of 
bifidobacteria to adhere to vaginal epithelial cells and to inhibit growth and adherence of urogenital 
pathogens are essential to confirm that bifidobacteria, like lactobacilli, contribute to vaginal 
homeostasis.  
The importance of vaginal bifidobacteria has often been overlooked, however, gut 
bifidobacteria have been extensively studied due their health promoting characteristics and 
probiotic potential in the gastro-intestinal tract. In newborns, bifidobacteria are one of the most 
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abundant members of the gut microbiota and contribute to early immune system maturation. The 
results reported in Chapter 5 of this thesis indicated that gut and vaginal microbiomes share a 
population of bifidobacteria. The comparison of genome sequences of vaginal and gut isolates 
indicated that vaginal and gut microbiomes are colonized by a shared community of 
Bifidobacterium spp., which emphasizes the contribution of the vaginal microbiota as a source of 
bacteria for the neonatal gut. The contribution of maternal microbiota is undeniable, and many 
studies have demonstrated that the gut of neonates and their mothers harbour similar 
(bifido)bacteria species, which does not necessarily mean that they were vertically transmitted. 
This gap in knowledge related to the specific contribution of each maternal microbiota in vertical 
transmission might be clarified with further studies using high-resolution methods to compare the 
bifidobacteria species, at strain level, from the same women (from gut and vagina) or from paired 
samples of women and their babies.  
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